Document:

EX-10.1

EXHIBIT 10.1

EXECUTION DOCUMENT

THIRD AMENDED AND RESTATED

REVOLVING CREDIT, TERM LOAN AND SECURITY AGREEMENT

THIS THIRD AMENDED AND RESTATED REVOLVING CREDIT, TERM LOAN AND SECURITY AGREEMENT (the
“Agreement”) dated as of April 11, 2007, is entered into among UNITED STATES PHARMACEUTICAL GROUP,
L.L.C. d/b/a NATIONSHEALTH, a Delaware limited liability company (“USPG”), NATIONSHEALTH HOLDINGS,
L.L.C., a Florida limited liability company (“NHH”), and NATIONSHEALTH, INC., a Delaware
corporation (“NationsHealth”) (jointly and severally, the “Borrower”) and CAPITALSOURCE FINANCE
LLC, a Delaware limited liability company (the “Lender”).

WHEREAS, pursuant to a certain Revolving Credit and Security Agreement by and between USPG,
NHH and Lender dated as of April 30, 2004 (the “Original Credit Agreement”), Lender made available
to USPG and NHH a revolving credit facility (the “Revolving Facility”) in a maximum principal
amount at any time outstanding of up to Ten Million Dollars ($10,000,000) (the “Facility Cap”); and

WHEREAS, USPG, NHH and Lender amended and restated the Original Credit Agreement pursuant to a
certain Amended and Restated Revolving Credit and Security Agreement by and among USPG, NHH and
Lender dated as of June 29, 2004 (the “First Restated Credit Agreement”) and a certain Second
Amended and Restated Revolving Credit and Security Agreement by and among USPG, NHH and Lender
dated March 21, 2006 (the “Second Restated Credit Agreement”); and

WHEREAS, USPG and NHH have requested that Lender further amend and restate the Second Restated
Credit Agreement to continue the Revolving Facility and to make available to Borrower a multi-draw
term loan (the “Term Loan”) in a maximum principal amount of Seven Million Dollars ($7,000,000)
(the “Term Loan Amount”); and

WHEREAS, Lender is willing to amend and restate the terms and conditions of the Second
Restated Credit Agreement to continue the Revolving Facility and make the Term Loan available to
Borrower upon the terms and subject to the conditions set forth herein;

NOW, THEREFORE, in consideration of the foregoing and for other good and valuable
consideration, the receipt and adequacy of which hereby are acknowledged, Borrower and Lender
hereby agree that the Second Restated Credit Agreement shall be amended and restated as follows:

	I.	 	DEFINITIONS

1.1 General Terms

For purposes of this Agreement, in addition to the definitions above and elsewhere in this
Agreement, the terms listed in Appendix A and Annex I hereto shall have the
meanings given such terms in Appendix A and Annex I, which are incorporated herein
and made a part hereof. All capitalized terms used which are not specifically defined herein shall
have meanings provided in Article 9 of the UCC in effect on the date hereof to the extent the same
are used or defined therein. Unless otherwise specified herein or in Appendix A, Annex
I, any agreement, contract or instrument referred to herein or in Appendix A or
Annex I shall mean such agreement, contract or instrument as modified, amended, restated or
supplemented from time to time. Unless otherwise specified, as used in the Loan Documents or in
any certificate, report, instrument or other document made or delivered pursuant to any of the Loan
Documents, all accounting terms not defined in Appendix A, Annex I or elsewhere in
this Agreement shall have the meanings given to such terms in and shall be interpreted in
accordance with GAAP.

	 	 	 	 	 	 	 
	II.	 	ADVANCES, PAYMENT AND INTEREST
	 
	 	 	 	 	 	 
	
 
	 	 	2.1	 	 	The Revolving Facility

(a) Subject to the provisions of this Agreement, Lender shall continue the Existing Advances
and make Advances to Borrower under the Revolving Facility from time to time during the Term,
provided that, notwithstanding any other provision of this Agreement, the aggregate amount
of all Advances at any one time outstanding under the Revolving Facility shall not exceed either of
(a) the Facility Cap, or (b) the Availability. The Revolving Facility is a revolving credit
facility, which may be drawn, repaid and redrawn, from time to time as permitted under this
Agreement. Any determination as to whether there is Availability for Advances shall be made by
Lender in its sole discretion and, absent demonstrable error, is final and binding upon Borrower.
Unless otherwise permitted by Lender, each Advance shall be in an amount of at least $1,000.
Subject to the provisions of this Agreement, Borrower may request Advances under the Revolving
Facility up to and including the value, in U.S. Dollars, of the sum of (i) Eighty-Five
percent (85%) of the Borrowing Base for Eligible Billed Receivables, (ii) Sixty percent (60%) of
the Borrowing Base for Eligible Unbilled Receivables, and (iii) as determined by Lender in its sole
discretion following the completion of the Inventory Field Examination, either (a) Fifty percent
(50%) of the Borrowing Base for Eligible Finished Goods Inventory valued at the lower of cost basis
or market value or (b) Eighty-Five percent (85%) of the Borrowing Base for Eligible Inventory
valued at orderly liquidation value, minus, the US Bio Reserve and, if applicable, any
other amounts adjusted or reserved pursuant to this Agreement (such calculated amount being
referred to herein as the “Availability”); provided, however, that at no time shall
more than Four Hundred Thousand Dollars ($400,000) of the Availability be comprised of Eligible
Inventory. Advances under the Revolving Facility automatically shall be made for the payment of
interest on the Advances and the Term Loan Draws and other Obligations on the date when due to the
extent available and as provided for herein. The proceeds of Advances under the Revolving Facility
shall be used by Borrower (i) as a provider of health care services, (ii) as a wholesaler,
retailer and provider of medical supplies and services, (iii) for the generation of
receivables/inventory, (iv) for the refinancing of existing indebtedness, (v) for payments to
Lender hereunder and (vi) for any other lawful purpose permitted under this Agreement.

(b) Lender has established the above-referenced advance rate for Availability and, in its sole
credit judgment, may further adjust the Availability and such advance rates by applying percentages
(known as “liquidity factors”) to Eligible Receivables by payor class based upon Borrower’s actual
recent collection history for each such payor class (i.e., Medicare, Medicaid, commercial
insurance, etc.) and to Eligible Inventory in a manner consistent with Lender’s underwriting
practices and procedures, including without limitation Lender’s review and analysis of, among other
things, Borrower’s historical returns, rebates, discounts, credits and allowances (collectively,
the “Dilution Items”). Such liquidity factors and the advance rate for Availability may be
adjusted by Lender throughout the Term as warranted by Lender’s underwriting practices and
procedures in its sole credit judgment. Also, Lender shall have the right to establish from time
to time, in its sole credit judgment, reserves against the Borrowing Base, which reserves shall
have the effect of reducing the amounts otherwise eligible to be disbursed to Borrower under the
Revolving Facility pursuant to this Agreement.

2.2 Revolving Facility Maturity Date

All amounts outstanding under the Revolving Facility and other Obligations relating to
Advances shall be due and payable in full, if not earlier in accordance with this Agreement, on the
earlier of (i) the occurrence and continuance of an Event of Default if required pursuant hereto or
Lender’s demand upon the occurrence and continuance of an Event of Default, and (ii) the last day
of the Term (such earlier date being the “Revolving Facility Maturity Date”).

2.3 Revolving Facility Disbursements; Requirement to Deliver Borrowing Certificate

So long as no Default or Event of Default shall have occurred and be continuing, Borrower may
give Lender irrevocable written notice requesting an Advance under the Revolving Facility by
delivering to Lender not later than 11:00 a.m. (Eastern Standard Time) at least one (1) but not
more than four (4) Business Days before the proposed borrowing date of such requested Advance (the
“Borrowing Date”), a completed Borrowing Certificate and relevant supporting documentation
satisfactory to Lender, which shall (i) specify the proposed Borrowing Date of such Advance which
shall be a Business Day, (ii) specify the principal amount of such requested Advance, (iii) certify
the matters contained in Section 4.2, and (iv) specify the amount of any Medicare or
Medicaid recoupments and/or recoupments of any third-party payor being sought, requested or
claimed, or, to Borrower’s knowledge, threatened against Borrower or Borrower’s Affiliates. Each
time a request for an Advance is made, and, in any event and regardless of whether an Advance is
being requested, on Tuesday of each week during the Term (and so long as a Default or Event of
Default exists, more frequently if Lender shall so request) until the Obligations are indefeasibly
paid in cash in full and this Agreement is terminated, Borrower shall deliver to Lender a Borrowing
Certificate accompanied by a separate detailed aging and categorizing of Borrower’s accounts
receivable and accounts payable and such other supporting documentation with respect to the figures
and information in the Borrowing Certificate as Lender shall reasonably request from a credit or
security perspective or otherwise. On each Borrowing Date, Borrower irrevocably authorizes Lender
to disburse the proceeds of the requested Advance to the appropriate Borrower’s account(s) as set
forth on Schedule 2.4, in all cases for credit to the appropriate Borrower (or to such
other account as to which the appropriate Borrower shall instruct Lender) via Federal funds wire
transfer no later than 4:00 p.m. (Eastern Standard Time). Notwithstanding any provision of this
Agreement to the contrary, if the average outstanding balance under the Revolving Facility during
any calendar month is less than Two Million Five Hundred Thousand Dollars ($2,500,000) Borrower
acknowledges and agrees that Lender shall be entitled to calculate interest and fees hereunder,
including without limitation, the calculations set forth in Sections 2.4, 3.1 and 3.5, as
if the average outstanding balance for such calendar month was Two Million Five Hundred Thousand
Dollars ($2,500,000). Notwithstanding the requirement of Borrower delivering a Borrowing
Certificate in connection with each requested Advance, Borrower may give Lender irrevocable written
notice requesting an Advance under the Revolving Facility in an amount necessary to make the total
outstanding Advances at such time equal Two Million Five Hundred Thousand Dollars ($2,500,000), and
so long as (i) no Default or Event of Default shall have occurred and be continuing, and (ii)
Lender has a Borrowing Certificate that its not more than four (4) Business Days before the
proposed borrowing date of such requested Advance, subject to Availability, Lender shall disburse
the proceeds of such requested Advance.

2.4 Revolving Facility Collections; Repayment; Borrowing Availability and Lockbox

Each Borrower shall maintain one or more lockbox accounts (individually and collectively, the
“Lockbox Account”) with one or more banks acceptable to Lender (each, a “Lockbox Bank”), and shall
execute with each Lockbox Bank one or more agreements acceptable to Lender (individually and
collectively, the “Lockbox Agreement”), and such other agreements related thereto as Lender may
require. Each Borrower shall ensure that all collections of their respective Accounts and all
other cash payments received by any Borrower, including CIGNA Receipts, are paid and delivered
directly from Account Debtors and other Persons into the appropriate Lockbox Account. The Lockbox
Agreements shall provide that the Lockbox Banks will transfer on the same Business Day all funds
paid into the Lockbox Accounts into a depository account or accounts maintained by Lender or an
Affiliate of Lender at such bank as Lender may communicate to Borrower and the applicable Lockbox
Bank from time to time in accordance with the Lockbox Agreement (the “Concentration Account”),
except, with respect only to Accounts payable by Medicaid/Medicare Account Debtors, as instructed
by the applicable Borrower to whom such Accounts are payable as permitted pursuant to the
applicable Lockbox Agreement. Notwithstanding and without limiting any other provision of any Loan
Document, Lender shall apply, on a daily basis, all funds transferred into the Concentration
Account pursuant to the Lockbox Agreement and this Section 2.4 in such order and manner as
determined by Lender. To the extent that any Accounts are collected by any Borrower or any other
cash payments received by any Borrower are not sent directly to the appropriate Lockbox Account but
are received by any Borrower or any of their Affiliates, such collections and proceeds shall be
held in trust for the benefit of Lender and immediately remitted (and in any event within two (2)
Business Days), in the form received, to the appropriate Lockbox Account for immediate transfer to
the Concentration Account. Borrower acknowledges and agrees that compliance with the terms of this
Section 2.4 is an essential term of this Agreement, and that, in addition to and
notwithstanding any other rights Lender may have hereunder, under any other Loan Document, under
applicable law or at equity, upon each and every failure by any Borrower or any of their Affiliates
to comply with any such terms Lender shall be entitled to assess a non-compliance fee which shall
operate to increase the Applicable Rate by two percent (2.0%) per annum during any period of
non-compliance, whether or not a Default or an Event of Default occurs or is declared, provided
that nothing shall prevent Lender from considering any failure to comply with the terms of this
Section 2.4 to be a Default or an Event of Default. All funds transferred to the
Concentration Account for application to the Obligations under the Revolving Facility shall be
applied to reduce the Obligations under the Revolving Facility, but, for purposes of calculating
interest hereunder shall be subject to a five (5) Business Day clearance period. If as the result
of collections of Accounts and/or any other cash payments received by any Borrower pursuant to this
Section 2.4 a credit balance exists with respect to the Concentration Account, such credit
balance shall not accrue interest in favor of a Borrower, but shall be available to Borrower upon
Borrower’s written request. If applicable, at any time prior to the execution of all or any of the
Lockbox Agreements and operation of all or any of the Lockbox Accounts, each Borrower and their
Affiliates shall direct all collections or proceeds it receives on Accounts or from other
Collateral to the accounts(s) and in the manner specified by Lender in its sole discretion.

2.5 The Term Loan Facility

Subject to the terms and conditions set forth in this Agreement, Lender agrees to make the
Term Loan available to Borrower, so that as long as no Default or Event of Default has occurred or
is continuing, Borrower may, commencing as of the Restatement Date from time to time prior to the
close of business on the Term Loan Draw Termination Date, borrow, in one or more Term Loan Draws,
an amount which does not to exceed in the aggregate the Term Loan Amount; provided, however, that
until the receipt and approval by Lender of the Initial Appraisal, Lender shall only be obligated
to make (i) a Term Loan Draw in the amount of $1,500,000 on the Restatement Date to fund the
Minimum Liquidity Amount and (ii) subsequent Term Loan Draws not to exceed the amount of $2,000,000
in the aggregate (exclusive of the Term Loan Draw referenced in clause (i) of this proviso) to fund
Diabetes Business Acquisitions permitted under this Agreement. So long as no Default or Event of
Default shall have occurred and be continuing, Borrower may give Lender irrevocable written notice
requesting a Term Loan Draw by delivering to Lender not later than 11:00 a.m. (Eastern Standard
Time) at least one (1) but not more than four (4) Business Days before the proposed borrowing date
of such requested Term Loan Draw (the “Term Loan Borrowing Date”), a completed Borrowing
Certificate and relevant supporting documentation satisfactory to Lender, which shall (i) specify
the proposed Term Loan Borrowing Date which shall be a Business Day, (ii) specify the principal
amount of such requested Term Loan Draw, (iii) certify the matters contained in Section 4.2 and
Section 4.3. Subject to contrary written instructions from Borrower, each Term Loan Draw shall
be disbursed on the applicable Term Loan Borrowing Date to the appropriate Borrower’s account(s) as
set forth on Schedule 2.4. The Term Loan is not a revolving credit facility, and any
repayments of principal shall be applied to permanently reduce the Term Loan. The proceeds of the
Term Loan shall be used solely to fund the Minimum Liquidity Amount on the Restatement Date and to
finance the purchase price for, and the reasonable fees, expenses and costs, incurred by Borrower
in connection with the acquisition of Diabetes Customer Lists as permitted under this Agreement.

	 	2.6	 	Repayment of Term Loan; Maturity

Payment of the outstanding principal balance of the Term Loan (in addition to the interest
payments in Section 3.2) and all other amounts (other than interest) outstanding under the
Term Loan shall be made as follows:

(a) Commencing on January 1, 2008 (the “Initial Principal Repayment Date”), and continuing on
the first day of each calendar month thereafter, the outstanding principal amount of the Term Loan
as of the Initial Principal Repayment Date, together with accrued and unpaid interest thereon,
shall be payable in twenty nine (29) consecutive monthly installments, the first twenty eight (28)
of such installments to be calculated on a straightline basis according to an amortization schedule
of twenty nine (29) months and, if not sooner paid, the twenty ninth (29th) and final
installment of the then unpaid principal amount of the Term Loan, together with accrued and unpaid
interest thereon and all other amounts due and owing under this Agreement with respect to the Term
Loan, shall be due and payable on the last day of the Term.

(b) All Term Loan Obligations shall be due and payable in full, if not earlier in accordance
with this Agreement, on the earlier of (i) the occurrence and continuance of an Event of Default if
required pursuant hereto or Lender’s demand upon the occurrence and continuance of an Event of
Default, (ii) a Revolver Termination and (iii) the last day of the Term, the earlier of the
foregoing (i), (ii) or (iii) being the “Term Loan Maturity Date”.

2.7 Promise to Pay; Manner of Payment

Borrower absolutely and unconditionally promises to pay principal, interest and all other
amounts payable hereunder, or under any other Loan Document, without any right of rescission and
without any deduction whatsoever, including any deduction for any setoff, counterclaim or
recoupment, and notwithstanding any damage to, defects in or destruction of the Collateral or any
other event, including obsolescence of any property or improvements. All payments made by Borrower
(other than payments automatically paid through Advances under the Revolving Facility as provided
herein), shall be made only by wire transfer on the date when due, without offset or counterclaim,
in U.S. Dollars, in immediately available funds to such account as may be indicated in writing by
Lender to Borrower from time to time. Any such payment received after 2:00 p.m. (Eastern Standard
Time) on the date when due shall be deemed received on the following Business Day. Whenever any
payment hereunder shall be stated to be due or shall become due and payable on a day other than a
Business Day, the due date thereof shall be extended to, and such payment shall be made on, the
next succeeding Business Day, and such extension of time in such case shall be included in the
computation of payment of any interest (at the interest rate then in effect during such extension)
and/or fees, as the case may be.

2.8 Repayment of Excess Advances

Any balance of Advances under the Revolving Facility outstanding at any time in excess of the
lesser of the Facility Cap or the Availability shall be immediately due and payable by Borrower
without the necessity of any demand, at the Payment Office, whether or not a Default or Event of
Default has occurred or is continuing and shall be paid in the manner specified in Section
2.7.

2.9 Payments by Lender

Should any amount required to be paid under any Loan Document be unpaid, such amount may be
paid by Lender, which payment shall be deemed a request for an Advance under the Revolving Facility
as of the date such payment is due, and Borrower irrevocably authorizes disbursement of any such
funds to Lender by way of direct payment of the relevant amount, interest or Obligations. No
payment or prepayment of any amount by Lender or any other Person shall entitle any Person to be
subrogated to the rights of Lender under any Loan Document unless and until the Obligations have
been fully performed and paid irrevocably in cash and this Agreement has been terminated. Any sums
expended by Lender as a result of any Borrower’s or any Guarantor’s failure to pay, perform or
comply with any Loan Document or any of the Obligations may be charged to Borrower’s account as an
Advance under the Revolving Facility and added to the Obligations.

2.10 Evidence of Loans

(a) Lender shall maintain, in accordance with its usual practice, electronic or written
records evidencing the Indebtedness and Obligations to Lender resulting from each Loan made by
Lender from time to time, including without limitation, the amounts of principal and interest
payable and paid to Lender from time to time under this Agreement. Lender and Borrower acknowledge
and agree that the Existing Advances under the Revolving Facility have been evidenced by certain
Revolving Notes dated April 30, 2004 in the aggregate principal amount of Ten Million Dollars
($10,000,000) (the “Existing Revolving Notes”). Lender and Borrower acknowledge and agree that (i)
the Existing Revolving Notes shall be cancelled by Lender and returned to Borrower as of the
Restatement Date but that the cancellation of the Existing Revolving Notes shall not constitute a
novation of the Existing Advances or any other amounts evidenced thereby and (ii) all Advances
(including the Existing Advances) shall as of the Restatement Date be evidenced as provided in this
Section 2.10(a).

(b) The entries made in the electronic or written records maintained pursuant to subsection
(a) of this Section 2.10 (the “Register”) shall be prima facie evidence, absent manifest
error, of the existence and amounts of the Obligations and Indebtedness therein recorded;
provided however, that the failure of Lender to maintain such records or any error
therein shall not in any manner affect the joint and several obligations of Credit Parties to repay
the Loans or Obligations in accordance with their terms.

(c) Lender will account to Borrower monthly with a statement of Advances under the Revolving
Facility, and any charges and payments made pursuant to this Agreement, and in the absence of
manifest error, such accounting rendered by Lender shall be deemed final, binding and conclusive
unless Lender is notified by Borrower in writing to the contrary within fifteen calendar days of
Receipt of such accounting, which notice shall be deemed an objection only to items specifically
objected to therein.

(d) Borrower agrees that:

(i) upon written notice by Lender to Borrower that a Note or other evidence of Indebtedness is
requested by Lender to evidence the Loans and other Obligations owing or payable to, or to be made
by, Lender, Borrower shall promptly (and in any event within three (3) Business Days of any such
request) execute and deliver to Lender an appropriate Note or Notes in form and substance
reasonably acceptable to Lender and Borrower;

(ii) all references to Notes in the Loan Documents shall mean Notes, if any, to the extent
issued (and not returned to Borrower for cancellation) hereunder, as the same may be amended,
modified, divided, supplemented, extended or restated from time to time; and

(iii) upon Lender’s written request, and in any event within three (3) Business Days of any
such request, Borrower shall execute and deliver to Lender new Notes and divide the Notes in
exchange for then existing Notes in such smaller amounts or denominations as Lender shall specify
in its sole and absolute discretion; provided, that the aggregate principal amount of such
new Notes shall not exceed the aggregate principal amount of the Notes outstanding at the time such
request is made; and provided, further, that such Notes that are to be replaced shall then be
deemed no longer outstanding hereunder and replaced by such new Notes and returned to Borrower
within a reasonable period of time after Lender’s receipt of the replacement Notes.

2.11 Grant of Security Interest; Collateral

(a) To secure the payment and performance of the Obligations, each Borrower hereby grants to
Lender a continuing security interest in and Lien upon, and pledges to Lender, all of its right,
title and interest in and to the following (collectively and each individually, the “Collateral”),
which security interest is intended to be a first priority security interest:

(i) all of such Borrower’s tangible personal property, including without limitation all
present and future Inventory and Equipment (including items of equipment which are or become
Fixtures), now owned or hereafter acquired;

(ii) all of such Borrower’s intangible personal property, including without limitation all
present and future Accounts, contract rights, Permits, General Intangibles, Chattel Paper,
Documents, Instruments, Deposit Accounts, Investment Property, Letter-of-Credit Rights, Supporting
Obligations, rights to the payment of money or other forms of consideration of any kind, tax
refunds, insurance proceeds, now owned or hereafter acquired, and all intangible and tangible
personal property relating to or arising out of any of the foregoing;

(iii) all of such Borrower’s present and future Government Contracts and rights thereunder and
the related Government Accounts and proceeds thereof, now or hereafter owned or acquired by such
Borrower; provided, however, that Lender shall not have a security interest in any
rights under any Government Contract of such Borrower or in the related Government Account where
the taking of such security interest is a violation of an express prohibition contained in the
Government Contract (for purposes of this limitation, the fact that a Government Contract is
subject to, or otherwise refers to, Title 31, § 203 or Title 41, § 15 of the United States Code
shall not be deemed an express prohibition against assignment thereof) or is prohibited by
applicable law, unless in any case consent is otherwise validly obtained; and

(iv) any and all additions and accessions to any of the foregoing, and any and all
replacements, products and proceeds (including insurance proceeds) of any of the foregoing.

(b) Notwithstanding the foregoing provisions of this Section 2.11, such grant of a
security interest shall not extend to, and the term “Collateral” shall not include, any General
Intangibles of Borrower to the extent that (i) such General Intangibles are not assignable or
capable of being encumbered as a matter of law or under the terms of any license or other agreement
applicable thereto (but solely to the extent that any such restriction shall be enforceable under
applicable law) without the consent of the licensor thereof or other applicable party thereto, and
(ii) such consent has not been obtained; provided, however, that the foregoing
grant of a security interest shall extend to, and the term “Collateral” shall include, each of the
following: (a) any General Intangible which is in the nature of an Account or a right to the
payment of money or a proceed of, or otherwise related to the enforcement or collection of, any
Account or right to the payment of money, or goods which are the subject of any Account or right to
the payment of money, (b) any and all proceeds of any General Intangible that is otherwise excluded
to the extent that the assignment, pledge or encumbrance of such proceeds is not so restricted, and
(c) upon obtaining the consent of any such licensor or other applicable party with respect to any
such otherwise excluded General Intangible, such General Intangible as well as any and all proceeds
thereof that might theretofore have been excluded from such grant of a security interest and from
the term “Collateral.”

(c) Upon the execution and delivery of this Agreement, and upon the proper filing of the
necessary financing statements, recordation of the Collateral Patent, Trademark and Copyright
Assignment in the United States Patent and Trademark Office and/or the United States Copyright
Office without any further action, Lender will have a good, valid and perfected first priority Lien
and security interest in the Collateral, subject to no transfer or other restrictions or Liens of
any kind in favor of any other Person except for Permitted Liens. No financing statement relating
to any of the Collateral is on file in any public office except those (i) on behalf of Lender, (ii)
in connection with Permitted Liens and/or (iii) those being terminated.

2.12 Collateral Administration

(a) All Collateral (except Deposit Accounts) will at all times be kept by Borrower at the
locations set forth on Schedule 5.18B hereto and shall not, without thirty (30) calendar
days prior written notice to Lender, be moved therefrom unless Lender has entered into the
necessary documents to perfect and enforce its security interest therein at such new location, and
in any case shall not be moved outside the continental United States.

(b) Borrower shall keep accurate and complete records of its Accounts and all payments and
collections thereon and shall submit such records to Lender on such periodic bases as Lender may
request. In addition, if Accounts of Borrower in an aggregate face amount in excess of $30,000
become ineligible because they fall within one of the specified categories of ineligibility set
forth in the definition of Eligible Receivables, Borrower shall notify Lender of such occurrence on
the first Business Day following such occurrence and the Borrowing Base shall thereupon be adjusted
to reflect such occurrence. Following the occurrence and during the continuance of an Event of
Default, if requested by Lender, Borrower shall execute and deliver to Lender formal written
assignments (or, in the case of Medicaid/Medicare Account Debtors, documents necessary to comply
with the Federal Assignment of Claims Act) of all of its Accounts weekly or daily as Lender may
request, including all Accounts created since the date of the last assignment, together with copies
of claims, invoices and/or other information related thereto. To the extent that collections from
such assigned accounts exceed the amount of the Obligations, such excess amount shall not accrue
interest in favor of Borrower, but shall be available to Borrower upon Borrower’s written request.

(c) Following an occurrence or during the continuance of an Event of Default, any of Lender’s
officers, employees, representatives or agents shall have the right, at any time during normal
business hours, in the name of Lender, any designee of Lender or Borrower, to verify the validity,
amount or any other matter relating to any Accounts or Inventory of Borrower. Borrower shall
cooperate fully with Lender in an effort to facilitate and promptly conclude such verification
process.

(d) To expedite collection, Borrower shall endeavor in the first instance to make collection
of its Accounts for Lender. Lender shall have the right at all times after the occurrence and
during the continuance of an Event of Default to notify (i) Account Debtors owing Accounts to
Borrower other than Medicaid/Medicare Account Debtors that their Accounts have been assigned to
Lender and to collect such Accounts directly in its own name and to charge collection costs and
expenses, including reasonable attorney’s fees, to Borrower, and (ii) Medicaid/Medicare Account
Debtors that Borrower has waived any and all defenses and counterclaims it may have or could
interpose in any such action or procedure brought by Lender to obtain a court order recognizing the
collateral assignment or security interest and lien of Lender in and to any Account or other
Collateral and that Lender is seeking or may seek to obtain a court order recognizing the
collateral assignment or security interest and lien of Lender in and to all Accounts and other
Collateral payable by Medicaid/Medicare Account Debtors.

(e) As and when determined by Lender in its sole discretion but not more often than four (4)
times per year prior to the occurrence and continuance of an Event of Default, Lender will perform
the searches described in clauses (i) and (ii) below against Borrower (the results of which are to
be consistent with Borrower’s representations and warranties under this Agreement), all at
Borrower’s expense: (i) UCC searches with the Secretary of State of the jurisdiction of
organization of each Borrower and Guarantor and the Secretary of State and local filing offices of
each jurisdiction where each Borrower and/or any Guarantors maintain their respective executive
offices, a place of business or assets; (ii) lien searches with the United States Patent and
Trademark Office and the United States Copyright Office; and (iii) judgment, federal tax lien and
corporate and partnership tax lien searches, in each jurisdiction searched under clause (i) above.

(f) Borrower (i) shall provide prompt written notice to its current bank to transfer all
items, collections and remittances to the Concentration Account, (ii) shall provide prompt written
notice to each Account Debtor (other than Medicaid/Medicare Account Debtors) that Lender has been
granted a lien and security interest in, upon and to all Accounts applicable to such Account Debtor
and shall direct each Account Debtor to make payments to the appropriate Lockbox Account, and
Borrower hereby authorizes Lender, upon any failure to send such notices and directions within ten
(10) calendar days after the date of this Agreement (or ten (10) calendar days after the Person
becomes an Account Debtor), to send any and all similar notices and directions to such Account
Debtors, and (iii) shall do anything further that may be lawfully required by Lender to create and
perfect Lender’s lien on any collateral and effectuate the intentions of the Loan Documents. At
Lender’s request, Borrower shall immediately deliver or make arrangements to deliver to Lender all
items for which Lender must receive possession to obtain a perfected security interest and all
notes, certificates, and documents of title, Chattel Paper, warehouse receipts, Instruments, and
any other similar instruments constituting Collateral.

2.13 Power of Attorney

Lender is hereby irrevocably made, constituted and appointed the true and lawful attorney for
Borrower (without requiring Lender to act as such) with full power of substitution to do the
following: (i) endorse the name of any such Person upon any and all checks, drafts, money orders,
and other instruments for the payment of money that are payable to such Person and constitute
collections on its or their Accounts; (ii) execute in the name of such Person any financing
statements, schedules, assignments, instruments, documents, and statements that it is or they or
are obligated to give Lender under any of the Loan Documents; and (iii) do such other and further
acts and deeds in the name of such Person that Lender may deem necessary or desirable to enforce
any Account or other Collateral or to perfect Lender’s security interest or lien in any Collateral.
In addition, if any such Person breaches its obligation hereunder to direct payments of Accounts
or the proceeds of any other Collateral to the appropriate Lockbox Account, Lender, as the
irrevocably made, constituted and appointed true and lawful attorney for such Person pursuant to
this paragraph, may, by the signature or other act of any of Lender’s officers or authorized
signatories (without requiring any of them to do so), direct any federal, state or private payor or
fiscal intermediary to pay proceeds of Accounts or any other Collateral to the appropriate Lockbox
Account.

	 	 	 	 	 	 	 
	III.	 	INTEREST, FEES AND OTHER CHARGES
	 
	 	 	 	 	 	 
	
 
	 	 	3.1	 	 	Interest on the Revolving Facility

Commencing May 1, 2007, and continuing until the later of the expiration of the Term and the
Payment in Full and full performance of all of the Obligations and termination of this Agreement
interest on outstanding Advances under the Revolving Facility shall be payable monthly in arrears
on the first day of each calendar month at an annual rate of Prime Rate plus 2.5% in accordance
with the procedures provided for in Section 2.7 and Section 2.4, provided
however, that, notwithstanding any provision of any Loan Document, for the purpose of
calculating interest at any time hereunder, the Prime Rate shall be not less than 4%, in each case
calculated on the basis of a 360-day year and for the actual number of calendar days elapsed in
each interest calculation period. The payment due under this Section 3.1 on May 1, 2007
shall include any accrued and unpaid interest on outstanding Advances under the Revolving Facility
existing under the Second Restated Credit Agreement.

3.2 Interest on the Term Loan

Commencing May 1, 2007, and continuing until the later of the expiration of the Term and the
Payment in Full and full performance of all of the Obligations and termination of this Agreement
interest on the outstanding principal balance of the Term Loan shall be payable monthly in arrears
on the first day of each calendar month at an annual rate of Prime Rate plus 1.0% in accordance
with the procedures provided for in Section 2.7 and Section 2.4., provided
however, that, notwithstanding any provision of any Loan Document, for the purpose of
calculating interest at any time hereunder, the Prime Rate shall be not less than 4%, in each case
calculated on the basis of a 360-day year and for the actual number of calendar days elapsed in
each interest calculation period. Advances under the Revolving Facility shall be made automatically
for the payment of Obligations under the Term Loan on the date when due to the extent available and
as provided for herein. 

3.3 Commitment Fees and Amended and Restated Equity Participation Fee

(a) Borrower acknowledges that it is obligated to pay (and does hereby agree to pay) the
final installment of One Hundred Thousand Dollars ($100,000) in respect of non-refundable
restatement fee which Borrower agreed to pay under Section 3.1 of the Second Restated Credit
Agreement on March 21, 2008. Borrower acknowledges and agrees that such installment shall be
immediately due and payable upon the termination of this Agreement (whether at maturity, by reason
of acceleration, by notice of intention to prepay, by required prepayment or otherwise).

(b) In consideration of the making of the Term Loan, Borrower hereby agrees to pay a
non-refundable commitment fee in the amount of One Hundred Five Thousand Dollars ($105,000) on the
Restatement Date.

(c) In consideration of the making of the Term Loan, Borrower hereby agrees to execute and
deliver the Equity Participation Fee Agreement as of the Restatement Date and obligated itself to
pay the fee set forth therein in accordance with the terms and conditions of the Equity
Participation Fee Agreement.

3.4 Unused Line Fee

Borrower shall pay to Lender monthly an unused line fee (the “Unused Line Fee”) in an amount
equal to 0.04167% (per month) of the difference derived by subtracting (i) the daily average amount
of the balances under the Revolving Facility outstanding during the preceding month, from (ii) the
Facility Cap. The Unused Line Fee shall be payable monthly in arrears on the first day of each
successive calendar month commencing May 1, 2007 (which monthly payment shall include any accrued
and unpaid Unused Line Fee existing under the Second Restated Credit Agreement).

3.5 Collateral Management Fee

Borrower shall pay Lender as additional interest a monthly collateral management fee (the
“Collateral Management Fee”) equal to 0.0833% per month calculated on the basis of the daily
average amount of the balances under the Revolving Facility outstanding during the preceding month.
The Collateral Management Fee shall be payable monthly in arrears on the first day of each
successive calendar month commencing May 1, 2007 (which monthly payment shall include any accrued
and unpaid Collateral Management Fee existing under the Second Restated Credit Agreement).

3.6 Computation of Fees; Lawful Limits

All fees hereunder shall be computed on the basis of a year of 360 days and for the actual
number of days elapsed in each calculation period, as applicable. In no contingency or event
whatsoever, whether by reason of acceleration or otherwise, shall the interest and other charges
paid or agreed to be paid to Lender for the use, forbearance or detention of money hereunder exceed
the maximum rate permissible under applicable law which a court of competent jurisdiction shall, in
a final determination, deem applicable hereto. If, due to any circumstance whatsoever, fulfillment
of any provision hereof, at the time performance of such provision shall be due, shall exceed any
such limit, then, the obligation to be so fulfilled shall be reduced to such lawful limit, and, if
Lender shall have received interest or any other charges of any kind which might be deemed to be
interest under applicable law in excess of the maximum lawful rate, then such excess shall be
applied first to any unpaid fees and charges hereunder, then to unpaid principal balance owed by
Borrower hereunder, and if the then remaining excess interest is greater than the previously unpaid
principal balance, Lender shall promptly refund such excess amount to Borrower and the provisions
hereof shall be deemed amended to provide for such permissible rate. The terms and provisions of
this Section 3.6 shall control to the extent any other provision of any Loan Document is
inconsistent herewith.

3.7 Default Rate of Interest

Upon the occurrence and during the continuation of an Event of Default, the Applicable Rate of
interest in effect at such time with respect to the Obligations shall be increased by 3.0% per
annum (the “Default Rate”).

3.8 Acknowledgement of Joint and Several Liability

Each Borrower acknowledges that it is jointly and severally liable for all of the Obligations
under the Loan Documents. Each Borrower expressly understands, agrees and acknowledges that (i)
they are all affiliated entities by common ownership, (ii) each Borrower desires to have the
availability of one common credit facility instead of separate credit facilities, (iii) each
Borrower has requested that Lender extend such a common credit facility on the terms herein
provided, (iv) Lender will be lending against, and relying on a lien upon, all of Borrower’s assets
even though the proceeds of any particular loan made hereunder may not be advanced directly to a
particular Borrower, (v) each Borrower will nonetheless benefit by the making of all such loans by
Lender and the availability of a single credit facility of a size greater than each could
independently warrant, and (vi) all of the representations, warranties, covenants, obligations,
conditions, agreements and other terms contained in the Loan Documents shall be applicable to and
shall be binding upon each Borrower.

	 	 	 	 	 
	IV.

	 	CONDITIONS PRECEDENT

4.1
	 	

Conditions to Advances on or after Restatement Date

The obligations of Lender to consummate the transactions contemplated herein and to make
Advances and Term Loan Draws on or after the Restatement Date are subject to the satisfaction, in
the sole judgment of Lender, of the following:

(a) (i) Borrower shall have delivered to Lender this Agreement and, if required by Lender,
amendments to, or confirmations of, any of the other Loan Documents, each duly executed by an
authorized officer of Borrower and the other parties thereto;

(b) all in form and substance satisfactory to Lender in its sole discretion, Lender shall have
received (i) a report of Uniform Commercial Code financing statement, tax and judgment lien
searches performed with respect to Borrower and Guarantor, if any, in each jurisdiction determined
by Lender in its sole discretion, and such report shall show no Liens on the Collateral (other than
Permitted Liens), (ii) each document (including, without limitation, any Uniform Commercial Code
financing statement) required by any Loan Document or under law or requested by Lender to be filed,
registered or recorded to create or continue in favor of Lender, a perfected first priority
security interest upon the Collateral, and (iii) evidence of each such filing, registration or
recordation and of the payment by Borrower of any necessary fee, tax or expense relating thereto;

(c) Lender shall have received (i) the Charter and Good Standing Documents, all in form and
substance acceptable to Lender, (ii) a certificate of the corporate secretary or assistant
secretary of each Borrower dated the Restatement Date, as to the incumbency and signature of the
Persons executing this Agreement, in form and substance acceptable to Lender, and (iii) the written
legal opinion of counsel for Borrower in form and substance satisfactory to Lender and its counsel;

(d) Lender shall have received a certificate of the chief financial officer (or, in the
absence of a chief financial officer, the chief executive officer) of each Borrower, in form and
substance satisfactory to Lender (each, a “Solvency Certificate”), certifying (i) the solvency of
such Person after giving effect to the transactions and the Indebtedness contemplated by the Loan
Documents, and (ii) as to such Person’s financial resources and ability to meet its obligations and
liabilities as they become due, to the effect that as of the Restatement Date and after giving
effect to such transactions and Indebtedness: (A) the assets of such Person, at a Fair Valuation,
exceed the total liabilities (including contingent, subordinated, unmatured and unliquidated
liabilities) of such Person, and (B) no unreasonably small capital base with which to engage in its
anticipated business exists with respect to such Person;

(e) Lender shall have completed examinations, the results of which shall be satisfactory in
form and substance to Lender, of the Collateral, the financial statements and the books, records,
business, obligations, financial condition and operational state of Borrower and Guarantor, and
each such Person shall have demonstrated to Lender’s satisfaction that (i) its operations comply,
in all respects deemed material by Lender, in its sole judgment, with all applicable federal,
state, foreign and local laws, statutes and regulations, (ii) its operations are not the subject of
any governmental investigation, evaluation or any remedial action which could result in any
expenditure or liability deemed material by Lender, in its sole judgment, and (iii) it has no
liability (whether contingent or otherwise) that is deemed material by Lender, in its sole
judgment;

(f) all in form and substance satisfactory to Lender in its sole discretion, Lender shall have
received such consents, approvals and agreements, including, without limitation, any applicable
Landlord Waivers and Consents with respect to any and all leases set forth on Schedule 5.4,
from such third parties as Lender and its counsel shall determine are necessary or desirable with
respect to (i) the Loan Documents and/or the transactions contemplated thereby, and/or (ii) claims
against Borrower or Guarantor or the Collateral;

(g) Borrower shall be in compliance with Section 6.5, and Lender shall have received
copies of all insurance policies or binders, original certificates of all insurance policies of
Borrower confirming that they are in effect and that the premiums due and owing with respect
thereto have been paid in full and naming Lender as loss payee or additional insured, as
appropriate;

(h) Lender shall have received all fees, charges and expenses payable to Lender on or prior to
the Restatement Date pursuant to the Loan Documents;

(i) all corporate and other proceedings, documents, instruments and other legal matters in
connection with the transactions contemplated by the Loan Documents (including, but not limited to,
those relating to corporate and capital structures of Borrower) shall be satisfactory to Lender;

(j) Borrower shall have executed and filed an updated IRS Form 8821 with the appropriate
office of the Internal Revenue Service;

(k) Borrower shall have funded the Minimum Liquidity Amount into the Minimum Liquidity
Account; and

(l) Lender shall have received such other documents, certificates, information or legal
opinions as Lender may reasonably request, all in form and substance reasonably satisfactory to
Lender.

4.2 Conditions to Each Advance

The obligations of Lender to make any Advance are subject to the satisfaction, in the
Permitted Discretion of Lender, of the following additional conditions precedent:

(a) Borrower shall have delivered to Lender a Borrowing Certificate for the Advance executed
by an authorized officer of Borrower, which shall constitute a representation and warranty by
Borrower as of the Borrowing Date of such Advance that the conditions contained in this Section
4.2 have been satisfied; provided, however, that any determination as to
whether the conditions contained in this Section 4.2 and the other conditions set forth in
this Agreement to Lender’s obligation to make Advances have been satisfied shall be made by Lender
in its Permitted Discretion;

(b) each of the representations and warranties made by Borrower in or pursuant to this
Agreement shall be accurate, before and after giving effect to such Advance, and no Default or
Event of Default shall have occurred or be continuing or would exist after giving effect to the
Advance under the Revolving Facility on such date;

(c) immediately after giving effect to the requested Advance, the aggregate outstanding
principal amount of Advances under the Revolving Facility shall not exceed either the Availability
or the Facility Cap;

(d) except as disclosed in the historical financial statements, there shall be no liabilities
or obligations with respect to Borrower of any nature whatsoever which, either individually or in
the aggregate, would reasonably be likely to have a Material Adverse Effect; and

(e) Lender shall have received all fees, charges and expenses payable to Lender on or prior to
such date pursuant to the Loan Documents.

4.3 Conditions to Term Loan Draws

In addition to the satisfaction of the conditions set forth in Section 4.1 hereof, the
obligation of the Lender to make any Term Loan Draw for a Diabetes Business Acquisition is subject
to the satisfaction of the following conditions precedent:

(a) Borrower shall have delivered to Lender a Borrowing Certificate for the Term Loan Draw
executed by an authorized officer of Borrower, which shall constitute a representation and warranty
by Borrower as of the Term Loan Borrowing Date of such Term Loan Draw that the conditions contained
in this Section 4.3 have been satisfied; provided, however,
provided, however, that any determination as to whether the conditions contained in
this Section 4.3 and the other conditions set forth in this Agreement to Lender’s
obligation to make Term Loan Draw have been satisfied shall be made by Lender in its Permitted
Discretion;

(b) each of the representations and warranties made by Borrower in or pursuant to this
Agreement shall be accurate, before and after giving effect to such Term Loan Draw, and no Default
or Event of Default shall have occurred or be continuing or would exist after giving effect to the
Term Loan Draw on such date;

(c) immediately after giving effect to the requested Term Loan Draw, the aggregate outstanding
principal amount of all Term Loan Draws shall not exceed the Term Loan Amount;

(d) except as disclosed in the historical financial statements, there shall be no liabilities
or obligations with respect to Borrower of any nature whatsoever which, either individually or in
the aggregate, would reasonably be likely to have a Material Adverse Effect;

(e) Lender shall have received all fees, charges and expenses payable to Lender on or prior to
such date pursuant to the Loan Documents;

(f) All of the terms and conditions set forth in Section 7.4 shall have been satisfied
in form and substance satisfactory to the Lender (or waived in writing by the Lender); and

(g) Borrower shall promptly take such actions, and execute and deliver such documents,
agreements and instruments as the Lender and its counsel shall require to insure that the Lender
obtain (subject to Permitted Liens) a first priority perfected lien and security interest on any of
the properties and assets acquired by Borrower in connection with the proposed Diabetes Business
Acquisition, including but not being limited to uniform commercial code financing statements and
termination statements, all of the foregoing to be acceptable to the Lender and its counsel.

V. REPRESENTATIONS AND WARRANTIES

Borrower, jointly and severally, represents and warrants as of the date hereof and each
Borrowing Date and Term Loan Borrowing Date as follows:

5.1 Organization and Authority

Each Borrower is a corporation or limited liability company duly organized, validly existing
and in good standing under the laws of its state of formation. Borrower (i) has all requisite
corporate or limited liability company power and authority to own its properties and assets and to
carry on its business as now being conducted and as contemplated in the Loan Documents, (ii) is
duly qualified to do business in every jurisdiction in which failure so to qualify would reasonably
be expected to have a Material Adverse Effect, and (iii) has all requisite corporate or limited
liability company power and authority (A) to execute, deliver and perform the Loan Documents to
which it is a party, (B) to borrow hereunder, (C) to consummate the transactions contemplated under
the Loan Documents, and (D) to grant the Liens with regard to the Collateral pursuant to the
Security Documents to which it is a party. No Borrower is an “investment company” registered or
required to be registered under the Investment Company Act of 1940, as amended, or is controlled by
such an “investment company.”

5.2 Loan Documents

The execution, delivery and performance by Borrower of the Loan Documents to which it is a
party, and the consummation of the transactions contemplated thereby, (i) have been duly authorized
by all requisite action of each such Person and have been duly executed and delivered by or on
behalf of each such Person; (ii) do not violate any provisions of (A) applicable law, statute,
rule, regulation, ordinance or tariff, (B) any order of any Governmental Authority binding on any
such Person or any of their respective properties, or (C) the certificate of incorporation or
bylaws (or any other equivalent governing agreement or document) of any such Person, or any
agreement between any such Person and its respective stockholders, members, partners or equity
owners or among any such stockholders, members, partners or equity owners; (iii) are not in
conflict with, and do not result in a breach or default of or constitute an event of default, or an
event, fact, condition or circumstance which, with notice or passage of time, or both, would
constitute or result in a conflict, breach, default or event of default under, any indenture,
agreement or other instrument to which any such Person is a party, or by which the properties or
assets of such Person are bound; (iv) except as set forth therein or Permitted Liens, will not
result in the creation or imposition of any Lien of any nature upon any of the properties or assets
of any such Person, and (v) except as set forth on Schedule 5.2, do not require the
consent, approval or authorization of, or filing, registration or qualification with, any
Governmental Authority or any other Person. When executed and delivered, each of the Loan
Documents to which Borrower is a party will constitute the legal, valid and binding obligation of
Borrower, enforceable against Borrower in accordance with its terms, subject to the effect of any
applicable bankruptcy, moratorium, insolvency, reorganization or other similar law affecting the
enforceability of creditors’ rights generally and to the effect of general principles of equity
which may limit the availability of equitable remedies (whether in a proceeding at law or in
equity).

5.3 Subsidiaries, Capitalization and Ownership Interests

Except as listed on Schedule 5.3, Borrower has no Subsidiaries. NationsHealth Supply,
L.L.C. is presently inactive but has not been dissolved. Schedule 5.3 states the
authorized and issued capitalization of Borrower, the number and class of equity securities and/or
ownership, voting or partnership interests issued and outstanding of Borrower and the record and
beneficial owners thereof (including options, warrants and other rights to acquire any of the
foregoing) (provided however, beneficial ownership information for NationsHealth is not required to
be included in Schedule 5.3). The ownership or partnership interests of each Borrower that is a
limited partnership or a limited liability company are not certificated, the documents relating to
such interests do not expressly state that the interests are governed by Article 8 of the Uniform
Commercial Code, and the interests are not held in a securities account. The outstanding equity
securities and/or ownership, voting or partnership interests of Borrower have been duly authorized
and validly issued and are fully paid and nonassessable, and each Person listed on
Schedule 5.3 owns beneficially and of record all the equity securities and/or ownership,
voting or partnership interests it is listed as owning free and clear of any Liens other than Liens
created by the Security Documents. Schedule 5.3 also lists the directors, members,
managers and/or partners of Borrower. Except as listed on Schedule 5.3, Borrower does not
own an interest in, participate in or engage in any joint venture, partnership or similar
arrangements with any Person.

5.4 Properties

Borrower (i) is the sole owner and has good, valid and marketable title to, or a valid
leasehold interest in, all of its properties and assets, including the Collateral, whether personal
or real, subject to no transfer restrictions or Liens of any kind except for Permitted Liens, and
(ii) is in compliance in all material respects with each lease to which it is a party or otherwise
bound. Schedule 5.4 lists all real properties (and their locations) owned or leased by or
to, and all other assets or property that are leased or licensed by, Borrower and all leases
(including leases of leased real property) covering or with respect to such properties and assets
and all warehouses, fulfillment houses or other locations at which any of Borrower’s Inventory is
located. Borrower enjoys peaceful and undisturbed possession under all such leases and such leases
are all the leases necessary for the operation of such properties and assets, are valid and
subsisting and are in full force and effect. All warehouse, fulfillment and other agreements
relating to Borrower’s Inventory are in full force and effect.

5.5 Other Agreements

Borrower is not (i) a party to any judgment, order or decree or any agreement, document or
instrument, or subject to any restriction, which would affect its ability to execute and deliver,
or perform under, any Loan Document or to pay the Obligations, (ii) in default in the performance,
observance or fulfillment of any obligation, covenant or condition contained in any agreement,
document or instrument to which it is a party or to which any of its properties or assets are
subject, which default, if not remedied within any applicable grace or cure period would reasonably
be expected to have a Material Adverse Effect, nor is there any event, fact, condition or
circumstance which, with notice or passage of time or both, would constitute or result in a
conflict, breach, default or event of default under, any of the foregoing which, if not remedied
within any applicable grace or cure period would reasonably be expected to have a Material Adverse
Effect; or (iii) a party or subject to any agreement, document or instrument with respect to, or
obligation to pay any, Management or Service Fee with respect to, the ownership, operation, leasing
or performance of any of its business or any facility, nor is there any manager with respect to any
such facility.

5.6 Litigation

There is no action, suit, proceeding or investigation pending or, to their knowledge,
threatened against Borrower that (i) questions or could prevent the validity of any of the Loan
Documents or the right of Borrower to enter into any Loan Document or to consummate the
transactions contemplated thereby, (ii) would reasonably be expected to be or have, either
individually or in the aggregate, any Material Adverse Change or Material Adverse Effect, or
(iii) would reasonably be expected to result in any Change of Control or other change in the
current ownership, control or management of Borrower. Borrower is not aware that there is any
basis for the foregoing. Borrower is not a party or subject to any order, writ, injunction,
judgment or decree of any Governmental Authority. There is no action, suit, proceeding or
investigation initiated by Borrower currently pending. Borrower has no existing accrued and/or
unpaid Indebtedness to any Governmental Authority or any other governmental payor.

5.7 Hazardous Materials

Borrower is in compliance with all applicable Environmental Laws. Borrower has not been
notified of any action, suit, proceeding or investigation (i) relating in any way to compliance by
or liability of Borrower under any Environmental Laws, (ii) which otherwise deals with any
Hazardous Substance or any Environmental Law, or (iii) which seeks to suspend, revoke or terminate
any license, permit or approval necessary for the generation, handling, storage, treatment or
disposal of any Hazardous Substance, except where such non-compliance would not reasonably be
expected to have a Material Adverse Effect.

5.8 Potential Tax Liability; Tax Returns; Governmental Reports

(a) Except as disclosed in Schedule 5.8, Borrower (i) has not received any oral or
written communication from the Internal Revenue Service with respect to any investigation or
assessment relating to the Borrower directly, or relating to any consolidated tax return which was
filed on behalf of Borrower, (ii) is not aware of any year which remains open pending tax
examination or audit by the IRS, and (iii) is not aware of any information that could give rise to
an IRS tax liability or assessment.

(b) Borrower (i) has filed all federal, state, foreign (if applicable) and local tax returns
and other reports which are required by law to be filed by Borrower, and (ii) has paid all taxes,
assessments, fees and other governmental charges, including, without limitation, payroll and other
employment related taxes, in each case that are due and payable, except only for items that
Borrower is currently contesting in good faith with adequate reserves under GAAP, which contested
items are described on Schedule 5.8.

5.9 Financial Statements and Reports

All financial statements and financial information relating to Borrower that have been or may
hereafter be delivered to Lender by Borrower are accurate and complete in all material respects and
have been prepared in accordance with GAAP consistently applied with prior periods. Borrower has
no material obligations or liabilities of any kind not disclosed in such financial information or
statements, and since the date of the most recent financial statements submitted to Lender, there
has not occurred any Material Adverse Change, Material Adverse Effect or Liability Event or, to
Borrower’s knowledge, any other event or condition that would reasonably be expected to have a
Material Adverse Effect or cause or constitute a Liability Event.

5.10 Compliance with Law

Borrower (i) is in compliance with all laws, statutes, rules, regulations, ordinances and
tariffs of any Governmental Authority applicable to Borrower and/or Borrower’s business, assets or
operations, including, without limitation, applicable requirements of the Standards for Privacy of
Individually Identifiable Health Information which were promulgated pursuant to the Health
Insurance Portability and Accountability Act of 1996 (as amended, and collectively with the
regulations promulgated thereunder, “HIPAA”), ERISA and Healthcare Laws, and (ii) is not in
violation of any order of any Governmental Authority or other board or tribunal, except in the case
of (i) and (ii) above where noncompliance or violation could not reasonably be expected to have a
Material Adverse Effect. There is no event, fact, condition or circumstance which, with notice or
passage of time, or both, would constitute or result in any noncompliance with, or any violation
of, any of the foregoing, in each case except where noncompliance or violation could not reasonably
be expected to have a Material Adverse Effect. Borrower has not received any notice that Borrower
is not in compliance in any respect with any of the requirements of any of the foregoing. Borrower
has (a) not engaged in any Prohibited Transactions as defined in Section 406 of ERISA and
Section 4975 of the Internal Revenue Code of 1986, as amended, and the rules and regulations
promulgated thereunder, (b) not failed to meet any applicable minimum funding requirements under
Section 302 of ERISA in respect of its plans and no funding requirements have been postponed or
delayed, (c) no knowledge of any amounts due but unpaid to the Pension Benefit Guaranty
Corporation, or of any event or occurrence which would cause the Pension Benefit Guaranty
Corporation to institute proceedings under Title IV of ERISA to terminate any of the employee
benefit plans, (d) no fiduciary responsibility under ERISA for investments with respect to any plan
existing for the benefit of Persons other than its employees or former employees, or (e) not
withdrawn, completely or partially, from any multi-employer pension plans so as to incur liability
under the MultiEmployer Pension Plan Amendments of 1980. With respect to Borrower, there exists no
event described in Section 4043 of ERISA, excluding Subsections 4043(b)(2) and 4043(b)(3) thereof,
for which the thirty (30) day notice period contained in 12 C.F.R. § 2615.3 has not been waived.
Borrower has maintained in all material respects all records required to be maintained by the Joint
Commission on Accreditation of Healthcare Organizations, the Food and Drug Administration, Drug
Enforcement Agency and State Boards of Pharmacy and the federal and state Medicare and Medicaid
programs as required by the Healthcare Laws and, to the best knowledge of Borrower, there are no
presently existing circumstances which would reasonably be expected to result in material
violations of the Healthcare Laws. There is no Liability Event.

5.11 Intellectual Property

Except as set forth on Schedule 5.11, Borrower does not own, license or utilize, and
is not a party to, any material patents, patent applications, trademarks, trademark applications,
service marks, registered copyrights, copyright applications, copyrights, trade names, trade
secrets, software or licenses (collectively, the “Intellectual Property”).

5.12 Licenses and Permits; Labor

Borrower is in compliance with and has all Permits and Intellectual Property necessary or
required by applicable law or Governmental Authority for the operation of its businesses except any
of the foregoing which would not reasonably be expected to have a Material Adverse Effect. All of
the foregoing are in full force and effect and not in known conflict with the rights of others.
Borrower is not (i) in breach of or default under the provisions of any of the foregoing, nor is
there any event, fact, condition or circumstance which, with notice or passage of time or both,
would constitute or result in a conflict, breach, default or event of default under, any of the
foregoing which, if not remedied within any applicable grace or cure period would reasonably be
expected to have a Material Adverse Effect, (ii) a party to or subject to any agreement, instrument
or restriction that is so unusual or burdensome that it might have a Material Adverse Effect,
and/or (iii) and has not been, involved in any labor dispute, strike, walkout or union organization
which would reasonably be expected to have a Material Adverse Effect.

5.13 No Default

There does not exist any Default or Event of Default or any event, fact, condition or
circumstance which, with the giving of notice or passage of time or both, would constitute or
result in a Default or Event of Default.

5.14 Disclosure

No Loan Document nor any other agreement, document, certificate, or statement furnished to
Lender by or on behalf of Borrower in connection with the transactions contemplated by the Loan
Documents, nor any representation or warranty made by Borrower in any Loan Document, contains any
untrue statement of material fact or omits to state any fact necessary to make the statements
therein not materially misleading. There is no fact known to Borrower which has not been disclosed
to Lender in writing which would reasonably be expected to have a Material Adverse Effect.

5.15 Existing Indebtedness; Investments, Guarantees and Certain Contracts

Except for Permitted Indebtedness, Borrower (i) has no outstanding Indebtedness, (ii) is not
subject or party to any mortgage, note, indenture, indemnity or guarantee of, with respect to or
evidencing any Indebtedness of any other Person, or (iii) does not own or hold any equity or
long-term debt investments in, and does not have any outstanding advances to or any outstanding
guarantees for the obligations of, or any outstanding borrowings from, any Person. Borrower has
performed all material obligations required to be performed by Borrower pursuant to or in
connection with all Permitted Indebtedness and there has occurred no breach, default or event of
default under any document evidencing any such items, including without limitation the MHR
Subordinated Debt, or any fact, circumstance, condition or event which, with the giving of notice
or passage of time or both, would constitute or result in a breach, default or event of default
thereunder. Schedule 5.15 sets forth all Indebtedness with a maturity date during the
Term, and identifies such maturity date.

5.16 Other Agreements

Except as set forth on Schedule 5.16 and Schedule 5.23, (i) there are no
existing or proposed agreements, arrangements, understandings or transactions between Borrower and
any of Borrower’s officers, members, managers, directors, stockholders, partners, other interest
holders, employees or Affiliates or any members of their respective immediate families, and (ii)
none of the foregoing Persons are directly or indirectly, indebted to or have any direct or
indirect ownership, partnership or voting interest in, to Borrower’s knowledge, any Affiliate of
Borrower or any Person that competes with Borrower (except that any such Persons may own stock in
(but not exceeding two (2%) percent of the outstanding capital stock of) any publicly traded
company that may compete with Borrower.

5.17 Insurance

Borrower has in full force and effect such insurance policies as are customary in its industry
and as may be required pursuant to Section 6.5 hereof. All such insurance policies are
listed and described on Schedule 5.17.

5.18 Names; Location of Offices, Records and Collateral

During the preceding five years, Borrower has not conducted business under or used any name
(whether corporate, partnership or assumed) other than as shown on Schedule 5.18A.
Borrower is the sole owner of all of its names listed on Schedule 5.18A, and any and all
business done and invoices issued in such names are Borrower’s sales, business and invoices. Each
trade name of Borrower represents a division or trading style of Borrower. Borrower maintains its
places of business and chief executive offices only at the locations set forth on Schedule
5.18B, and all Accounts of Borrower arise, originate and are located, and all of the
Collateral, including Inventory, and all books and records in connection therewith or in any way
relating thereto or evidencing the Collateral are located and shall only be located, in and at such
locations. All of the Collateral is located only in the continental United States.

5.19 Non-Subordination

The Obligations are not subordinated in any way to any other obligations of Borrower or to the
rights of any other Person.

5.20 Accounts and Inventory

(a) In determining which Accounts are Eligible Receivables, Lender may rely on all statements
and representations made by Borrower with respect to any Account. Unless otherwise indicated in
writing to Lender (including, without limitation, any Borrowing Certificate), (i) each Account of
Borrower is genuine and in all respects what it purports to be and is not evidenced by a judgment,
(ii) each Account of Borrower arises out of a completed, bona fide sale and delivery of goods or
rendering of Services by Borrower in the ordinary course of business and in accordance with the
terms and conditions of all purchase orders, contracts, certifications, participations,
certificates of need and other documents relating thereto or forming a part of the contract between
Borrower and the Account Debtor, (iii) each Account of Borrower is for a liquidated amount maturing
as stated in a claim or invoice covering such sale of goods or rendering of Services, a copy of
which has been furnished or is available to Lender, (iv) each Account of Borrower together with
Lender’s security interest therein, is not and will not be in the future (by voluntary act or
omission by Borrower), subject to any offset, lien, deduction, defense, dispute, counterclaim or
other adverse condition, is absolutely owing to Borrower and is not contingent in any respect or
for any reason (except Accounts owed or owing by Medicaid/Medicare Account Debtors that may be
subject to offset or deduction under applicable law), (v) there are no facts, events or occurrences
which in any way impair the validity or enforceability of any Account of Borrower or tend to reduce
the amount payable thereunder from the face amount of the claim or invoice and statements delivered
to Lender with respect thereto, (vi) (A) to the knowledge of Borrower, the Account Debtor under
each Account of Borrower had the capacity to contract at the time any contract or other document
giving rise thereto was executed and (B) to the knowledge of Borrower, each such Account Debtor is
solvent, (vii) to the knowledge of Borrower, there are no proceedings or actions which are
threatened or pending against any Account Debtor under any Account of Borrower which might result
in any Material Adverse Change in such Account Debtor’s financial condition or the collectability
thereof, (viii) each Account of Borrower has been billed and forwarded to the Account Debtor for
payment in accordance with applicable laws and is in compliance and conformance with any requisite
procedures, requirements and regulations governing payment by such Account Debtor with respect to
such Account, and, if due from a Medicaid/Medicare Account Debtor, is properly payable directly to
Borrower, (ix) Borrower has obtained and currently has all material Permits necessary in the
generation of each Account of Borrower, and (x) Borrower has disclosed to Lender on each Borrowing
Certificate the amount of all Accounts of Borrower for which Medicare is the Account Debtor and for
which payment has been denied and subsequently appealed pursuant to the procedure described in the
definition of Eligible Receivables hereof. Borrower is pursuing all available appeals in respect of
such Accounts which Borrower usually and customarily appeals in the ordinary course of its
business.

(b) In determining which Inventory is Eligible Inventory, Lender may rely on all statements
and representations made by Borrower with respect to any Inventory. Unless otherwise indicated in
writing to Lender (including, without limitation, any Borrowing Certificate), (i) Borrower has at
all times maintained correct and accurate records itemizing and describing the kind, type, quality
and quantity of Inventory in all material respects, Borrower’s cost therefore and daily withdrawals
therefrom and additions thereto; (b) has not removed any Inventory from the locations set forth or
permitted herein, except for sales of Inventory in the ordinary course of Borrower’s business and
except to move Inventory directly from one location set forth or permitted herein to another such
location; (c) has produced, used, stored, shipped and maintained Inventory with all reasonable care
and caution and in accordance with applicable standards of any insurance and in conformity with
applicable laws (including the requirements of the Federal Fair Labor Standards Act of 1938, as
amended and all rules, regulations and orders related thereto); (d) except as set forth on
Schedule 5.20, has not sold Inventory to any customer on approval, or any other basis which
entitles the customer to return or may obligate Borrower to repurchase such Inventory; (e) has kept
Inventory in good and marketable condition; and (f) has not acquired or accepted any Inventory on
consignment or approval except as set forth on Schedule 5.20 and (g) has not permitted
Inventory to be subject to any Lien except Liens in favor of Lender.

5.21 Healthcare

Without limiting or being limited by any other provision of any Loan Document, Borrower has
timely filed or caused to be filed all cost and other reports of every kind required under any
Healthcare Laws or any provider or other agreement relating to Borrower’s participation in Medicare
or Medicaid programs. Subject to subsection (a)(x) of Section 5.20, there are no claims,
actions or appeals pending (and Borrower has not filed any claims or reports which could reasonably
result in any such claims, actions or appeals) before any commission, board or agency or other
Governmental Authority, including, without limitation, any intermediary or carrier, the Provider
Reimbursement Review Board or the Administrator of the Centers for Medicare and Medicaid Services,
with respect to any state or federal Medicare or Medicaid cost reports or claims filed by Borrower,
or any disallowance by any commission, board or agency or other Governmental Authority in
connection with any audit of such cost reports. No validation review or program integrity review
related to Borrower or the consummation of the transactions contemplated herein or to the
Collateral have been conducted by any commission, board or agency or other Governmental Authority
in connection with the Medicare or Medicaid programs, and to the knowledge of Borrower, no such
reviews are scheduled, pending or threatened against or affecting any of the providers, any of the
Collateral or the consummation of the transactions contemplated hereby.

5.22 Survival

Borrower makes the representations and warranties contained herein with the knowledge and
intention that Lender is relying and will rely thereon. All such representations and warranties
will survive the execution and delivery of this Agreement and the making of the Advances under the
Revolving Facility and any Term Loan Draws.

	 	5.23	 	MHR Subordinated Debt and Employment Agreements

(a) Except as set forth on Schedule 5.23, no Borrower is in default in the
performance, observance or fulfillment of any obligation, covenant or condition contained in the
MHR Subordinated Note or any of the documents, agreements and instruments executed and delivered in
connection therewith, nor is there any event, fact, condition or circumstance which, with notice or
passage of time or both, would constitute or result in a conflict, breach, default or event of
default under any of the foregoing which, if not remedied within any applicable grace or cure
period could reasonably be expected to have a Material Adverse Effect. There does not exist any
default or event of default or any event, fact, condition or circumstance, which, with the giving
of notice or passage of time or both, would constitute or result in a default or event of default
on the part of any Borrower in connection with the MHR Subordinated Note. No amendment or
modification has been made to the MHR Subordinated Note or any of the documents, agreements and
instruments executed and delivered in connection therewith.

(b) No Borrower is in default in the performance, observance or fulfillment of any obligation,
covenant or condition contained in any Employment Agreement, nor is there any event, fact,
condition or circumstance which, with notice or passage of time or both, would constitute or result
in a conflict, breach, default or event of default under any of the foregoing which, if not
remedied within any applicable grace or cure period could reasonably be expected to have a Material
Adverse Effect on any Employment Agreement. No amendment or modification has been made to any
Employment Agreement which has not been provided to Lender. No Employment Agreement has been
terminated or, to Borrower’s knowledge, threatened with termination.

	VI.	 	AFFIRMATIVE COVENANTS

Each Borrower, jointly and severally, covenants and agrees that, until full performance and
satisfaction, and indefeasible payment in full in cash, of all the Obligations and termination of
this Agreement:

	 	6.1	 	Financial Statements, Borrowing Certificate, Financial Reports and Other
Information

(a) Financial Reports. In addition to providing the Borrowing Certificate in
accordance with Section 2.4, Borrower shall furnish to Lender (i) as soon as available and
in any event within ninety (90) calendar days after the end of each fiscal year of Borrower (or
such earlier date required by the laws, regulations and rules of the Securities and Exchange
Commission), audited annual consolidated and consolidating financial statements of Borrower,
including the notes thereto, consisting of a consolidated and consolidating balance sheet at the
end of such completed fiscal year and the related consolidated and consolidating statements of
income, retained earnings, cash flows and owners’ equity for such completed fiscal year, which
financial statements shall be prepared and certified without qualification by an independent
certified public accounting firm satisfactory to Lender and accompanied by related management
letters, if available, and (ii) as soon as available and in any event within thirty (30) calendar
days after the end of each calendar month, unaudited consolidated and consolidating financial
statements of Borrower consisting of a balance sheet and statements of income, retained earnings,
cash flows and owners’ equity as of the end of the immediately preceding calendar month. All such
financial statements shall be prepared in accordance with GAAP consistently applied with prior
periods. With each such financial statement, Borrower shall also deliver a certificate of its
chief financial officer in substantially the form of Exhibit B hereto (a “Compliance
Certificate”) stating that (A) such person has reviewed the relevant terms of the Loan Documents
and the condition of Borrower, (B) no Default or Event of Default has occurred or is continuing,
or, if any of the foregoing has occurred or is continuing, specifying the nature and status and
period of existence thereof and the steps taken or proposed to be taken with respect thereto, and
(C) Borrower is in compliance with all financial covenants attached as Annex I hereto. Such
certificate shall be accompanied by the calculations necessary to show compliance with the
financial covenants in a form satisfactory to Lender and shall also set forth any payments made in
respect of Permitted Subordinated Debt as permitted under any Subordination Agreement applicable
thereto.

(b) Other Materials. Borrower shall furnish to Lender as soon as available, and in any
event within ten (10) calendar days after the preparation or issuance thereof or at such other time
as set forth below: (i) copies of such financial statements (other than those required to be
delivered pursuant to Section 6.1(a)) prepared by, for or on behalf of Borrower and any
other notes, reports and other materials related thereto, including, without limitation, any pro
forma financial statements, (ii) any reports, returns, information, notices and other materials
that Borrower shall send to its stockholders, members, partners or other equity owners at any time,
(iii) all Medicare and Medicaid cost reports and other documents and materials filed by Borrower
and any other reports, materials or other information regarding or otherwise relating to Medicaid
or Medicare prepared by, for or on behalf of Borrower, including, without limitation, (A) copies of
licenses and permits required by any applicable federal, state, foreign or local law, statute
ordinance or regulation or Governmental Authority for the operation of its business, (B) Medicare
and Medicaid provider numbers and agreements, (C) state surveys pertaining to any healthcare
facility operated, owned or leased by Borrower or any of its Affiliates or Subsidiaries, and (D)
participating agreements relating to medical plans, (iv) (A) within fifteen (15) calendar days
(thirty (30) calendar days in the case of the first four (4) months following the Restatement Date)
(after the end of each calendar month for such month, a summary report of the status of all
payments, denials and appeals of all Medicare and/or Medicaid Accounts and accounts receivable and
account payable aging schedule and (B), within thirty (30) calendar days after the end of each
calendar month for such month, a sales and collection report, including a report of sales, credits
issued and collections received, all such reports showing a reconciliation to the amounts reported
in the monthly financial statements, (v) promptly upon receipt thereof, copies of any reports
submitted to Borrower by its independent accountants in connection with any interim audit of the
books of such Person or any of its Affiliates and copies of each management control letter provided
by such independent accountants, (vi) within fifteen (15) calendar days after the execution
thereof, a copy of any contracts with the federal government or with a Governmental Authority in
the State of New York, Vermont or Washington, and (vii) such additional information, documents,
statements, reports and other materials as Lender may reasonably request from a credit or security
perspective or otherwise from time to time.

(c) Notices. Borrower shall promptly, and in any event within three (3) calendar days
after Borrower or any authorized officer of Borrower obtains knowledge thereof, notify Lender in
writing of (i) any pending or threatened litigation, suit, investigation, arbitration, dispute
resolution proceeding or administrative proceeding brought or initiated by or against Borrower or
otherwise affecting or involving or relating to Borrower or any of their property or assets to the
extent (A) the amount in controversy exceeds $30,000, or (B) to the extent any of the foregoing
seeks injunctive or declarative relief, (ii) any Default or Event of Default, which notice shall
specify the nature and status thereof, the period of existence thereof and what action is proposed
to be taken with respect thereto, (iii) any other development, event, fact, circumstance or
condition that would reasonably be likely to have a Material Adverse Effect, in each case
describing the nature and status thereof and the action proposed to be taken with respect thereto,
(iv) any notice received by Borrower from any payor of a claim, suit or other action such payor
has, claims or has filed against Borrower in an amount exceeding $30,000, (v) any matter(s)
affecting the value, enforceability or collectability of any of the Collateral, including, without
limitation, claims or disputes in the amount of $30,000 or more, singly or in the aggregate, in
existence at any one time, (vi) any notice given by Borrower to any other lender of Borrower, which
notice to Lender shall be accompanied by a copy of the applicable notice given to the other Lender,
(vii) receipt of any notice or request from any Governmental Authority or governmental payor
regarding any liability or claim of liability (other than notices received from any Governmental
Authority in connection the usual and customary processing of claims by Borrower in the ordinary
course of business), (viii) any notice given by or received by Borrower regarding any default,
noncompliance, proposed termination, waiver or consent under the MHR Subordinated Note, the
Employment Agreements, or the CIGNA Strategic Agreement, and/or (ix) any Account becoming evidenced
or secured by an Instrument or Chattel Paper.

(d) Consents. Borrower shall obtain and deliver from time to time all required
consents, approvals and agreements from such third parties as Lender shall determine are necessary
or desirable in its sole discretion, each of which must be satisfactory to Lender in its sole
discretion, with respect to (i) the Loan Documents and the transactions contemplated thereby, (ii)
claims against Borrower or the Collateral, and/or (iii) any agreements, consents, documents or
instruments to which Borrower is a party or by which any properties or assets of Borrower or any of
the Collateral is or are bound or subject, including, without limitation, Landlord Waivers and
Consents with respect to leases and Warehouse Waivers and Consents with respect to warehouse,
fulfillment and similar agreements.

(e) Operating Budget. Borrower shall furnish to Lender on or prior to the Restatement
Date and for each fiscal year of Borrower thereafter not later than the earlier of (i) thirty (30)
calendar days after the end of each fiscal year or (ii) thirty (30) calendar days after the same is
available, consolidated and consolidating month by month projected operating budgets, annual
projections, profit and loss statements, balance sheets and cash flow reports of and for Borrower
for such upcoming fiscal year (including an income statement for each month and a balance sheet as
at the end of the last month in each fiscal quarter), in each case prepared in accordance with GAAP
consistently applied with prior periods.

(f) Non-Compliance Fee. To the extent any of the foregoing items in this Section
6.1 are not delivered to Lender on a timely basis, Borrower shall be obligated to Lender for a
daily fee equal to the greater of (i) $500, or (ii) five one-hundredths of one percent (0.05%) of
the then current outstanding principal balance of the Obligations, for each day until such item is
delivered to Lender, whether or not a Default or Event of Default occurs or is declared, provided
that nothing shall prevent Lender from considering any failure to comply with the terms of this
Section 6.1 to be a Default or an Event of Default.

6.2 Payment of Obligations

Borrower shall make full and timely indefeasible payment in cash of the principal of and
interest on the Loans, Advances and all other Obligations.

6.3 Conduct of Business and Maintenance of Existence and Assets

Borrower shall (i) conduct its business in accordance with good business practices customary
to the industry, (ii) engage principally in the same or similar lines of business substantially as
heretofore conducted, (iii) collect its Accounts in the ordinary course of business, (iv) maintain
all of its material properties, assets and equipment used or useful in its business in good repair,
working order and condition (normal wear and tear excepted and except as may be disposed of in the
ordinary course of business and in accordance with the terms of the Loan Documents and otherwise as
determined by Borrower using commercially reasonable business judgment), (v) from time to time to
make all necessary or desirable repairs, renewals and replacements thereof, as determined by
Borrower using commercially reasonable business judgment, (vi) maintain and keep in full force and
effect its existence and all material Permits and qualifications to do business and good standing
in each jurisdiction in which the ownership or lease of property or the nature of its business
makes such Permits or qualification necessary and in which failure to maintain such Permits or
qualification could reasonably be expected to have a Material Adverse Effect; and (vii) remain in
good standing and maintain operations in all jurisdictions in which currently located, except where
the failure to maintain such good standing could not reasonably be expected to have a Material
Adverse Effect.

6.4 Compliance with Legal and Other Obligations

Borrower shall (i) comply in all material respects with all laws, statutes, rules,
regulations, ordinances and tariffs of all Governmental Authorities applicable to it or its
business, assets or operations, including applicable requirements of the Standards for Privacy of
Individually Identifiable Health Information which were promulgated pursuant to HIPAA; (ii) pay all
taxes, assessments, fees, governmental charges, claims for labor, supplies, rent and all other
obligations or liabilities of any kind, except liabilities being contested in good faith and
against which adequate reserves have been established in accordance with GAAP, (iii) perform in
accordance with its terms each contract, agreement or other arrangement to which it is a party or
by which it or any of the Collateral is bound, except where the failure to comply, pay or perform
would not reasonably be expected to have a Material Adverse Effect, (iv) maintain and comply with
all material Permits necessary to conduct its business and comply with any new or additional
requirements that may be imposed on it or its business, and (v) properly file all
Medicaid/Medicare cost reports.

6.5 Insurance

Borrower shall (i) comply in all material respects with all laws, statutes, rules,
regulations, ordinances and tariffs of all Governmental Authorities applicable to it or its
business, assets or operations, including applicable requirements of the Standards for Privacy of
Individually Identifiable Health Information which were promulgated pursuant to HIPAA; (ii) pay all
taxes, assessments, fees, governmental charges, claims for labor, supplies, rent and all other
obligations or liabilities of any kind, except liabilities being contested in good faith and
against which adequate reserves have been established in accordance with GAAP, (iii) perform in
accordance with its terms each contract, agreement or other arrangement to which it is a party or
by which it or any of the Collateral is bound, except where the failure to comply, pay or perform
would not reasonably be expected to have a Material Adverse Effect, (iv) maintain and comply with
all material Permits necessary to conduct its business and comply with any new or additional
requirements that may be imposed on it or its business, and (v) properly file all Medicaid/Medicare
cost reports.

6.6 True Books

Borrower shall (i) keep true, complete and accurate books of record and account in accordance
with commercially reasonable business practices in which true and correct entries are made of all
of its and their dealings and transactions in all material respects; and (ii) set up and maintain
on its books such reserves as may be required by GAAP with respect to doubtful accounts and all
taxes, assessments, charges, levies and claims and with respect to its business, and include such
reserves in its quarterly as well as year end financial statements.

6.7 Inspection; Periodic Audits

Borrower shall permit the representatives of Lender, at the expense of Borrower, from time to
time during normal business hours upon reasonable notice, to (i) visit and inspect any of its
offices or properties or any other place where Collateral is located to inspect the Collateral
and/or to examine or audit all of its books of account, records, reports and other papers (but not
more often than four (4) times per year so long as no Default or Event of Default exists), (ii)
make copies and extracts therefrom, and (iii) discuss its business, operations, prospects,
properties, assets, liabilities, condition and/or Accounts and Inventory with its officers and
independent public accountants (and by this provision such officers and accountants are authorized
to discuss the foregoing).

6.8 Further Assurances; Post Closing

At Borrower’s cost and expense, Borrower shall (i) take such further actions, obtain such
consents and approvals and duly execute and deliver such further agreements, assignments,
instructions or documents as Lender may request with respect to the purposes, terms and conditions
of the Loan Documents and the consummation of the transactions contemplated thereby, and
(ii) without limiting and notwithstanding any other provision of any Loan Document, execute and
deliver, or cause to be executed and delivered, such agreements and documents, and take or cause to
be taken such actions, and otherwise perform, observe and comply with such obligations, as are set
forth on Schedule 6.8.

6.9 Payment of Indebtedness

Except as otherwise prescribed in the Loan Documents, Borrower shall pay, discharge or
otherwise satisfy at or before maturity (subject to applicable grace periods and, in the case of
trade payables, to ordinary course payment practices) all of its material obligations and
liabilities, except when the amount or validity thereof is being contested in good faith by
appropriate proceedings and with respect to which adequate reserves or other appropriate provisions
are being maintained by Borrower in accordance with GAAP to the satisfaction of Lender in its sole
discretion.

6.10 Lien Searches

If Liens other than Permitted Liens exist, Borrower immediately shall take, execute and
deliver all actions, documents and instruments necessary to release and terminate such Liens.

6.11 Use of Proceeds

Borrower shall use the proceeds from the Revolving Facility only for the purposes set forth in
Section 2.1(a) and the proceeds of the Term Loan only for the purposes set forth in
Section 2.5.

6.12 Collateral Documents; Security Interest in Collateral

Borrower shall (i) execute, obtain, deliver, file, register and/or record any and all
financing statements, continuation statements, stock powers, instruments and other documents, or
cause the execution, filing, registration, recording or delivery of any and all of the foregoing,
that are necessary or required under law or otherwise or reasonably requested by Lender to be
executed, filed, registered, obtained, delivered or recorded to create, maintain, perfect,
preserve, validate or otherwise protect the pledge of the Collateral to Lender and Lender’s
perfected first priority Lien on the Collateral (and Borrower irrevocably grants Lender the right,
at Lender’s option, to file any or all of the foregoing), (ii) within two business days of learning
thereof, report to Lender any reclamation, return or repossession of goods in excess of $10,000
(individually or in the aggregate), and (iii) defend the Collateral and Lender’s perfected first
priority Lien thereon against all claims and demands of all Persons at any time claiming the same
or any interest therein adverse to Lender, and pay all reasonable costs and expenses (including,
without limitation, reasonable in-house documentation and diligence fees and legal expenses and
reasonable attorneys’ fees and expenses) in connection with such defense, which may at Lender’s
discretion be added to the Obligations.

6.13 Right of First Refusal

If at any time any Borrower or Guarantor (each, a “Credit Party”) or any of their respective
Subsidiaries or Affiliates receives from a third party an offer, term sheet or commitment or makes
a proposal accepted by any Person (each, an “Offer”) which provides for any type of financing
(other than an offering of common stock or other equity securities which do not contain or enjoy
any debt or debt-like rights or features, which are not convertible or exchangeable into debt or
debt-like instruments or which may otherwise be characterized, whether for accounting, income tax
or any other purposes, as debt) to or for a Credit Party or any of its Affiliates, such Credit
Party, on behalf of itself or such Affiliate, shall immediately notify such third party making the
offer of Lender’s rights under this Section 6.13, and further shall immediately notify
Lender of the Offer in writing (including all material terms of the Offer). Lender shall have
thirty (30) calendar days after Receipt of such notice (the “Option Period”) to agree to provide
similar financing in the place of such Person upon substantially the same terms and conditions (or
terms more favorable to such Credit Party or Affiliate) as set forth in the Offer. Lender shall
notify Credit Party or Affiliate in writing of Lender’s acceptance of the Offer pursuant hereto
(the “Acceptance Notice”), in which case Credit Party shall obtain, or shall cause Affiliate to
obtain, such financing from Lender and shall not accept the Offer from such other Person. If no
Acceptance Notice has been Received from Lender within the Option Period, Credit Party or Affiliate
may consummate the Offer with the other Person on the terms and conditions set forth in the Offer
(the “Transaction”); provided, however, that none of foregoing or any failure by
Lender to issue an Acceptance Notice shall be construed as a waiver of any of the terms, covenants
or conditions of any of the Loan Documents. If the Transaction is not consummated on the terms set
forth in the Offer or with the Person providing the Offer or during the ninety (90) calendar day
period following the expiration of the Option Period, Credit Party shall not be permitted, and
shall not permit its Affiliate, to consummate the Transaction without again complying with this
Section 6.13. The provisions of this Section 6.13 shall survive the payment in
full of the Obligations and termination of this Agreement for a period of six months. For purposes
of this Section 6.13, “Lender” shall include CapitalSource Finance LLC and any of its
parents, subsidiaries or Affiliates. The provisions of this Section 6.13 shall not apply
to any Offer to an Affiliate of any Borrower or Guarantor (or any of their respective Subsidiaries
or Affiliates (other than the Affiliate receiving the Offer)) if such financing is intended to be
used solely for a business conducted by or to be conducted by such Affiliate which is unrelated to
the business of any such Borrower or Guarantor (or any such respective Subsidiaries or Affiliates)
as such business exists from time to time or may result from any acquisition, merger or similar
transaction how so ever structured which is the subject of the Offer.

6.14 Taxes and Other Charges

(a) All payments and reimbursements to Lender made under any Loan Document shall be free and
clear of and without deduction for all taxes, levies, imposts, deductions, assessments, charges or
withholdings, and all liabilities with respect thereto of any nature whatsoever, excluding taxes to
the extent imposed on Lender’s net income or franchise. If Borrower shall be required by law to
deduct any such amounts from or in respect of any sum payable under any Loan Document to Lender,
then the sum payable to Lender shall be increased as may be necessary so that, after making all
required deductions, Lender receives an amount equal to the sum it would have received had no such
deductions been made. Notwithstanding any other provision of any Loan Document, if at any time
after the Restatement Date (i) any change in any existing law, regulation, treaty or directive or
in the interpretation or application thereof, (ii) any new law, regulation, treaty or directive
enacted or any interpretation or application thereof, or (iii) compliance by Lender with any
request or directive (whether or not having the force of law) from any Governmental Authority: (A)
subjects Lender to any tax, levy, impost, deduction, assessment, charge or withholding of any kind
whatsoever with respect to any Loan Document, or changes the basis of taxation of payments to
Lender of any amount payable thereunder (except for net income taxes, or franchise taxes imposed in
lieu of net income taxes, imposed generally by federal, state or local taxing authorities with
respect to interest or commitment fees or other fees payable hereunder or changes in the rate of
tax on the overall net income of Lender), or (B) imposes on Lender any other condition or increased
cost in connection with the transactions contemplated thereby or participations therein; and the
result of any of the foregoing is to increase the cost to Lender of making or continuing any Loan
hereunder or to reduce any amount receivable hereunder, then, in any such case, Borrower shall
promptly pay to Lender any additional amounts necessary to compensate Lender, on an after-tax
basis, for such additional cost or reduced amount as determined by Lender. If Lender becomes
entitled to claim any additional amounts pursuant to this Section 6.14 it shall promptly
(but in any event within ninety (90) days of becoming aware thereof) notify Borrower of the event
by reason of which Lender has become so entitled and a detailed calculation thereof, and each such
notice of additional amounts payable pursuant to this Section 6.14 submitted by Lender to
Borrower shall, absent manifest error, be final, conclusive and binding for all purposes.

(b) Borrower shall promptly, and in any event within five (5) Business Days after Borrower or
any authorized officer of Borrower obtains knowledge thereof, notify Lender in writing of any oral
or written communication from the Internal Revenue Service or otherwise with respect to any (i) tax
investigations, relating to the Borrower directly, or relating to any consolidated tax return which
was filed on behalf of Borrower, (ii) notices of tax assessment or possible tax assessment, (iii)
years that are designated open pending tax examination or audit, and (iv) information that could
give rise to an IRS tax liability or assessment.

6.15 Payroll Taxes

Without limiting or being limited by any other provision of any Loan Document, Borrower at all
times shall retain and use a Person acceptable to Lender to process, manage and pay its payroll
taxes and shall cause to be delivered to Lender within ten (10) calendar days after the end of each
calendar month a report of its payroll taxes for the immediately preceding calendar month and
evidence of payment thereof. Lender acknowledges that ADP is an acceptable company engaged by
Borrower to process, manage and pay its payroll taxes as of the Restatement Date. Borrower
acknowledges that in the event Borrower wishes to remove ADP as the company engaged to process,
manage and pay its payroll taxes, it will not do so until such time that Lender has consented in
writing to such change, which consent will not be unreasonably withheld.

6.16 Inventory Covenants

With respect to the Inventory, Borrower: (a) shall at all times maintain inventory records
reasonably satisfactory to Lender, keeping correct and accurate records itemizing and describing
the kind, type, quality and quantity of Inventory, Borrower’s cost therefore and daily withdrawals
therefrom and additions thereto; (b) shall not remove any Inventory from the locations set forth or
permitted herein, without the prior written consent of Lender, which consent shall not be
unreasonably denied or delayed, except for sales of Inventory in the ordinary course of Borrower’s
business and except to move Inventory directly from one location set forth or permitted herein to
another such location; (c) shall produce, use, store, ship and maintain the Inventory with all
reasonable care and caution and in accordance with applicable standards of any insurance and in
conformity with applicable laws (including the requirements of the Federal Fair Labor Standards Act
of 1938, as amended and all rules, regulations and orders related thereto); (d) assumes all
responsibility and liability arising from or relating to the production, use, sale or other
disposition of the Inventory; (e) shall not sell Inventory to any customer on approval, or any
other basis which entitles the customer to return or may obligate Borrower to repurchase such
Inventory except as set forth on Schedule 5.20; (f) shall keep the Inventory in good and
marketable condition; and (g) shall not, without prior written notice to Lender, acquire or accept
any Inventory on consignment or approval except as set forth on Schedule 5.20.

	 	6.17	 	Diabetes Customer List Covenants.

(a) Borrower shall at all times maintain true, complete and accurate list of all Diabetes
Customers in a form and manner reasonably acceptable to the Lender (the “Diabetes Customer List”).

(b) Borrower shall not later than (i) thirty (30) days after the end of each calendar quarter
during the Term, (ii) following the closing by Borrower of a Diabetes Business
Acquisition under Section 7.4 having a purchase price in excess of $1,000,000  or (iii)
immediately upon the written request of the Lender deliver to the Escrow Agent in the manner set
forth in the Escrow Agreement (which shall include the transmission thereof in a sealed envelope or
other package) true and correct copies of the Diabetes Customer List maintained by Borrower as of
such time in either (a) hard-copy paper print-out or (b) a readable, electronic format on CD or
other electronic media in a form acceptable to the Lender but containing, at a minimum for each
Diabetes Customer, patient name and address, billing and payor information, patient number, date
and amount of last shipment and cumulative balance of all shipments. Lender acknowledges that the
Escrow Agent shall execute and deliver a business associate agreement in a form mutually agreeable
to Lender and Borrower.

(c) At the written request of Lender, Borrower shall promptly (but in any event within 15
Business Days following its Receipt of such written request) commence to cause an appraisal to be
made of the Diabetes Customer List during the Term in its Permitted Discretion, which appraisal
shall be completed in a reasonable time period, be at the cost and expense of Borrower in
furtherance of its healthcare operations and be conducted by an appraiser acceptable to Lender;
provided that as long as no Event of Default shall have occurred and be continuing such an
appraisal shall not be required to be obtained on more than one occasion during any period of
twelve (12) consecutive calendar months. Lender acknowledges that the appraiser shall execute and
deliver a business associate agreement in a form mutually agreeable to Lender and Borrower and any
disclosures to be made by such appraiser of information subject to HIPAA to Lender shall be in
compliance with such business associate agreement.

(d) At the written request of Lender, Borrower shall promptly (but in any event within 15
Business Days following its Receipt of such written request) (but not more than twice during any
period of twelve (12) consecutive calendar months unless a Default or Event of Default shall have
occurred) engage Borrower’s independent certified public accounting firm or such other independent
auditor selected by Borrower and reasonably acceptable to Lender, in furtherance of Borrower’s
healthcare operations, to perform an audit (or similar agreed upon procedure) of the Diabetes
Customer List in the possession of the Escrow Agent to confirm that (i) the Diabetes Customer List
is the same list of customers in the possession of Borrower (excepting additions of Diabetes
Customers thereto since the date of the submission of the last Diabetes Customer List to the Escrow
Agent) and (ii) the information contained therein is true, accurate and complete and in conformance
with the applicable provisions of this Agreement. Any such audits shall be completed in a
reasonable period of time and be at the cost and expense of Borrower. Lender acknowledges that the
auditor shall execute and deliver a business associate agreement in a form mutually agreeable to
Lender and Borrower and shall not make any disclosures of “protected health information” as defined
by HIPAA to Lender.

(e) Borrower acknowledges and agrees that the Diabetes Customer List, whether now existing or
hereinafter acquired or arising, constitutes a part of the Collateral granted to Lender under this
Agreement.

(f) Once all of the Obligations have been fully performed and indefeasibly paid in full in
cash and this Agreement shall have been terminated, Lender shall deliver a joint written
notification promptly to the Escrow Agent to terminate the Escrow Agreement and have the Diabetes
Customer List then held in escrow to be returned to Borrower or as otherwise instructed by Borrower
in writing.

6.18 US Bio Reserve

Borrower shall establish the US Bio Reserve in the amounts and at the times set forth in the
definition of the term “US Bio Reserve” and shall maintain such US Bio Reserve at all times until
the US Bio Note has been paid in full.

6.19 Minimum Liquidity Account

Contemporaneously with the execution of this Agreement, as additional security for the payment
and performance of the Obligations, Borrower shall deposit with an FDIC insured bank (or other
financial or investment institution) reasonably acceptable to Lender the amount of One Million Five
Hundred Thousand Dollars ($1,500,000) if in the form of cash or Cash Equivalents (One Million Eight
Hundred Seventy Five Thousand Dollars ($1,875,000) if in the form of securities which do not
constitute Cash Equivalents) (the “Minimum Liquidity Amount”) to be placed into a depository or
investment account (“Minimum Liquidity Account") in which Lender shall have a first priority lien
and security interest pursuant to an account control agreement acceptable to Lender and its legal
counsel. Notwithstanding anything contained in the Loan Documents to the contrary, upon the
occurrence and during the continuance of an Event of Default Lender may apply amounts held in the
Minimum Liquidity Account to the Obligations at such times and in such amounts as Lender shall from
time to time determine in its sole and absolute discretion. Borrower understands and agrees that,
notwithstanding the establishment of the Minimum Liquidity Account, all proceeds of the Term Loan
Draw made on the Restatement Date to fund the Minimum Liquidity Amount shall have been and shall be
considered fully disbursed and shall bear interest and be payable on the terms provided in this
Agreement.

	VII.	 	NEGATIVE COVENANTS

Each Borrower, jointly and severally, covenants and agrees that, until full performance and
satisfaction, and indefeasible payment in full in cash, of all of the Obligations and termination
of this Agreement:

	 	7.1	 	Financial Covenants

Borrower shall not violate the financial covenants set forth on Annex I to this
Agreement, which is incorporated herein and made a part hereof.

	 	7.2	 	Permitted Indebtedness

Borrower shall not create, incur, assume or suffer to exist any Indebtedness, except the
following (collectively, “Permitted Indebtedness”): (i) Indebtedness under the Loan Documents, (ii)
any Indebtedness set forth on Schedule 7.2, (iii) Capitalized Lease Obligations incurred
after April 30, 2004 and Indebtedness incurred pursuant to purchase money Liens permitted by
Section 7.3(v), provided that the aggregate amount of such Capitalized Lease Obligations
and purchase money indebtedness outstanding at any time shall not exceed $150,000, (iv)
Indebtedness in connection with advances made by a stockholder in order to cure any default of the
financial covenants set forth on Annex I; provided, however, that such
Indebtedness shall be on an unsecured basis, subordinated in right of repayment and remedies to all
of the Obligations and to all of Lender’s rights pursuant to a subordination agreement in form and
substance satisfactory to Lender; (v) accounts payable to trade creditors and current operating
expenses (other than for borrowed money) which are not aged more than 120 calendar days from the
billing date or more than 30 days from the due date, in each case incurred in the ordinary course
of business and paid within such time period, unless the same are being contested in good faith and
by appropriate and lawful proceedings and such reserves, if any, with respect thereto as are
required by GAAP and deemed adequate by Borrower’s independent accountants shall have been
reserved; (vi) borrowings incurred in the ordinary course of business and not exceeding $10,000
individually or in the aggregate outstanding at any one time, provided, however,
that such Indebtedness shall be on an unsecured basis, subordinated in right of repayment and
remedies to all of the Obligations and to all of Lender’s rights pursuant to a subordination
agreement in form and substance satisfactory to Lender; (vii) Permitted Subordinated Debt or
Indebtedness to US Bioservices Corporation evidenced by the US Bio Note as permitted under the
Joint Venture Dissolution Consent and (viii) Indebtedness consisting of unsecured Deferred Purchase
Price Obligations not to exceed $250,000 outstanding at any time; provided, however, that the
deposit of monies in escrow or the establishment of holdbacks for purchase price adjustments shall
not be deemed to constitute security for such Indebtedness and the amount thereof shall not be
included in the computation of the foregoing $250,000 allowance. Borrower shall not make
prepayments on any existing or future Indebtedness in excess of $10,000 to any Person other than to
Lender or to the extent specifically permitted by this Agreement or any subsequent agreement
between Borrower and Lender.

7.3 Permitted Liens

Borrower shall not create, incur, assume or suffer to exist any Lien upon, in or against, or
pledge of, any of the Collateral, or any of its properties or assets or any of its authorized but
unissued or treasury shares, securities or other equity or ownership or partnership interests,
whether now owned or hereafter acquired, except the following (collectively, “Permitted Liens”):
(i) Liens under the Loan Documents or otherwise arising in favor of Lender, (ii) Liens imposed by
law for taxes (other than payroll taxes), assessments or charges of any Governmental Authority for
claims not yet due or which are being contested in good faith by appropriate proceedings and with
respect to which adequate reserves or other appropriate provisions are being maintained by such
Person in accordance with GAAP to the satisfaction of Lender in its sole discretion, (iii) (A)
statutory Liens of landlords (provided that any such landlord has executed a Landlord Waiver and
Consent in form and substance satisfactory to Lender) and of carriers, warehousemen (provided that
any such warehousemen have executed a Warehouse Waiver and Consent in form and substance
satisfactory to Lender), mechanics, materialmen, and (B) other Liens imposed by law or that arise
by operation of law in the ordinary course of business from the date of creation thereof, in each
case only for amounts not yet due or which are being contested in good faith by appropriate
proceedings and with respect to which adequate reserves or other appropriate provisions are being
maintained by such Person in accordance with GAAP to the satisfaction of Lender in its sole
discretion, (iv) Liens (A) incurred or deposits made in the ordinary course of business (including,
without limitation, surety bonds and appeal bonds) in connection with workers’ compensation,
unemployment insurance and other types of social security benefits or to secure the performance of
tenders, bids, leases, contracts (other than for the repayment of Indebtedness), statutory
obligations and other similar obligations, or (B) arising as a result of progress payments under
government contracts, (v) purchase money Liens (A) securing Indebtedness permitted under
Section 7.2(iii), or (B) in connection with the purchase by such Person of equipment in the
normal course of business, provided that such payables shall not exceed any limits on
Indebtedness provided for herein and shall otherwise be Permitted Indebtedness hereunder, (vi)
Liens securing the MHR Subordinated Debt, and (vii) Liens disclosed on Schedule 7.3;
provided, that the Lien in favor of Gilbraltar Bank, FSB shall not extend to any additional
collateral or secure any Indebtedness in excess of $300,000.

7.4 Investments; New Facilities or Collateral; Subsidiaries

Borrower, directly or indirectly, shall not (i) purchase, own, hold, invest in or otherwise
acquire obligations or stock or securities of, or any other interest in, or all or substantially
all of the assets of, any Person or any joint venture, or (ii) make or permit to exist any loans,
advances or guarantees to or for the benefit of any Person or assume, guarantee, endorse,
contingently agree to purchase or otherwise become liable for or upon or incur any obligation of
any other Person (other than those created by the Loan Documents and Permitted Indebtedness and
other than (A) trade credit extended in the ordinary course of business, (B) advances for business
travel and similar temporary advances made in the ordinary course of business to officers,
directors and employees, and (C) the endorsement of negotiable instruments for deposit or
collection or similar transactions in the ordinary course of business). Borrower, directly or
indirectly, shall not purchase, own, operate, hold, invest in or otherwise acquire any facility,
property or assets or allow the warehousing, location or storage of any Collateral other than at
the locations set forth on Schedule 5.18B unless Borrower shall provide to Lender at least
thirty (30) Business Days prior written notice. Borrower shall have no Subsidiaries other than
those Subsidiaries, if any, existing on the Restatement Date and set forth in Schedule
5.3.

Notwithstanding any provision of this Section 7.4 to the contrary, Borrower may
make a Diabetes Business Acquisition, provided that the following terms and conditions are
satisfied:

(i) the Lender shall have provided its prior written consent to the proposed Diabetes Business
Acquisition; provided, however, that the consent of the Lender shall not be required if all of the
following apply:

(a) the terms and conditions of the proposed Diabetes Business Acquisition shall be set
forth in an asset purchase agreement in substantially the form of Exhibit D-1
attached hereto and the proposed Diabetes Business Acquisition shall be consummated without
any material amendment or modification to, or waiver of, such terms and conditions;

(b) the purchase price (including any Deferred Purchase Price Obligations) for the
proposed Diabetes Business Acquisition involved does not exceed $250,000;

(c) the proposed Acquisition consists solely of, and is structured as, the
acquisition by Borrower of assets consisting solely of Diabetes Customer Lists and the
inventory and equipment of the seller from whom such Diabetes Customer Lists are purchased
in which the purchase price is allocated solely to Diabetes Customer Lists and such
inventory and equipment (and not to any non-competition agreement or other assets);

(d) the purchase price for the Diabetes Customer List and any associated inventory and
equipment of the seller shall not exceed the amount of $350 per Diabetes Customer;

(e) the asset purchase agreement for the proposed Diabetes Business Acquisition shall
provide for a purchase price holdback or escrow in an amount of not less than 25% of the
aggregate purchase price;

(f) Borrower will not establish a new business premises in connection with the proposed
Diabetes Business Acquisition;

(g) Borrower will not incur or assume any Indebtedness or other contingent liabilities
or obligations in connection with the proposed Diabetes Business Acquisition other than Term
Loan Draws used to pay the purchase price and Deferred Purchase Price Obligations as
permitted under this Agreement;

(h) the portion of the purchase price for the proposed Diabetes Business Acquisition
which consists of Indebtedness constituting Deferred Purchase Price Obligations shall not
exceed twenty percent (20%) of the aggregate purchase price, such Indebtedness shall be
unsecured, shall qualify as Permitted Subordinated Debt and the aggregate Deferred Purchase
Price Obligations of Borrower after taking into account any Deferred Purchase Price
Obligations incurred in connection with the proposed Diabetes Business Acquisition shall not
exceed the amounts set forth in Section 7.2(viii); and

(i) Borrower will attach to the Borrowing Certificate to be submitted in connection
with the proposed Diabetes Business Acquisition (a) copies of UCC search reports (together
with copies of underlying UCC financing statements) from a reputable corporate search
company against the seller of the assets, (b) a copy of the corporate due diligence obtained
by Borrower to verify the legal name and state of organization of the seller of the assets,
(c) payoff letters from the holders of any Liens covering the assets to be purchased (which
payoff letter shall include wire instructions and authorize the filing of termination
statements with respect to such Liens upon the receipt of the funds specified in the payoff
letter) and (d) if not provided in a required payoff letter, wire instructions signed by an
authorized officer of the seller or any other Person to whom Lender will be transferring
funds as directed by Borrower in connection with the acquisition.

(ii) If the prior consent of the Lender is required under paragraph (i) above, Borrower shall
deliver to Lender for its review and approval at least three (3) Business Days (ten (10) Business
Days if the proposed Diabetes Business Acquisition shall be made pursuant to an asset purchase
agreement which is not in substantially the form of Exhibit D-1 attached hereto) prior to
the closing date of the proposed Diabetes Business Acquisition (i) the draft versions of the asset
purchase agreement, bill of sale, assignment, non-competition and/or non-solicitation agreement,
and other material transaction documents; (ii) copies of UCC search reports (together with copies
of underlying UCC financing statements) from a reputable corporate search company against the
seller of the assets, (iii) a copy of the corporate due diligence obtained by Borrower to verify
the legal name and state of organization of the seller of the assets, (iv) payoff letters from the
holders of any Liens covering the assets to be purchased (which payoff letter shall include wire
instructions and authorize the filing of termination statements with respect to such Liens upon the
receipt of the funds specified in the payoff letter) and (v) if not provided in a required payoff
letter, wire instructions signed by an authorized officer of the seller or any other Person to whom
Lender will be transferring funds as directed by Borrower in connection with the acquisition and,
if the Lender does not provide any objections or comments to the proposed Diabetes Business
Acquisition within one (1) Business Day (three (3) Business Days if the Lender is required to
provide at least ten (10) Business Days prior notice thereof as set forth above) of the delivery
thereof to the Lender, all of the foregoing shall be deemed to be satisfactory in form and
substance to and consented to by the Lender;

(iii) Borrower shall deliver to Lender as soon as practicable (but not later than seven (7)
Business Days) following the closing date of the proposed Diabetes Business Acquisition the final,
execution versions of the asset purchase agreement, bill of sale, assignment, non-competition
and/or non-solicitation agreement, and other material transaction documents, together with a copy
of (a) any resolutions of the seller’s board of directors, managers or otherwise authorizing the
transaction, (b) if the purchase price for proposed Diabetes Business Acquisition is in excess of
$1,000,000 deliver to the Escrow Agent an updated Diabetes Customer List as required under
Section 6.17, and (c) a certificate stating that the Diabetes Business Acquisition has been
closed in accordance with the terms and conditions of this Agreement.

(iv) Borrower shall have collaterally assigned (or caused to be assigned) to Lender the
purchase agreement, non-compete agreements and restrictive covenants, if any, arising out of such
Diabetes Business Acquisition (and the consent of the person bound thereby shall either have been
obtained or shall not be required) and, if required by Lender, executed such documents, agreements
and instruments and granted such liens and security interests as may be required by Lender and its
legal counsel.

(v) Borrower shall promptly take such actions, and execute and deliver such documents,
agreements and instruments as Lender and its legal counsel shall require to insure that Lender
obtains (subject to Permitted Liens) a first priority perfected Lien on any of the assets acquired
by Borrower in connection with the proposed Diabetes Business Acquisition, including but not being
limited to uniform commercial code financing statements and termination statements, all of the
foregoing to be acceptable to the Lender and its legal counsel.

All documents, agreements, instruments and other information required to be delivered to
Lender under this Section 7.4 shall be sent to the following persons at the addresses set
forth below (or to such other persons and such other address as such party may hereafter specify in
a notice given in the manner required under this Section 12.5 of this Agreement):

	 	 	 	 	 
	Todd Gordon
Director
CapitalSource Finance LLC
	 	 	 	 
	4445 Willard Avenue, 12th Floor

	Chevy Chase, MD 20815
Telephone:
	 	 	(301) 841-2978	 
	Facsimile:
	 	 	(301) 841-2340	 

	 	 	 	 	 
	John F. Wolter
	 	 	 	 
	Updike, Kelly & Spellacy, P.C.

	P.O. Box 231277
One State Street
Hartford, CT 06123-1277
Telephone:
	 	 	(860) 548-2645	 
	Facsimile:
	 	 	(860) 548-6072	 

Any delivery under this Section 7.4 shall be given, and shall be deemed to have been
received by Lender, in the manner specified, and as otherwise set forth, in Section 12.15.

7.5 Dividends; Redemptions

Borrower shall not (i) declare, pay or make any dividend or Distribution on any shares of
capital stock or other securities or interests (other than dividends or Distributions payable in
its stock, or split-ups or reclassifications of its stock), (ii) apply any of its funds, property
or assets to the acquisition, redemption or other retirement of any capital stock or other
securities or interests or of any options to purchase or acquire any of the foregoing (provided,
however, that Borrower may redeem its capital stock from terminated employees (other than the
Employees except to the extent permitted under the Employee Subordination Agreements) pursuant to,
but only to the extent required under, the terms of the related employment agreements as long as no
Default or Event of Default has occurred and is continuing or would be caused by or result from the
payment thereof and as long as the aggregate amount of payments made to such terminating employees
in any fiscal year does not exceed $50,000), (iii) otherwise make any payments or Distributions to
any stockholder, member, partner or other equity owner in such Person’s capacity as such, or (iv)
make any payment of any Management or Service Fee; provided, however, Borrower may
(A) make payments in the ordinary course of business in accordance with the terms of the Employment
Agreements to the extent that such payments are not otherwise prohibited under the terms of the
Employee Subordination Agreements, (B) payments of Tax Distributions as long as no Event of Default
has occurred and is continuing or would result therefrom, and (C) payments for redemptions or puts
as contemplated by Section 5 of the MHR Subordinated Note to the extent that such payments are not
otherwise prohibited under the terms of the MHR Subordination Agreement and, if such redemption
occurs under (a) Section 5(a), either the Lender has consented to Borrower’s incurrence of the
Indebtedness necessary to consummate the Contravening Transaction under Section 7.1 of this
Agreement (which consent shall be deemed to be a consent to such redemption under this Section 7.5)
or the Obligations are being simultaneously paid in full in cash, (b) Section 5(b) or 5(c) of the
MHR Subordinated Note, either the Lender has consented thereto or the Obligations are being
simultaneously paid in full in cash, or (c) Section 5(d) of the MHR Subordinated Note, such
redemption is made only in strict accordance with such Section 5(d), as in effect on February 28,
2005 and without amendment or modification and the proceeds (net of fees, expenses, commissions and
other amounts required to be paid from such proceeds) to Borrower from the exercise of warrants
contemplated and described in such Section 5(d) are at least four (4) times the proceeds utilized
by Borrower to effect such redemption; provided, further, that Borrower shall not
make or suffer to exist any such payment described in (i) through (iv) above if a Default of Event
of Default has occurred and is continuing or would result therefrom.

7.6 Transactions with Affiliates

Borrower shall not enter into or consummate any transaction of any kind with (i) any of its
Affiliates or (ii) any Guarantor or any of their respective Affiliates other than: (a) salary,
bonus, severance, employee stock option and other compensation and employment arrangements with
directors or officers in the ordinary course of business, provided, that no payment of any
bonus or severance shall be permitted if a Default or Event of Default has occurred and remains in
effect or would be caused by or result from such payment and provided further that, regardless of
whether a Default or Event of Default shall have occurred and remain in effect or would be caused
by or result from such payment, no payment of any severance shall be made, individually or in the
aggregate, in excess of $250,000 in any twelve (12) month period, (b) Distributions and dividends
permitted pursuant to Section 7.5, (c) transactions with Lender or any Affiliate of Lender,
(d) payments permitted under and pursuant to written agreements entered into by and between
Borrower and one or more of its Affiliates that both (A) reflect and constitute transactions on
overall terms at least as favorable to Borrower as would be the case in an arm’s-length transaction
between unrelated parties of equal bargaining power, and (B) are subject to such terms and
conditions as determined by Lender in its sole discretion; provided, that notwithstanding
the foregoing clauses (A) and (B) above Borrower shall not (Y) enter into or consummate any
transaction or agreement pursuant to which it becomes a party to any mortgage, note, indenture or
guarantee evidencing any Indebtedness of any of its Affiliates or otherwise to become responsible
or liable, as a guarantor, surety or otherwise, pursuant to agreement for any Indebtedness of any
such Affiliate, or (Z) make any payment to any of its Affiliates in excess of $10,000 without the
prior written consent of Lender and (e) notwithstanding subsection (a) above, (i) payments of
salary, bonus, severance and deferred compensation under the Gregg Separation Agreement; provided
however that payments in respect of “Put Right(s)” under the Gregg Separation Agreement shall
continue to be governed by the Employee Subordination Agreement and (ii) severance payments during
the period commencing as of September 30, 2006 and ending December 31, 2007 in the aggregate amount
of $1,000,000.

	 	7.7	 	Charter Documents; Fiscal Year; Name; Jurisdiction of Organization;
Dissolution; Use of Proceeds

Borrower shall not (i) amend, modify, restate or change its certificate of incorporation or
formation or bylaws or similar charter documents in a manner that would be adverse to Lender,
(ii) change its fiscal year unless Borrower demonstrates to Lender’s satisfaction compliance with
the covenants contained herein for both the fiscal year in effect prior to any change and the new
fiscal year period by delivery to Lender of appropriate interim and annual pro forma, historical
and current compliance certificates for such periods and such other information as Lender may
reasonably request, (iii) without at least 20 days prior written notice to Lender, change its name
or change its jurisdiction of organization; (iv) amend, alter or suspend or terminate or make
provisional in any material way, any Permit without the prior written consent of Lender, which
consent shall not be unreasonably withheld, (v) wind up, liquidate or dissolve (voluntarily or
involuntarily) or commence or suffer any proceedings seeking or that would result in any of the
foregoing, or (vi) use any proceeds of any Advance for “purchasing” or “carrying” “margin stock” as
defined in Regulations U, T or X of the Board of Governors of the Federal Reserve System.

7.8 Truth of Statements

Borrower shall not furnish to Lender any certificate or other document that contains any
untrue statement of a material fact or that omits to state a material fact necessary to make it not
misleading in light of the circumstances under which it was furnished.

7.9 IRS Form 8821

Borrower shall not alter, amend, restate, or otherwise modify, or withdraw, terminate or
re-file the IRS Form 8821 required to be filed pursuant to the Conditions Precedent in Section
4.1 hereof.

7.10 Transfer of Assets

Notwithstanding any other provision of this Agreement or any other Loan Document, Borrower
shall not sell, lease, transfer, assign or otherwise dispose of any interest in any properties or
assets (other than obsolete equipment or excess equipment no longer needed in the conduct of the
business in the ordinary course of business and sales of Inventory in the ordinary course of
business), or agree to do any of the foregoing at any future time, except that:

(a) Borrower may lease (as lessee) real or personal property or surrender all or a portion of
a lease of the same, in each case in the ordinary course of business (so long as such lease does
not create or result in and is not otherwise a Capitalized Lease Obligation prohibited under this
Agreement), provided that a Landlord Waiver and Consent and such other consents as are
required by Lender are signed and delivered to Lender with respect to any lease of real or other
property, as applicable, if such real or other property serves as corporate headquarters or a
billing office, if any books or records, Accounts or other properties relating to Accounts are
located thereat or if other assets in excess of $10,000 are maintained at such property;

(b) Borrower may arrange for the warehousing, fulfillment or storage of Inventory at locations
not owned or leased by Borrower, in each case in the ordinary course of business, provided
that a Warehouse Waiver and Consent and such other consents as are required by Lender are signed
and delivered to Lender with respect to any such location;

(c) Borrower may license or sublicense Intellectual Property or customer lists from third
parties in the ordinary course of business, provided, that such licenses or sublicenses
shall not interfere with the business or other operations of Borrower and that Borrower’s rights,
title and/or interest in or to such Intellectual Property and customer lists and interests therein
are pledged to Lender as further security for the Obligations and included as part of the
Collateral if permitted in accordance with its terms; and

(d) Borrower may consummate such other sales or dispositions of property or assets (including
any sale or transfer or disposition of all or any part of its assets and thereupon and within one
year thereafter rent or lease the assets so sold or transferred) only to the extent prior written
notice has been given to Lender and to the extent Lender has given its prior written consent
thereto, subject in each case to such conditions as may be set forth in such consent.

7.11 Payment on Permitted Subordinated Debt

Except as permitted by the Subordination Agreement relating to such Permitted Subordinated
Debt, Borrower shall not (i) make any prepayment of any part or all of any Permitted Subordinated
Debt, (ii) repurchase, redeem or retire any instrument evidencing any such Permitted Subordinated
Debt prior to maturity, or (iii) enter into any agreement (oral or written) which could in any way
be construed to amend, modify, alter or terminate any one or more instruments or agreements
evidencing or relating to any Permitted Subordinated Debt in a manner adverse to Lender, as
determined by Lender in its sole discretion.

7.12 Diabetes Customer Lists

Borrower shall not sell, lease or otherwise dispose of any Diabetes Customer List, permit any
Diabetes Customer List to be subject to any Lien or provide or permit access to any Diabetes
Customer List to any Person other than the Lender, the Escrow Agent or as otherwise required by
applicable law.

	VIII.	 	EVENTS OF DEFAULT

The occurrence of any one or more of the following shall constitute an “Event of Default:”

(a) Borrower shall fail to pay any amount on the Obligations or provided for in any Loan
Document when due (whether on any payment date, at maturity, by reason of acceleration, by notice
of intention to prepay, by required prepayment or otherwise);

(b) any representation, statement or warranty made or deemed made by Borrower or any Guarantor
in any Loan Document or in any other certificate, document, report or opinion delivered in
conjunction with any Loan Document to which it is a party, shall not be true and correct in all
material respects or shall have been false or misleading in any material respect on the date when
made or deemed to have been made (except to the extent already qualified by materiality, in which
case it shall be true and correct in all respects and shall not be false or misleading in any
respect);

(c) Borrower or any Guarantor or other party thereto other than Lender shall be in violation,
breach or default of, or shall fail to perform, observe or comply with any covenant, obligation or
agreement set forth in, any Loan Document and such violation, breach, default or failure shall not
be cured within the applicable period set forth in the applicable Loan Document; provided
that, with respect to the affirmative covenants set forth in Article VI (other than
Sections 6.1(c), 6.2, 6.3(i), (ii) and (iii), 6.5, 6.8, 6.9, 6.11, 6.17, 6.18 and
6.19 for which there shall be no cure period), there shall be a fifteen (15) calendar day cure
period commencing from the earlier of (i) Receipt by such Person of written notice of such breach,
default, violation or failure, and (ii) the time at which such Person or any authorized officer
thereof knew or became aware, or should have known or been aware, of such failure, violation,
breach or default, but no Advances will be made during the cure period;

(d) (i) any of the Loan Documents ceases to be in full force and effect, or (ii) any Lien
created thereunder ceases to constitute a valid perfected first priority Lien on the Collateral in
accordance with the terms thereof (other than as a result of the action or inaction of Lender), or
Lender ceases to have a valid perfected first priority security interest in any of the Collateral
or any securities pledged to Lender pursuant to the Security Documents;

(e) one or more tax assessments, judgments or decrees is rendered against any Borrower or
Guarantor in an amount in excess of $10,000 individually or $50,000 in the aggregate, which is/are
not satisfied, stayed, vacated or discharged of record within thirty (30) calendar days of being
rendered but no Advances will be made before the judgment is stayed, vacated or discharged;

(f) (i) any default occurs, which is not cured or waived, (x) in the payment of any amount
with respect to any Indebtedness for borrowed money (other than the Obligations) of any Borrower or
Guarantor in excess of $10,000, (y) in the performance, observance or fulfillment of any provision
contained in any agreement, contract, document or instrument to which any Borrower or Guarantor is
a party or to which any of their properties or assets are subject or bound under or pursuant to
which any Indebtedness was issued, created, assumed, guaranteed or secured and such default
continues for more than any applicable grace period or permits the holder of any Indebtedness to
accelerate the maturity thereof, or (z) in the performance, observance or fulfillment of any
provision contained in any agreement, contract, document or instrument between any Borrower or
Guarantor and Lender or any Affiliate of Lender (other than the Loan Documents), or (ii) any
Indebtedness of any Borrower or any Guarantor is declared to be due and payable or is required to
be prepaid (other than by a regularly scheduled payment) prior to the stated maturity thereof, or
any obligation of such Person for the payment of Indebtedness (other than the Obligations) is not
paid when due or within any applicable grace period, or any such obligation becomes or is declared
to be due and payable before the expressed maturity thereof, or there occurs an event which, with
the giving of notice or lapse of time, or both, would cause any such obligation to become, or allow
any such obligation to be declared to be, due and payable;

(g) any Borrower or Guarantor shall (i) be unable to pay its debts generally as they become
due, (ii) have total liabilities (including contingent, subordinated, unmatured and unliquidated
liabilities) that exceed its assets, at a Fair Valuation, (iii) have an unreasonably small capital
base with which to engage in its anticipated business, (iv) file a petition under any insolvency
statute, (v) make a general assignment for the benefit of its creditors, (vi) commence a proceeding
for the appointment of a receiver, trustee, liquidator or conservator of itself or of the whole or
any substantial part of its property, or (vii) file a petition seeking reorganization or
liquidation or similar relief under any Debtor Relief Law or any other applicable law or statute;

(h) a court of competent jurisdiction shall (A) enter an order, judgment or decree appointing
a custodian, receiver, trustee, liquidator or conservator of any Borrower or Guarantor or the whole
or any substantial part of any such Person’s properties, which shall continue unstayed and in
effect for a period of thirty (30) calendar days, (B) shall approve a petition filed against any
Borrower or Guarantor seeking reorganization, liquidation or similar relief under the any Debtor
Relief Law or any other applicable law or statute, which is not dismissed within thirty (30)
calendar days or, (C) under the provisions of any Debtor Relief Law or other applicable law or
statute, assume custody or control of any Borrower or Guarantor or of the whole or any substantial
part of any such Person’s properties, which is not irrevocably relinquished within thirty (30)
calendar days, or (ii) there is commenced against any Borrower or Guarantor any proceeding or
petition seeking reorganization, liquidation or similar relief under any Debtor Relief Law or any
other applicable law or statute and either (A) any such proceeding or petition is not
unconditionally dismissed within thirty (30) calendar days after the date of commencement, or (B)
any Borrower or Guarantor takes any action to indicate its approval of or consent to any such
proceeding or petition, but no Advances will be made before any such order, judgment or decree
described above is stayed, vacated or discharged, any such petition described above is dismissed,
or any such custody or control described above is relinquished;

(i) (i) any Change of Control occurs or any agreement or commitment to cause or that may
result in any such Change of Control is entered into, (ii) any Material Adverse Effect, or Material
Adverse Change occurs or is reasonably expected to occur, (iii) any Liability Event occurs or is
reasonably expected to occur, or (iv) any Borrower or Guarantor ceases a material portion of its
business operations as currently conducted;

(j) Lender receives any indication or evidence that any Borrower or Guarantor may have
directly or indirectly been engaged in any type of activity which, in Lender’s judgment, is likely
to result in forfeiture of any property to any Governmental Authority which shall have continued
unremedied for a period of ten (10) calendar days after written notice from Lender (but no Advances
will be made before any such activity ceases);

(k) an Event of Default occurs under any other Loan Document;

(l) uninsured damage to, or loss, theft or destruction of, any portion of the Collateral
occurs that exceeds $10,000 in the aggregate;

(m) any Borrower or Guarantor or any of their respective directors or senior officers is
criminally indicted or convicted under any law that could lead to a forfeiture of any Collateral;

(n) the issuance of any process for levy, attachment or garnishment or execution upon or prior
to any judgment against any Borrower or Guarantor or any of their property or assets which is/are
not satisfied, stayed, vacated or discharged of record within thirty (30) calendar days of being
issued;

(o) any Borrower or Guarantor does, or enters into or becomes a party to any agreement or
commitment to do, or cause to be done, any of the things described in this Article VIII or
otherwise prohibited by any Loan Document (subject to any cure periods set forth therein);

(p) any Employment Agreements shall be terminated in a manner which requires the payment of
termination benefits in accordance with Section 5(b) thereof or any “Notice of Enforcement
Action” or “Notice of Final Determination” shall be delivered to Lender pursuant to the Employee
Subordination Agreement;

(q) any default or event of default shall occur under the MHR Subordinated Note or any of the
documents, agreements and instruments evidencing or securing the MHR Subordinated Debt, provided
such default or event of default is not cured within any applicable cure periods under the
documents, instruments and other agreements evidencing or securing the MHR Subordinated Debt; or

(r) Borrower or any Guarantor or other party thereto other than Lender shall be in violation,
breach or default of, or shall fail to perform, observe or comply with any covenant, obligation or
agreement set forth in, any document governing the relations between any Borrower with any
Affiliate and such violation, breach, default or failure shall not be cured within the applicable
period set forth in that document;

then, and in any such event, notwithstanding any other provision of any Loan Document, Lender may,
without notice or demand, do any of the following: (i) terminate its obligations to make Advances
hereunder, whereupon the same shall immediately terminate and (ii) declare all or any of the Loans,
all interest thereon and all other Obligations to be due and payable immediately (except in the
case of an Event of Default under Section 8(d), (g), (h) or
(i)(iii), in which event all of the foregoing shall automatically and without further act
by Lender be due and payable, provided that, with respect to non-material breaches or
violations that constitute Events of Default under clause (ii) of Section 8(d), there shall
be a three (3) Business Day cure period (but no Advances will be made during any such cure period)
commencing from the earlier of (A) Receipt by the applicable Person of written notice of such
breach or violation or of any event, fact or circumstance constituting or resulting in any of the
foregoing, and (B) the time at which such Person or any authorized officer thereof knew or became
aware, or should have known or been aware, of such breach or violation and resulting Event of
Default or of any event, fact or circumstance constituting or resulting in any of the foregoing),
in each case without presentment, demand, protest or further notice of any kind, all of which are
hereby expressly waived by Borrower.

	 	 	 	 	 	 	 
	IX.	 	RIGHTS AND REMEDIES AFTER DEFAULT
	 
	 	 	 	 	 	 
	
 
	 	 	9.1	 	 	Rights and Remedies

(a) In addition to the acceleration provisions set forth in Article VIII above, upon
the occurrence and continuation of an Event of Default, Lender shall have the right to exercise any
and all rights, options and remedies provided for in the Loan Documents, under the UCC or at law or
in equity, including, without limitation, the right to (i) apply any property of any Borrower held
by Lender to reduce the Obligations, (ii) foreclose the Liens created under the Security Documents,
(iii) realize upon, take possession of and/or sell any Collateral or securities pledged (other than
Collateral consisting of Accounts owed or owing by Medicaid/Medicare Account Debtors absent a court
order or compliance with applicable law) with or without judicial process (subject, in the case of
the Diabetes Customer Lists only, to the provisions of (x) subsection (b) of this Section 9.1 and
(y) Section 9.4), (iv) exercise all rights and powers with respect to the Collateral as any
Borrower, as applicable, might exercise (other than with respect to Collateral consisting of
Accounts owed or owing by Medicaid/Medicare Account Debtors absent a court order or compliance with
applicable law), (v) collect and send notices regarding the Collateral (other than with respect to
Collateral consisting of Accounts owed or owing by Medicaid/Medicare Account Debtors absent a court
order or compliance with applicable law), with or without judicial process, (vi) by its own means
or with judicial assistance, enter any premises at which Collateral and/or pledged securities are
located, or render any of the foregoing unusable or dispose of the Collateral and/or pledged
securities on such premises without any liability for rent, storage, utilities, or other sums, and
no Borrower shall resist or interfere with such action, (vii) at Borrower’s expense, require that
all or any part of the Collateral be assembled and made available to Lender at any place designated
by Lender, (viii) reduce or otherwise change the Facility Cap or the Term Loan Amount, (ix)
relinquish or abandon any Collateral or securities pledged or any Lien thereon and/or (x) continue
to charge all interest, fees and other amounts provided under this Agreement on the Minimum Balance
regardless of whether Advances are made or outstanding. Notwithstanding any provision of any Loan
Document, Lender shall have the right, at any time that Borrower fails to do so, and from time to
time, without prior notice, to: (i) obtain insurance covering any of the Collateral to the extent
required hereunder or Lender to the extent required under Landlord Waiver and Consent or Warehouse
Waiver and Consent; (ii) pay for the performance of any of Obligations; (iii) discharge taxes or
Liens on any of the Collateral that are in violation of any Loan document unless Borrower is in
good faith with due diligence by appropriate proceedings contesting those items; and (iv) pay for
the maintenance and preservation of the Collateral, including the payment of rent, warehouse fees
or other per diem charges if required under any Landlord Waiver and Consent or Warehouse Waiver and
Consent. Such expenses and advances shall be added to the Obligations until reimbursed to Lender
and shall be secured by the Collateral, and such payments by Lender shall not be construed as a
waiver by Lender of any Event of Default or any other rights or remedies of Lender.

(b) Borrower agrees that notice received by it at least ten (10) calendar days before the time
of any intended public sale, or the time after which any private sale or other disposition of
Collateral (fifteen (15) calendar days in the case of any intended public sale, or the time after
which any private sale or other disposition of the Diabetes Customer List) is to be made, shall be
deemed to be reasonable notice of such sale or other disposition. If permitted by applicable law,
any perishable Collateral which threatens to speedily decline in value or which is sold on a
recognized market may be sold immediately by Lender without prior notice to Borrower. At any sale
or disposition of Collateral or securities pledged, Lender may (to the extent permitted by
applicable law) purchase all or any part thereof free from any right of redemption by any Borrower
which right is hereby waived and released. Borrower covenants and agrees not to, and not to permit
or cause any of its Subsidiaries to, interfere with or impose any obstacle to Lender’s exercise of
its rights and remedies with respect to the Collateral. Lender, in dealing with or disposing of
the Collateral or any part thereof, shall not be required to give priority or preference to any
item of Collateral or otherwise to marshal assets or to take possession or sell any Collateral with
judicial process.

9.2 Application of Proceeds

In addition to any other rights, options and remedies Lender has under the Loan Documents, the
UCC, at law or in equity, all dividends, interest, rents, issues, profits, fees, revenues, income
and other proceeds collected or received from collecting, holding, managing, renting, selling, or
otherwise disposing of all or any part of the Collateral or any proceeds thereof upon exercise of
its remedies hereunder shall be applied in the following order of priority: (i) first, to
the payment of all costs and expenses of such collection, storage, lease, holding, operation,
management, sale, disposition or delivery and of conducting Borrower’s business and of maintenance,
repairs, replacements, alterations, additions and improvements of or to the Collateral, and to the
payment of all sums which Lender may be required or may elect to pay, if any, for taxes,
assessments, insurance and other charges upon the Collateral or any part thereof, and all other
payments that Lender may be required or authorized to make under any provision of this Agreement
(including, without limitation, in each such case, in-house documentation and diligence fees and
legal expenses, search, audit, recording, professional and filing fees and expenses and reasonable
attorneys’ fees and all expenses, liabilities and advances made or incurred in connection
therewith); (ii) second, to the payment of all Obligations as provided herein;
(iii) third, to the satisfaction of Indebtedness secured by any subordinate security
interest of record in the Collateral if written notification of demand therefor is received before
distribution of the proceeds is completed, provided, that, if requested by Lender, the
holder of a subordinate security interest shall furnish reasonable proof of its interest, and
unless it does so, Lender need not address its claims; and (iv) fourth, to the payment of
any surplus then remaining to Borrower, unless otherwise provided by law or directed by a court of
competent jurisdiction, provided that Borrower shall be liable for any deficiency if such
proceeds are insufficient to satisfy the Obligations or any of the other items referred to in this
section.

9.3 Rights of Lender to Appoint Receiver

Without limiting and in addition to any other rights, options and remedies Lender has under
the Loan Documents, the UCC, at law or in equity, upon the occurrence and continuation of an Event
of Default, Lender shall have the right to apply for and have a receiver appointed by a court of
competent jurisdiction in any action taken by Lender to enforce its rights and remedies in order to
manage, protect and preserve the Collateral and continue the operation of the business of Borrower
and to collect all revenues and profits thereof and apply the same to the payment of all expenses
and other charges of such receivership including the compensation of the receiver and to the
payments as aforesaid until a sale or other disposition of such Collateral shall be finally made
and consummated.

9.4 Rights of Lender to Certain Assets of Borrower

Without limiting and in addition to any other rights, options and remedies Lender has
under the Loan Documents, the UCC, at law or in equity, upon (i) the termination by Lender of its
obligations to make Advances under Section 8, (ii) the declaration by Lender that all or any of the
Notes, all interest thereon and all other Obligations are due and payable immediately (or, in the
case of an Event of Default under Section 8(d), (g), (h) or
(i)(iii), the automatic acceleration of the foregoing as provided in Section 8 above, and
(iii) the failure of the Lender to pay all Obligations so due and payable (or post cash collateral
acceptable to the Lender in an amount equal to 105% of the Obligations) within a ten (10) Business
Days period commencing from the earlier of (A) Receipt by Borrower of written notice of such
termination and acceleration of the Loans, and (B) the time at which any authorized officer of
Borrower knew or became aware of such termination or acceleration, in each case without
presentment, demand, protest or further notice of any kind, all of which are hereby expressly
waived by Borrower, Lender may in connection with a Borrower Sale (whether by public sale, private
sale or other disposition), without notice or demand, instruct the Escrow Agent to immediately
deliver to Lender (or any investment banker or other consultant retained by Lender to conduct a
Borrower Sale and who has executed a business associate agreement substantially in the form of
Exhibit E attached hereto) the Diabetes Customer List then in the possession of the Escrow
Agent in order to permit Lender (or such investment banker or consultant) to perform due diligence
for the Borrower Sale. In addition, if Lender has not previously obtained possession of the
Diabetes Customer List from the Escrow Agent under this Section 9.4, Borrower acknowledges and
agrees that Lender may assign its rights under the Escrow Agreement (including, without limitation,
the right to obtain possession of the Diabetes Customer List) to a Person for the sole purpose of
consummating any Borrower Sale. The rights of Lender under this Section 9.4 shall be in addition
to, and without limitation upon, all rights of Lender to, and liens and security interests
possessed by Lender in, any other customer lists and other books, records and other information
concerning Borrower’s diabetes business then in the possession of Borrower or which may be in
transit to the Escrow Agent. The ten (10) Business Day period set forth in this Section 9.4 is not
a cure period and shall not restrict the right of the Lender to exercise any of its other rights
and remedies under this Agreement, the other Loan Documents or applicable law against Borrower, any
Guarantor or any other Collateral during such period. For purposes of this Section 9.4, “Borrower
Sale” shall mean the sale, transfer, merger or consolidation of all or a part of the assets of
Borrower to or with another “covered entity” under HIPAA or an entity that following such sale,
transfer, merger or consolidation will become a “covered entity” under HIPAA or due diligence with
respect to such sale, transfer, merger or consolidation.

9.5 Rights and Remedies not Exclusive

Lender shall have the right in its sole discretion to determine which rights, Liens and/or
remedies Lender may at any time pursue, relinquish, subordinate or modify, and such determination
will not in any way modify or affect any of Lender’s rights, Liens or remedies under any Loan
Document, applicable law or equity. The enumeration of any rights and remedies in any Loan
Document is not intended to be exhaustive, and all rights and remedies of Lender described in any
Loan Document are cumulative and are not alternative to or exclusive of any other rights or
remedies which Lender otherwise may have. The partial or complete exercise of any right or remedy
shall not preclude any other further exercise of such or any other right or remedy.

	X.	 	WAIVERS AND JUDICIAL PROCEEDINGS

10.1 Waivers

Except as expressly provided for herein, Borrower hereby waives setoff, counterclaim, demand,
presentment, protest, all defenses with respect to any and all instruments and all notices and
demands of any description, and the pleading of any statute of limitations as a defense to any
demand under any Loan Document. Borrower hereby waives any and all defenses and counterclaims it
may have or could interpose in any action or procedure brought by Lender to obtain an order of
court recognizing the assignment of, or Lien of Lender in and to, any Collateral, whether or not
payable by a Medicaid/Medicare Account Debtor. With respect to any action hereunder, Lender
conclusively may rely upon, and shall incur no liability to Borrower in acting upon, any request or
other communication that Lender reasonably believes to have been given or made by a person
authorized on Borrower’s behalf, whether or not such person is listed on the incumbency certificate
delivered pursuant to Section 4.1 hereof. In each such case, Borrower hereby waives the
right to dispute Lender’s action based upon such request or other communication, absent manifest
error.

10.2 Delay; No Waiver of Defaults

No course of action or dealing, renewal, release or extension of any provision of any Loan
Document, or single or partial exercise of any such provision, or delay, failure or omission on
Lender’s part in enforcing any such provision shall affect the liability of any Borrower or
Guarantor or operate as a waiver of such provision or affect the liability of any Borrower or
Guarantor or preclude any other or further exercise of such provision. No waiver by any party to
any Loan Document of any one or more defaults by any other party in the performance of any of the
provisions of any Loan Document shall operate or be construed as a waiver of any future default,
whether of a like or different nature, and each such waiver shall be limited solely to the express
terms and provisions of such waiver. Notwithstanding any other provision of any Loan Document, by
executing this Agreement and/or by making Advances on or after the Restatement Date, Lender does
not waive any breach of any representation or warranty under any Loan Document, and all of Lender’s
claims and rights resulting from any such breach or misrepresentation are specifically reserved.

10.3 Jury Waiver

EACH PARTY TO THIS AGREEMENT HEREBY EXPRESSLY WAIVES ANY RIGHT TO TRIAL BY JURY OF ANY CLAIM
OR CAUSE OF ACTION ARISING UNDER THE LOAN DOCUMENTS OR IN ANY WAY CONNECTED WITH OR INCIDENTAL TO
THE DEALINGS OF THE PARTIES WITH RESPECT TO THE LOAN DOCUMENTS OR THE TRANSACTIONS CONTEMPLATED
THEREBY, WHETHER NOW EXISTING OR HEREAFTER ARISING, AND WHETHER SOUNDING IN CONTRACT, TORT OR
OTHERWISE. EACH PARTY HEREBY AGREES AND CONSENTS THAT ANY SUCH CLAIM OR CAUSE OF ACTION SHALL BE
DECIDED BY COURT TRIAL WITHOUT A JURY, AND THAT ANY PARTY TO THIS AGREEMENT MAY FILE AN ORIGINAL
COUNTERPART OR A COPY OF THIS SECTION WITH ANY COURT AS WRITTEN EVIDENCE OF THE CONSENTS OF THE
PARTIES TO THE WAIVER OF THEIR RESPECTIVE RIGHTS TO TRIAL BY JURY.

	 	10.4	 	Cooperation in Discovery and Litigation

In any litigation, arbitration or other dispute resolution proceeding relating to any Loan
Document, Borrower waives any and all defenses, objections and counterclaims it may have or could
interpose with respect to (i) any of its directors, officers, employees or agents being deemed to
be employees or managing agents of Borrower for purposes of all applicable law or court rules
regarding the production of witnesses by notice for testimony (whether in a deposition, at trial or
otherwise), (ii) Lender’s counsel examining any such individuals as if under cross-examination and
using any discovery deposition of any of them as if it were an evidence deposition, and/or (iii)
using all commercially reasonable efforts to produce in any such dispute resolution proceeding, at
the time and in the manner requested by Lender, all Persons, documents (whether in tangible,
electronic or other form) and/or other things under its control and relating to the dispute.

	 	 	 	 	 	 	 
	XI.	 	EFFECTIVE DATE AND TERMINATION
	 
	 	 	 	 	 	 
	
 
	 	 	11.1	 	 	Termination and Effective Date Thereof

(a) Subject to Lender’s right to terminate and cease making Advances upon or after any Event
of Default, this Agreement shall continue in full force and effect until the full performance and
indefeasible payment in cash of all Obligations, unless terminated sooner as provided in this
Section 11.1. Borrower may terminate this Agreement at any time upon not less than thirty
(30) calendar days’ prior written notice to Lender and upon full performance and indefeasible
payment in full in cash of all Obligations on or prior to such 30th calendar day after
Receipt by Lender of such written notice. All of the Obligations shall be immediately due and
payable upon any such termination on the termination date stated in any notice of termination (the
“Termination Date”); provided that, notwithstanding any other provision of any Loan
Document, the Termination Date shall be effective no earlier than the first Business Day of the
month following the expiration of the thirty (30) calendar days’ prior written notice period.
Notwithstanding any other provision of any Loan Document, no termination of this Agreement shall
affect Lender’s rights or any of the Obligations existing as of the effective date of such
termination, and the provisions of the Loan Documents shall continue to be fully operative until
the Obligations have been fully performed and indefeasibly paid in cash in full. The Liens granted
to Lender under the Security Documents and the financing statements filed pursuant thereto and the
rights and powers of Lender shall continue in full force and effect notwithstanding the fact that
Borrower’s borrowings hereunder may from time to time be in a zero or credit position until all of
the Obligations have been fully performed and indefeasibly paid in full in cash.

(b) If (i) Borrower terminates the Revolving Facility under this Section 11.1,
(ii) Borrower voluntarily or involuntarily repays the Obligations (other than reductions to zero of
the outstanding balance of the Revolving Facility resulting from the ordinary course operation of
the provisions of Section 2.4), whether by virtue of Lender’s exercising its right of set
off or otherwise; (iii) the Obligations are accelerated by Lender (each of the events described in
(i), (ii) and (iii) above being hereinafter referred to as, a “Revolver Termination”), then at the
effective date of any such Revolver Termination, Borrower shall pay Lender (in addition to the then
outstanding principal, accrued interest and other Obligations relating to the Revolving Facility
pursuant to the terms of this Agreement and any other Loan Document), to compensate Lender for the
loss of bargain and not as a penalty, (i) on or before April 30, 2009, an amount equal to the
greater of (x) the applicable Minimum Termination Fee, and (y) Yield Maintenance, and (ii) after
April 30, 2009 an amount equal to the Minimum Termination Fee.

11.2 Survival

All obligations, covenants, agreements, representations, warranties, waivers and indemnities
made by Borrower in any Loan Document shall survive the execution and delivery of the Loan
Documents, the Closing, the making of the Advances and any termination of this Agreement until all
Obligations are fully performed and indefeasibly paid in full in cash. The obligations and
provisions of Sections 3.5, 3.6, 6.13, 10.1, 10.3, 11.1, 11.2, 12.4, 12.7 and 12.10 shall
survive termination of the Loan Documents and any payment, in full or in part, of the Obligations.

	 	 	 	 	 
	XII.

	 	MISCELLANEOUS

12.1
	 	

Governing Law; Jurisdiction; Service of Process; Venue

The Loan Documents shall be governed by and construed in accordance with the internal laws of
the State of Maryland without giving effect to its choice of law provisions. Any judicial
proceeding against Borrower with respect to the Obligations, any Loan Document or any related
agreement may be brought in any federal or state court of competent jurisdiction located in the
State of Maryland. By execution and delivery of each Loan Document to which it is a party,
Borrower (i) accepts the non-exclusive jurisdiction of the aforesaid courts and irrevocably agrees
to be bound by any judgment rendered thereby, (ii) waives personal service of process, (iii) agrees
that service of process upon it may be made by certified or registered mail, return receipt
requested, pursuant to Section 12.5 hereof, (iv) waives any objection to jurisdiction and
venue of any action instituted hereunder and agrees not to assert any defense based on lack of
jurisdiction, venue or convenience, and (v) agrees that this loan was made in Maryland, that Lender
has accepted in Maryland Loan Documents executed by Borrower and has disbursed Advances under the
Loan Documents in Maryland. Nothing shall affect the right of Lender to serve process in any
manner permitted by law or shall limit the right of Lender to bring proceedings against Borrower in
the courts of any other jurisdiction having jurisdiction. Any judicial proceedings against Lender
involving, directly or indirectly, the Obligations, any Loan Document or any related agreement
shall be brought only in a federal or state court located in the State of Maryland. All parties
acknowledge that they participated in the negotiation and drafting of this Agreement and that,
accordingly, no party shall move or petition a court construing this Agreement to construe it more
stringently against one party than against any other.

12.2 Successors and Assigns; Participations; New Lenders

THE LOAN DOCUMENTS SHALL INURE TO THE BENEFIT OF LENDER, TRANSFEREES AND ALL FUTURE HOLDERS OF
ANY NOTE, THE OBLIGATIONS AND/OR ANY OF THE COLLATERAL, AND EACH OF THEIR RESPECTIVE SUCCESSORS AND
ASSIGNS. EACH LOAN DOCUMENT SHALL BE BINDING UPON THE PERSONS’ OTHER THAN LENDER THAT ARE PARTIES
THERETO AND THEIR RESPECTIVE SUCCESSORS AND ASSIGNS, AND NO SUCH PERSON MAY ASSIGN, DELEGATE OR
TRANSFER ANY LOAN DOCUMENT OR ANY OF ITS RIGHTS OR OBLIGATIONS THEREUNDER WITHOUT THE PRIOR WRITTEN
CONSENT OF LENDER. NO RIGHTS ARE INTENDED TO BE CREATED UNDER ANY LOAN DOCUMENT FOR THE BENEFIT OF
ANY THIRD PARTY DONEE, CREDITOR OR INCIDENTAL BENEFICIARY OF ANY BORROWER OR GUARANTOR. NOTHING
CONTAINED IN ANY LOAN DOCUMENT SHALL BE CONSTRUED AS A DELEGATION TO LENDER OF ANY OTHER PERSON’S
DUTY OF PERFORMANCE. BORROWER ACKNOWLEDGES AND AGREES THAT LENDER AT ANY TIME AND FROM TIME TO
TIME MAY (I) DIVIDE AND RESTATE ANY NOTE, AND/OR (II) SELL, ASSIGN OR GRANT PARTICIPATING INTERESTS
IN OR TRANSFER ALL OR ANY PART OF ITS RIGHTS OR OBLIGATIONS UNDER ANY LOAN DOCUMENT, NOTE, THE
OBLIGATIONS AND/OR THE COLLATERAL TO OTHER PERSONS (EACH SUCH TRANSFEREE, ASSIGNEE OR PURCHASER, A
“TRANSFEREE”). EACH TRANSFEREE SHALL HAVE ALL OF THE RIGHTS AND BENEFITS WITH RESPECT TO THE
OBLIGATIONS, NOTES, COLLATERAL AND/OR LOAN DOCUMENTS HELD BY IT AS FULLY AS IF THE ORIGINAL HOLDER
THEREOF, AND EITHER LENDER OR ANY TRANSFEREE MAY BE DESIGNATED AS THE SOLE AGENT TO MANAGE THE
TRANSACTIONS AND OBLIGATIONS CONTEMPLATED THEREIN; PROVIDED THAT, NOTWITHSTANDING ANYTHING
TO THE CONTRARY IN ANY LOAN DOCUMENT, BORROWER SHALL NOT BE OBLIGATED TO PAY UNDER THIS AGREEMENT
TO ANY TRANSFEREE ANY SUM IN EXCESS OF THE SUM WHICH BORROWER WOULD HAVE BEEN OBLIGATED TO PAY TO
LENDER HAD SUCH PARTICIPATION NOT BEEN EFFECTED. NOTWITHSTANDING ANY OTHER PROVISION OF ANY LOAN
DOCUMENT, LENDER MAY DISCLOSE TO ANY TRANSFEREE ALL INFORMATION, REPORTS, FINANCIAL STATEMENTS,
CERTIFICATES AND DOCUMENTS OBTAINED UNDER ANY PROVISION OF ANY LOAN DOCUMENT.

12.3 Application of Payments

To the extent that any payment made or received with respect to the Obligations is
subsequently invalidated, determined to be fraudulent or preferential, set aside or required to be
repaid to a trustee, debtor in possession, receiver, custodian or any other Person under any Debtor
Relief Law, common law or equitable cause or any other law, then the Obligations intended to be
satisfied by such payment shall be revived and shall continue as if such payment had not been
received by Lender. Any payments with respect to the Obligations received shall be credited and
applied in such manner and order as Lender shall decide in its sole discretion.

12.4 Indemnity

Each Borrower jointly and severally shall indemnify Lender, its Affiliates and its and their
respective managers, members, officers, employees, Affiliates, agents, representatives, successors,
assigns, accountants and attorneys (collectively, the “Indemnified Persons”) from and against any
and all liabilities, obligations, losses, damages, penalties, actions, judgments, suits, costs,
expenses and disbursements of any kind or nature whatsoever (including, without limitation,
reasonable fees and disbursements of counsel and in-house documentation and diligence fees and
legal expenses) which may be imposed on, incurred by or asserted against any Indemnified Person
with respect to or arising out of, or in any litigation, proceeding or investigation instituted or
conducted by any Person with respect to any aspect of, or any transaction contemplated by or
referred to in, or any matter related to, any Loan Document or any agreement, document or
transaction contemplated thereby, whether or not such Indemnified Person is a party thereto, except
to the extent that any of the foregoing arises out of the gross negligence or willful misconduct of
such Indemnified Person. If any Indemnified Person uses in-house counsel for any purpose for which
any Borrower is responsible to pay or indemnify, each Borrower expressly agrees that its
indemnification obligations include reasonable charges for such work commensurate with the fees
that would otherwise be charged by outside legal counsel selected by such Indemnified Person in its
sole discretion for the work performed. Lender agrees to give Borrower reasonable notice of any
event of which Lender becomes aware for which indemnification may be required under this
Section 12.4, and Lender may elect (but is not obligated) to direct the defense thereof,
provided that the selection of counsel shall be subject to Borrower’s consent, which consent shall
not be unreasonably withheld or delayed. Any Indemnified Person may, in its reasonable discretion,
take such actions as it deems necessary and appropriate to investigate, defend or settle any event
or take other remedial or corrective actions with respect thereto as may be necessary for the
protection of such Indemnified Person or the Collateral. Notwithstanding the foregoing, if any
insurer agrees to undertake the defense of an event (an “Insured Event”), Lender agrees not to
exercise its right to select counsel to defend the event if that would cause any Borrower’s insurer
to deny coverage; provided, however, that Lender reserves the right to retain
counsel to represent any Indemnified Person with respect to an Insured Event at its sole cost and
expense. To the extent that Lender obtains recovery from a third party other than an Indemnified
Person of any of the amounts that any Borrower has paid to Lender pursuant to the indemnity set
forth in this Section 12.4, then Lender shall promptly pay to such Borrower the amount of
such recovery.

12.5 Notice

Any notice or request under any Loan Document shall be given to any party to this Agreement at
such party’s address set forth beneath its signature on the signature page to this Agreement, or at
such other address as such party may hereafter specify in a notice given in the manner required
under this Section 12.5. Any notice or request hereunder shall be given only by, and shall
be deemed to have been received upon (each, a “Receipt”): (i) registered or certified mail, return
receipt requested, on the date on which received as indicated in such return receipt, (ii) delivery
by a nationally recognized overnight courier, one (1) Business Day after deposit with such courier,
or (iii) facsimile transmission, in each case upon telephone or further electronic communication
from the recipient acknowledging receipt (whether automatic or manual from recipient), as
applicable. In the case of Borrower, any notice or request under this Section 12.5 shall
be effective upon the Receipt thereof by any one of the Persons designated to receive notices or
requests on the signature page to this Agreement.

12.6 Severability; Captions; Counterparts; Facsimile Signatures

If any provision of any Loan Document is adjudicated to be invalid under applicable laws or
regulations, such provision shall be inapplicable to the extent of such invalidity without
affecting the validity or enforceability of the remainder of the Loan Documents which shall be
given effect so far as possible. The captions in the Loan Documents are intended for convenience
and reference only and shall not affect the meaning or interpretation of the Loan Documents. The
Loan Documents may be executed in one or more counterparts (which taken together, as applicable,
shall constitute one and the same instrument) and by facsimile transmission, which facsimile
signatures shall be considered original executed counterparts. Each party to this Agreement agrees
that it will be bound by its own facsimile signature and that it accepts the facsimile signature of
each other party.

12.7 Expenses

Borrower shall pay, whether or not the Closing occurs, all reasonable costs and expenses
incurred by Lender and/or its Affiliates, including, without limitation, documentation and
diligence fees and expenses, all search, audit, appraisal, recording, professional and filing fees
and expenses and all other reasonable out-of-pocket charges and expenses (including, without
limitation, UCC and judgment and tax lien searches and UCC filings and fees for post-Closing UCC
and judgment and tax lien searches and wire transfer fees and audit expenses), and reasonable
attorneys’ fees and expenses, (i) in any effort to enforce, protect or collect payment of any
Obligation or to enforce any Loan Document or any related agreement, document or instrument, (ii)
in connection with entering into, negotiating, preparing, reviewing and executing the Loan
Documents and/or any related agreements, documents or instruments, (iii) arising in any way out of
administration of the Obligations, (iv) in connection with instituting, maintaining, preserving,
enforcing and/or foreclosing on Lender’s Liens in any of the Collateral or securities pledged under
the Loan Documents, whether through judicial proceedings or otherwise, (v) in defending or
prosecuting any actions, claims or proceedings arising out of or relating to Lender’s transactions
with Borrower, (vi) in seeking, obtaining or receiving any advice with respect to its rights and
obligations under any Loan Document and any related agreement, document or instrument, (vii) in
connection with any modification, restatement, supplement, amendment, waiver or extension of any
Loan Document and/or any related agreement, document or instrument and (viii) any of the foregoing
items (i) through (vii) which were incurred pursuant to, and remain unpaid under, the Second
Restated Agreement. All of the foregoing shall be charged to Borrower’s account and shall be part
of the Obligations. If Lender or any of its Affiliates uses in-house counsel for any purpose under
any Loan Document for which Borrower is responsible to pay or indemnify, Borrower expressly agrees
that its Obligations include the allocable costs of such in-house counsel. Without limiting the
foregoing, Borrower shall pay all taxes (other than taxes based upon or measured by Lender’s income
or revenues or any personal property tax), if any, in connection with the issuance of any Note and
the filing and/or recording of any documents and/or financing statements.

12.8 Entire Agreement

This Agreement and the other Loan Documents to which Borrower is a party constitute the entire
agreement between Borrower and Lender with respect to the subject matter hereof and thereof, and
supersede all prior agreements and understandings, if any, relating to the subject matter hereof or
thereof. Any promises, representations, warranties or guarantees not herein contained and
hereinafter made shall have no force and effect unless in writing signed by Borrower and Lender.
No provision of this Agreement may be changed, modified, amended, restated, waived, supplemented,
discharged, canceled or terminated orally or by any course of dealing or in any other manner other
than by an agreement in writing signed by Lender and Borrower. Each party hereto acknowledges that
it has been advised by counsel in connection with the negotiation and execution of this Agreement
and is not relying upon oral representations or statements inconsistent with the terms and
provisions hereof.

12.9 Lender Approvals

Unless expressly provided herein to the contrary, any approval, consent, waiver or
satisfaction of Lender with respect to any matter that is subject of any Loan Document may be
granted or withheld by Lender in its sole and absolute discretion.

12.10 Confidentiality and Publicity

(a) Borrower agrees, and agrees to cause each of its Affiliates, (i) not to transmit or
disclose provisions of any Loan Document to any Person (other than to Borrower’s advisors and
officers on a need-to-know basis or as otherwise may be required by law, regulation or judicial
process) without Lender’s prior written consent, (ii) to inform all Persons of the confidential
nature of the Loan Documents and to direct them not to disclose the same to any other Person and to
require each of them to be bound by these provisions. Borrower agrees to submit to Lender and
Lender reserves the right to review and approve all materials that Borrower or any of their
Affiliates prepares that contain Lender’s name or describe or refer to any Loan Document, any of
the terms thereof or any of the transactions contemplated thereby. Borrower further agrees that
except as required by law, regulation or judicial process, including, without limitation, the
filing of this Agreement with the United States Securities and Exchange Commission, Borrower shall
not use Lender’s name, logo or other indicia germane to Lender without the prior consent of Lender,
which consent shall not be unreasonably withheld.. Nothing contained in any Loan Document is
intended to permit or authorize Borrower or any of their Affiliates to contract on behalf of
Lender.

(b) Borrower hereby agrees that Lender or any Affiliate of Lender may (i) disclose a general
description of transactions arising under the Loan Documents for advertising, marketing or other
similar purposes, (ii) use Borrower’s or any Guarantor’s name, logo or other indicia germane to
such party in connection with such advertising, marketing or other similar purposes and (iii)
disclose any and all information concerning the Loan Documents, as well as any information
regarding Credit Party and its operations, received by Lender in connection with the Loan Documents
to its lenders or funding or financing sources.

12.11 Release of Lender

Notwithstanding any other provision of any Loan Document, Borrower voluntarily, knowingly,
unconditionally and irrevocably, with specific and express intent, for and on behalf of itself,
its managers, members, directors, officers, employees, stockholders, Affiliates, agents,
representatives, accountants, attorneys, successors and assigns and their respective Affiliates
(collectively, the “Releasing Parties”), hereby fully and completely releases and forever
discharges the Indemnified Parties and any other Person or insurer which may be responsible or
liable for the acts or omissions of any of the Indemnified Parties, or who may be liable for the
injury or damage resulting therefrom (collectively, with the Indemnified Parties, the “Released
Parties”), of and from any and all actions, causes of action, damages, claims, obligations,
liabilities, costs, expenses and demands of any kind whatsoever, at law or in equity, matured or
unmatured, vested or contingent, that any of the Releasing Parties has against any of the Released
Parties as of the Restatement Date. Borrower acknowledges that the foregoing release is a material
inducement to Lender’s decision to extend to Borrower the financial accommodations hereunder and
has been relied upon by Lender in agreeing to make the Advances.

12.12 Agent

Lender and its successors and assigns hereby (i) designate and appoint CapitalSource Finance
LLC, a Delaware limited liability company, and its successors and assigns (“CapitalSource”), to act
as agent for Lender and its successors and assigns under this Agreement and all other Loan
Documents, (ii) irrevocably authorize CapitalSource to take all actions on its behalf under the
provision of this Loan Agreement and all other Loan Documents, and (iii) to exercise all such
powers and rights, and to perform all such duties and obligations hereunder and thereunder. 
CapitalSource, on behalf of Lender, shall hold all Collateral, payments of principal and interest,
fees, charges and collections received pursuant to this Agreement and all other Loan Documents. 
Borrower acknowledges that Lender and its successors and assigns transfer and assign to
CapitalSource the right to act as Lender’s agent to enforce all rights and perform all obligations
of Lender contained herein and in all of the other Loan Documents.  Borrower shall within ten (10)
Business Days after Lender’s reasonable request, take such further actions, obtain such consents
and approvals and duly execute and deliver such further agreements, amendments, assignments,
instructions or documents as Lender may request to evidence the appointment and designation of
CapitalSource as agent for Lender and other financial institutions from time to time party hereto
and to the other Loan Documents.

12.13 Agreement Controls

In the event of any inconsistency between this Agreement and any of the other Loan Documents,
the terms of this Agreement shall control.

[INTENTIONALLY LEFT BLANK – SIGNATURE PAGE FOLLOWS]

1

IN WITNESS WHEREOF, each of the parties has duly executed this Second Amended and Restated
Revolving Credit, Term Loan and Security Agreement as of the date first written above.

UNITED STATES PHARMACEUTICAL GROUP, L.L.C. d/b/a
NATIONSHEALTH

	 	 	 
	By:

	 	/s/ Glenn M. Parker
	
 
	 	 
	Name:

Its:

	 	Glenn M. Parker, M.D.

Chief Executive Officer

Address for Notices:

13630 N.W. 8th Street

Suite 210

Sunrise, FL 33325

Attention: Tim Fairbanks

Telephone: (954) 903-5018

FAX: (954) 903-5005

With a copy to:

13630 N.W. 8th Street

Suite 210

Sunrise, FL 33325

Attention: Joshua Weingard, Esq.

Telephone: (954) 903-5840

FAX: (954) 846-8063

NATIONSHEALTH HOLDINGS, L.L.C.

	 	 	 
	By:

	 	/s/ Glenn M. Parker
	
 
	 	 
	Name:

Its:

	 	Glenn M. Parker, M.D.

Chief Executive Officer

Address for Notices:

13630 N.W. 8th Street

Suite 210

Sunrise, FL 33325

Attention: Tim Fairbanks

Telephone: (954) 903-5018

FAX: (954) 903-5005

With a copy to:

13630 N.W. 8th Street

Suite 210

Sunrise, FL 33325

Attention: Joshua Weingard, Esq.

Telephone: (954) 903-5840

FAX: (954) 846-8063

NATIONSHEALTH, INC.

	 	 	 
	By:

	 	/s/ Glenn M. Parker
	
 
	 	 
	Name:

Its:

	 	Glenn M. Parker, M.D.

Chief Executive Officer

Address for Notices:

13630 N.W. 8th Street

Suite 210

Sunrise, FL 33325

Attention: Tim Fairbanks

Telephone: (954) 903-5018

FAX: (954) 903-5005

With a copy to:

13630 N.W. 8th Street

Suite 210

Sunrise, FL 33325

Attention: Joshua Weingard, Esq.

Telephone: (954) 903-5840

FAX: (954) 846-8063

CAPITALSOURCE FINANCE LLC

	 
	 

	By:/s/ Todd S. Gordon

	 

	Name:Todd S. Gordon

Its:Director – Healthcare & Specialty Finance

	 

	Address for Notices:

	 

CapitalSource Finance LLC

4445 Willard Avenue, 12th Floor

Chevy Chase, MD 20815

Attention: Healthcare Finance Group, Portfolio Manager

Telephone: (301) 841-2700

FAX: (301) 841-2340

2

SCHEDULES

	 	 	 
	Schedule 2.4—

	 	Borrower’s Account(s)
	 

	 	

	Schedule 5.2—

	 	Required Consents
	 

	 	

	Schedule 5.3—

Schedule 5.4—

	 	Capitalization, Organization Chart (including all subsidiaries, authorized/issued

capitalization, owners, directors, officers and managers) and Joint Ventures

Liens; Real and Personal Property Owned or Leased; Leases
	 

	 	

	Schedule 5.8—

	 	Taxes
	 

	 	

	Schedule 5.11—

	 	Intellectual Property
	 

	 	

	Schedule 5.15A

	 	—Existing Indebtedness
	 

	 	

	Schedule 5.15B —

	 	Indebtedness Maturing During Term
	 

	 	

	Schedule 5.16—

	 	Other Agreements
	 

	 	

	Schedule 5.17—

	 	Insurance
	 

	 	

	Schedule 5.18A —

	 	Corporate Names
	 

	 	

	Schedule 5.18B —

	 	Places of Business; Collateral Location
	 

	 	

	 	 	 	 	 
	Schedule 5.20 — Inventory Sold or Acquired on Approval or Consignment Basis

	 
	 	 	 	 
	 

	 
	 	 	 	 
	Schedule 5.23 — MHR Subordinated Debt Defaults
	 	 
	 
	 	 	 	 
	 

	 
	 	 	 	 
	Schedule 6.8

	 	—
	 	Further Assurances/Post Closing
	 

	 	

	 	

	Schedule 7.2

	 	—
	 	Permitted Indebtedness
	 

	 	

	 	

	Schedule 7.3

	 	—
	 	Permitted Liens
	 

	 	

	 	

3

APPENDIX A

DEFINITIONS

“Acceptance Notice” shall have the meaning given such term in Section 6.13.

“Accounts” shall mean all “accounts” (as defined in the UCC) of Borrower (or, if
referring to another Person, of such other Person), including without limitation, accounts,
accounts receivables, monies due or to become due and obligations in any form (whether arising in
connection with contracts, contract rights, Instruments, General Intangibles or Chattel Paper), in
each case whether arising out of goods sold or services rendered or from any other transaction and
whether or not earned by performance, now or hereafter in existence, and all documents of title or
other documents representing any of the foregoing, and all collateral security and guaranties of
any kind, now or hereafter in existence, given by any Person with respect to any of the foregoing.

“Account Debtor” shall mean any Person who is obligated under an Account.

“Advance” shall mean a borrowing under the Revolving Facility. Any amounts paid by
Lender on behalf of Borrower or any Guarantor under any Loan Document shall be an Advance for
purposes of the Agreement.

“Affiliate” shall mean, as to any Person, any other Person (a) that, directly or
indirectly through one or more intermediaries, controls, is controlled by, or is under common
control with, such Person, (b) who is a director or officer (i) of such Person, (ii) of any
Subsidiary of such Person, or (iii) of any Person described in clause (a) above with respect to
such Person, or (c) which, directly or indirectly through one or more intermediaries, is the
beneficial or record owner (as defined in Rule 13d-3 of the Securities Exchange Act of 1934, as
amended, as the same is in effect on the date hereof) of five percent (5%) or more of any class of
the outstanding voting stock, securities or other equity or ownership interests of such Person.
For purposes of this definition, the term “control” (and the correlative terms, “controlled by” and
“under common control with”) shall mean the possession, directly or indirectly, of the power to
direct or cause the direction of the management or policies, whether through ownership of
securities or other interests, by contract or otherwise. “Affiliate” shall include any Subsidiary.

“Applicable Rate” shall mean the interest rates applicable from time to time to
Advances under the Agreement.

“Availability” shall have the meaning given such term in Section 2.1(a).

“Borrower Sale” shall have the meaning given such term in Section 9.4.

“Borrowing Base” shall mean, as of any date of determination, the sum of (a) the net
collectible U.S. Dollar value of Eligible Receivables, and (b) the U.S. Dollar Value of Eligible
Inventory, as determined with reference to the most recent Borrowing Certificate and otherwise in
accordance with this Agreement; provided, however, that if as of such date the most
recent Borrowing Certificate is of a date more than four (4) Business Days before or after such
date, the Borrowing Base shall be determined by Lender in its sole discretion.

“Borrowing Certificate” shall mean a Borrowing Certificate substantially in the form
of Exhibit A.

“Borrowing Date” shall have the meaning given such term in Section 2.4.

“Business Day” shall mean any day other than a Saturday, Sunday or other day on which
the Federal Reserve or Lender is closed.

“Capital Expenditures” shall mean, for any Test Period, the sum (without duplication)
of all expenditures (whether paid in cash or accrued as liabilities) during the Test Period that
are or should be treated as capital expenditures under GAAP.

“Capital Lease” shall mean, as to any Person, a lease of any interest in any kind of
property or asset by that Person as lessee that is, should be or should have been recorded as a
“capital lease” in accordance with GAAP.

“Capitalized Lease Obligations” shall mean all obligations of any Person under Capital
Leases, in each case, taken at the amount thereof accounted for as a liability in accordance with
GAAP.

“Cash Equivalents” shall mean (a) securities issued, or directly and fully guaranteed
or insured, by the United States or any agency or instrumentality thereof (provided that the full
faith and credit of the United States is pledged in support thereof) having maturities of not more
than six months from the date of acquisition, (b) U.S. dollar denominated time deposits,
certificates of deposit and bankers’ acceptances of (i) any domestic commercial bank of recognized
standing having capital and surplus in excess of $500,000,000, or (ii) any bank (or the parent
company of such bank) whose short-term commercial paper rating from Standard & Poor’s Ratings
Services (“S&P”) is at least A-2 or the equivalent thereof or from Moody’s Investors Service, Inc.
(“Moody’s”) is at least P-2 or the equivalent thereof in each case with maturities of not more than
six months from the date of acquisition (any bank meeting the qualifications specified in clauses
(b)(i) or (ii), an “Approved Bank”), (c) repurchase obligations with a term of not more than seven
days for underlying securities of the types described in clause (a), above, entered into with any
Approved Bank, (d) commercial paper issued by any Approved Bank or by the parent company of any
Approved Bank and commercial paper issued by, or guaranteed by, any industrial or financial company
with a short-term commercial paper rating of at least A-2 or the equivalent thereof by S&P or at
least P-2 or the equivalent thereof by Moody’s, or guaranteed by any industrial company with a long
term unsecured debt rating of at least A or A2, or the equivalent of each thereof, from S&P or
Moody’s, as the case may be, and in each case maturing within six months after the date of
acquisition and (e) investments in money market funds substantially all of whose assets are
comprised of securities of the type described in clauses (a) through (d) above.

“Change of Control” shall mean, with respect to any Borrower or Guarantor, the
occurrence of any of the following: (i) a merger, consolidation, reorganization, public offering
of securities, recapitalization or share or interest exchange, sale or transfer or any other
transaction or series of transactions in which its stockholders, managers, partners or interest
holders immediately prior to such transaction or series of transactions receive, in exchange for
the stock or interests owned by them, cash, property or securities of the resulting or surviving
entity or any Affiliate thereof, and, as a result thereof, Persons who, individually or in the
aggregate, were holders of 50% or more of its voting stock, securities or equity, partnership or
ownership interests immediately prior to such transaction or series of transactions hold less than
50% of the voting stock, securities or other equity, partnership or ownership interests of the
resulting or surviving entity or such Affiliate thereof, calculated on a fully diluted basis, (ii)
a direct or indirect sale, transfer or other conveyance or disposition, in any single transaction
or series of transactions, of all or substantially all of its assets, or (iii) any “change in/of
control” or “sale” or “disposition” or similar event as defined in any document governing
indebtedness of such Person which gives the holder of such indebtedness the right to accelerate or
otherwise require payment of such indebtedness prior to the maturity date thereof.

“Charter and Good Standing Documents” shall mean, for each Borrower and any Guarantor
(i) a copy of the certificate of incorporation or formation (or other charter document) certified
as of a date satisfactory to Lender before the Restatement Date by the applicable Governmental
Authority of the jurisdiction of incorporation or organization of such Borrower and Guarantor, if
amended since the Restatement Date, (ii) a copy of the bylaws or similar organizational documents
certified as of a date satisfactory to Lender before the Restatement Date by the corporate
secretary or assistant secretary of such Borrower, if amended since the Restatement Date, (iii) an
original certificate of good standing as of a date acceptable to Lender issued by the applicable
Governmental Authority of the jurisdiction of incorporation or organization of such Borrower and
Guarantor and of every other jurisdiction in which such Borrower has an office or conducts business
or is otherwise required to be in good standing, and (iv) copies of the resolutions of the Board of
Directors or managers (or other applicable governing body) and, if required, stockholders, members
or other equity owners authorizing the execution, delivery and performance of the Loan Documents to
which such Borrower and any Guarantor is a party, certified by an authorized officer of such Person
as of the Restatement Date.

“CIGNA” shall mean Connecticut General Life Insurance Company and its subsidiaries and
affiliates.

“CIGNA Receipts” shall mean any and all amounts received by any Borrower from CIGNA or
any other Person in respect of Borrower’s Medicare Part D program, including but not being limited
to, pursuant to the CIGNA Strategic Agreement.

“CIGNA Strategic Agreement” shall mean that certain Strategic Agreement dated May 4,
2005, by and among CIGNA, USPG and NationsHealth, together with any amendments, modifications or
supplements thereto.

“Closing” shall mean the satisfaction, or written waiver by Lender, of all of the
conditions precedent set forth in the Agreement required to be satisfied prior to the consummation
of the transactions contemplated hereby.

“Collateral” shall have the meaning given such term in Section 2.9.

“Collateral Patent, Trademark and Copyright Assignment” shall mean any patent,
trademark or copyright assignment or acknowledgement executed by and between Borrower and Lender,
as such may be modified, amended or supplemented from time to time.

“Collateral Management Fee” shall have the meaning given such term in Section
3.3.

“Concentration Account” shall have the meaning given such term in Section 2.4.

“Contravening Transaction” shall have the meaning set forth in that certain side
letter dated February 28, 2005 between Borrower, MHR Capital Partners LP, MHR Capital Partners
(100) LP and OTQ LLC setting forth certain procedures with respect to redemptions of the MHR
Subordinated Debt and related equity and equity related securities and attached hereto as
Exhibit C-1.

“Credit Party” shall have the meaning given such term in Section 6.13.

“Debtor Relief Law” shall mean, collectively, the Bankruptcy Code of the United States
of America and all other applicable liquidation, conservatorship, bankruptcy, moratorium,
rearrangement, receivership, insolvency, reorganization or similar debtor relief laws from time to
time in effect affecting the rights of creditors generally, as amended from time to time.

“Default” shall mean any event, fact, circumstance or condition that, with the giving
of applicable notice or passage of time or both, would constitute or be or result in an Event of
Default.

“Deferred Purchase Price Obligations” means any and all obligations of Borrower
incurred as permitted under this Agreement for amounts deferred, financed or withheld in respect of
the purchase price for any Diabetes Business Acquisition, including Indebtedness which consists of
purchase money financing by the seller and amounts withheld or escrowed as potential set-offs
against customer terminations, purchase price adjustments or otherwise.

“Diabetes Customers” shall mean any and all customers and patients of Borrower for the
purchase of diabetes medicines, supplies and other products, whether now existing or hereinafter
acquired or arising.

“Diabetes Customer Lists” shall have the meaning given such term in Section
6.17(a).

“Diabetes Business Acquisition” shall mean the acquisition by Borrower of Diabetes
Customer Lists and associated inventory and equipment of the seller.

“Dilution Items” shall have the meaning given such term in Section 2.1(b).

“Distribution” shall mean any fee, payment, bonus or other remuneration of any kind,
and any repayment of or debt service on loans or other indebtedness.

“Eligible Billed Receivables” shall mean each Account arising in the ordinary course
of Borrower’s business from the sale of goods or rendering of Services which Lender, in its sole
discretion, deems an Eligible Receivable unless:

(a) it is not subject to a valid perfected first priority security interest in favor of
Lender, subject to no other Lien;

(b) it is not evidenced by an invoice, statement or other documentary evidence satisfactory to
Lender; provided, that Lender in its sole discretion may from time to time include as
Accounts that are not evidenced by an invoice, statement or other documentary evidence satisfactory
to Lender as Eligible Billed Receivables and determine the advance rate, liquidity factors and
reserves applicable to Advances made on any such Accounts;

(c) it or any portion thereof (in which case only such portion shall not be an Eligible
Receivable) is payable by a beneficiary, recipient or subscriber individually and not directly by a
Medicaid/Medicare Account Debtor or commercial medical insurance carrier acceptable to Lender;

(d) it arises out of services rendered or a sale made to, or out of any other transaction
between Borrower or any of its Subsidiaries and, one or more Affiliates of Borrower or any of its
Subsidiaries;

(e) it remains unpaid for longer than the earlier of (i) 120 calendar days after the first to
occur of the claim date or invoice date, and (ii) 135 calendar days after the first to occur of
shipment or delivery of goods;

(f) with respect to all Accounts owed by any particular Account Debtor (other than Accounts
from Medicaid/Medicare Account Debtors) and/or its Affiliates, if more than 50% of the aggregate
balance of all such Accounts owing from such Account Debtor and/or its Affiliates remain unpaid for
longer than the earlier of (i) 120 calendar days after the first to occur of the claim date or
invoice date, and (ii) 135 calendar days after the first to occur of shipment or delivery of goods;

(g) with respect to all Accounts owed by any particular Account Debtor and/or its Affiliates,
25% or more of all such Accounts are not deemed Eligible Receivables for any reason hereunder
(which percentage may, in Lender’s sole discretion, be increased or decreased);

(h) with respect to all Accounts owed by any particular Account Debtor and/or its Affiliates
(except Medicaid/Medicare Account Debtors), if such Accounts exceed 20% of the net collectible
dollar value of all Eligible Receivables at any one time (including Accounts from Medicaid/Medicare
Account Debtors) (which percentage may, in Lender’s sole discretion, be increased or decreased);

(i) any covenant, agreement, representation or warranty contained in any Loan Document with
respect to such Account has been breached and remains uncured;

(j) the Account Debtor for such Account has commenced a voluntary case under any Debtor Relief
Law or has made an assignment for the benefit of creditors, or a decree or order for relief has
been entered by a court having jurisdiction in respect of such Account Debtor in an involuntary
case under any Debtor Relief Law, or any other petition or application for relief under any Debtor
Relief Law has been filed against such Account Debtor, or such Account Debtor has failed, suspended
business, ceased to be solvent, called a meeting of its creditors, or has consented to or suffered
a receiver, trustee, liquidator or custodian to be appointed for it or for all or a significant
portion of its assets or affairs, or Borrower, in the ordinary course of business, should have
known of any of the foregoing;

(k) it arises from the sale of property or services rendered to one or more Account Debtors
outside the continental United States or that have their principal place of business or chief
executive offices outside the continental United States;

(l) it represents the sale of goods or rendering of services to an Account Debtor on a
bill-and-hold, guaranteed sale, sale-and-return, sale on approval, consignment or any other
repurchase or return basis or is evidenced by Chattel Paper or an Instrument of any kind or has
been reduced to judgment;

(m) the applicable Account Debtor for such Account is any Governmental Authority, unless
rights to payment of such Account have been assigned to Lender pursuant to the Assignment of Claims
Act of 1940, as amended (31 U.S.C. Section 3727, et seq. and 41 U.S.C. Section 15, et seq.), or
otherwise only if all applicable statutes, regulations and other law respecting the assignment of
Government Accounts have been complied with (for example, with respect to all Accounts payable
directly by a Medicaid/Medicare Account Debtor the execution and delivery of a Lockbox Agreement in
appropriate form);

(n) to the extent that it is subject to any offset, credit (including any resource or other
income credit or offset) deduction, defense, discount, chargeback, freight claim, allowance,
adjustment, dispute or counterclaim, or is contingent in any respect or for any reason;

(o) there is any agreement with an Account Debtor for any deduction from such Account, except
for discounts or allowances made in the ordinary course of business for prompt payment, all of
which discounts or allowances are reflected in the calculation of the face value of each invoice
related thereto, such that only the discounted amount of such Account after giving effect to such
discounts and allowances shall be considered an Eligible Receivable;

(p) any return, rejection or repossession of goods or services related to it has occurred;

(q) it is not payable to Borrower;

(r) Borrower has agreed to accept or has accepted any non-cash payment for such Account;

(s) with respect to any Account arising from the sale of goods, the goods have not been
shipped to the Account Debtor or its designee;

(t) with respect to any Account arising from the performance of Services, the Services have
not been actually performed or the Services were undertaken in violation of any law; or

(u) such Account fails to meet such other specifications and requirements which may from time
to time be established by Lender or is not otherwise satisfactory to Lender, as determined in
Lender’s sole discretion.

“Eligible Deductible Unbilled Receivables” shall mean each Account (other than
Eligible Billed Receivables or Eligible Nondeductible Unbilled Receivables) arising in the ordinary
course of Borrower’s business from the shipment or delivery of goods which Lender, in its sole
discretion, deems an Eligible Deductible Unbilled Receivable and that otherwise would satisfy the
criteria for Eligible Billed Receivables but for the fact that: (i) an invoice has not been
rendered to the Account Debtor (due to the fact that the Borrower has not yet billed the Account
Debtor for such receivable as the Account Debtor has not yet reached his/her deductible with
Medicare for the applicable deductible period); and (ii) the Account remains unpaid for no longer
than 90 calendar days after the first to occur of shipment or delivery of goods.

“Eligible Inventory” shall mean Borrower’s saleable Inventory, after taking into
account all discounts, which Inventory is maintained in the ordinary course of Borrower’s business
which Lender, in its sole discretion, deems Eligible Inventory unless:

(a) such Inventory is not subject to a valid perfected first priority security interest in
favor of the Lender;

(b) any consent, license, approval or authorization required to be obtained by Borrower in
connection with the granting of a security interest under the Security Documents or in connection
with the manufacture or sale of such Inventory has not been or was not duly obtained and is not in
full force and effect;

(c) any covenant, representation or warranty contained in this Agreement or in any other Loan
Document with respect to such Inventory has been breached and remains uncured;

(d) such Inventory is not owned by Borrower;

(e) such Inventory does not comply, or was not manufactured in compliance, in all material
respects, with all applicable requirements of all statutes, laws, rules, regulations, ordinances,
codes, policies, rules of common law, and the like, now or hereafter in effect, of any Governmental
Authority, including any judicial or administrative interpretations thereof, and any judicial or
administrative orders, consents, decrees or judgments;

(f) such Inventory does not, or at the time of its purchase from the vendor did not,
constitute “inventory” under Article 9 of the UCC as then in effect in the jurisdiction whose law
governs perfection of the security interest;

(g) the Person for whose account such Inventory is being or was produced has commenced a
voluntary case under any federal bankruptcy or state or federal insolvency laws or has made an
assignment for the benefit of creditors, or if a decree or order for relief has been entered by a
court having jurisdiction in respect of such Person in an involuntary case under any federal
bankruptcy or state or federal insolvency laws, or if any other petition or application for relief
under any federal bankruptcy or state or federal insolvency laws has been filed against such
Person, or if such Person has failed, suspended business, ceased to be solvent, called a meeting of
its creditors, or has consented to or suffered a receiver, trustee, liquidator or custodian to be
appointed for it or for all or a significant portion of its assets or affairs;

(h) the transfer of Inventory to Borrower by vendor, supplier or other Person did not
constitute a valid sale and transfer to Borrower of all right, title and interest of such Person in
the inventory enforceable against all creditors of and purchasers from such person;

(i) (A) Borrower is not the sole owner of all right, title and interest in and to such
Inventory, (B) Borrower does not have a valid ownership interest therein free and clear of all
Liens other than Liens granted under the Loan Documents, or (C) any offsets, defenses or
counterclaims have been asserted or threatened in writing against such Inventory;

(j) such Inventory is not in good working order or is damaged;

(k) such Inventory is not located at a location which is owned by Borrower or subject to a
Landlord Waiver and Consent or Warehouseman Waiver and Consent;

(l) such Inventory consists only of packing materials, displays, supplies, parts or other
components or is returned, rejected, repossessed or discontinued product or Inventory;

(m) such Inventory is subject to a bona fide dispute or is or has been classified as
counterfeit or fraudulent;

(n) such Inventory has been sold, assigned, or otherwise encumbered by Borrower except
pursuant to the Loan Documents;

	 	(o)	 	such Inventory is not associated with a documented purchase
order;

(p) such Inventory consists of equipment that Borrower offers for rental or that is being
rented from the Borrower or equipment borrowed by Borrower or given to Borrower to serve as
demonstration equipment;

(q) such Inventory constitutes custom Inventory, private-label Inventory, raw materials, in
process, work-in-process, obsolete or unmerchantable Inventory, Inventory allocated to current
warranty assignments, Inventory that consists of spare parts or Inventory subject to a quality
assurance hold:

	 	(r)	 	such Inventory is in transit;

(s) such Inventory is (i) not in Borrower’s possession and control or (ii) outside the
continental United States; or

(t) such Inventory otherwise is not satisfactory to the Lender, as determined in the sole
discretion of the Lender.

“Eligible Nondeductible Unbilled Receivables” shall mean each Account (other than
Eligible Billed Receivables or Eligible Deductible Unbilled Receivables) arising in the ordinary
course of Borrower’s business from the shipment or delivery of goods which Lender, in its sole
discretion, deems an Eligible Nondeductible Unbilled Receivable and that otherwise would satisfy
the criteria for Eligible Billed Receivables but for the fact that: (i) an invoice has not been
rendered to the Account Debtor; (ii) the Account remains unpaid for no longer than 60 calendar days
after the first to occur of shipment or delivery of goods; and (iii) with respect to all Accounts
owed by any particular Account Debtor (other than Accounts from Medicaid/Medicare Account Debtors)
and/or its Affiliates, if more than 50% of the aggregate balance of all such Accounts owing from
such Account Debtor and/or its Affiliates remain unpaid for no longer 60 calendar days after the
shipment or delivery of goods.

“Eligible Receivables” shall mean, collectively, the Eligible Billed Receivables and
Eligible Unbilled Receivables.

“Eligible Unbilled Receivables” shall mean, collectively, the Eligible Deductible
Unbilled Receivables and Eligible Nondeductible Unbilled Receivables.

“Employee(s)” shall mean Lewis Stone and Glenn Parker, M.D.

“Employee Subordination Agreement” shall mean, collectively and each individually,
each Employee Subordination Agreement to which Lender and each Employee is a party.

“Employment Agreement” shall mean each Employment Agreement made as of March 9, 2004
by and between Millstream Acquisition Corporation and each Employee, as such may be modified,
amended or supplemented from time to time.

“Environmental Laws” shall mean, collectively and each individually, the Comprehensive
Environmental Response, Compensation and Liability Act of 1980, the Superfund Amendment and
Reauthorization Act of 1986, the Resource Conservation and Recovery Act, the Toxic Substances
Control Act, the Clean Air Act, the Clean Water Act, any other “Superfund” or “Superlien” law and
all other federal, state and local and foreign environmental, land use, zoning, health, chemical
use, safety and sanitation laws, statutes, ordinances and codes relating to the protection of the
environment and/or governing the use, storage, treatment, generation, transportation, processing,
handling, production or disposal of Hazardous Substances, in each case, as amended, and the rules,
regulations, policies, guidelines, interpretations, decisions, orders and directives of
Governmental Authorities with respect thereto.

“Equity Participation Fee Agreement” shall mean that certain Second Amended and
Restated Equity Participation Fee Agreement by and between Lender and Borrower dated as of the
Restatement Date, as such may be modified, amended or supplemented from time to time.

“ERISA” shall mean the Employee Retirement Income Security Act of 1974, as amended,
and the regulations thereunder.

“Escrow Agent” shall mean U.S. Bank National Association and any other temporary,
permanent or successor escrow agent appointed by Borrower and Lender in accordance with the Escrow
Agreement.

“Escrow Agreement” shall mean the escrow agreement executed by and among Borrower,
Lender and Escrow Agent with respect to the escrow of Diabetes Customer Lists, as such may be
modified, amended or supplemented from time to time.

“Event of Default” shall mean the occurrence of any event set forth in
Article VIII.

“Existing Advances” shall mean any Advances outstanding under the Second Restated
Credit Agreement as of the date hereof.

“Existing Revolving Notes” shall have the meaning given to such term in Section
2.10(a).

“Facility Cap” shall have the meaning given the term in the Recitals of this
Agreement.

“Fair Valuation” shall mean the determination of the value of the consolidated assets
of a Person on the basis of the amount which may be realized by a willing seller within a
reasonable time through collection or sale of such assets at market value on a going concern basis
to an interested buyer who is willing to purchase under ordinary selling conditions in an arm’s
length transaction.

“First Restated Credit Agreement” shall have the meaning given such term in the
Preamble hereof.

“GAAP” shall mean generally accepted accounting principles in the United States of
America in effect from time to time as applied by nationally recognized accounting firms.

“Government Account” shall mean all Accounts arising out of or with respect to any
Government Contract.

“Government Contract” shall mean all contracts with the United States Government or
with any agency thereof, and all amendments thereto.

“Governmental Authority” shall mean any federal, state, municipal, national, local or
other governmental department, court, commission, board, bureau, agency or instrumentality or
political subdivision thereof, or any entity or officer exercising executive, legislative or
judicial, regulatory or administrative functions of or pertaining to any government or any court,
in each case, whether of the United States or a state, territory or possession thereof, a foreign
sovereign entity or country or jurisdiction or the District of Columbia.

“Gregg Separation Agreement” shall mean that certain Separation Agreement and General
Release dated as of December 16, 2005 by Robert Gregg and NationsHealth and as in effect on such
date.

“Guarantor” shall mean, collectively and each individually, any and all guarantors of
the Obligations or any part thereof.

“Guaranty” shall mean, collectively and each individually, all guarantees executed by
any Guarantors.

“Hazardous Substances” shall mean, without limitation, any flammable explosives,
radon, radioactive materials, asbestos, urea formaldehyde foam insulation, polychlorinated
biphenyls, petroleum and petroleum products, methane, hazardous materials, hazardous wastes,
hazardous or toxic substances or related materials as defined in or subject to any applicable
Environmental Law.

“Healthcare Laws” shall mean all applicable statutes, laws, ordinances, rules and
regulations of any Governmental Authority with respect to regulatory matters primarily relating to
patient healthcare, healthcare providers and healthcare services (including without limitation
Section 1128B(b) of the Social Security Act, as amended, 42 U.S.C. Section 1320a-7(b) (Criminal
Penalties Involving Medicare or State Health Care Programs), commonly referred to as the “Federal
Anti-Kickback Statute,” and the Social Security Act, as amended, Section 1877, 42 U.S.C. Section
1395nn (Prohibition Against Certain Referrals), commonly referred to as “Stark Statute”).

“Indebtedness” of any Person shall mean, without duplication, (a) all items which, in
accordance with GAAP, would be included in determining total liabilities as shown on the liability
side of the balance sheet of such Person as of the date as of which Indebtedness is to be
determined, including any lease which, in accordance with GAAP would constitute Indebtedness, (b)
all indebtedness secured by any mortgage, pledge, security, Lien or conditional sale or other title
retention agreement to which any property or asset owned or held by such Person is subject, whether
or not the indebtedness secured thereby shall have been assumed, (c) all indebtedness of others
which such Person has directly or indirectly guaranteed, endorsed (otherwise than for collection or
deposit in the ordinary course of business), discounted or sold with recourse or agreed
(contingently or otherwise) to purchase or repurchase or otherwise acquire, or in respect of which
such Person has agreed to supply or advance funds (whether by way of loan, stock, equity or other
ownership interest purchase, capital contribution or otherwise) or otherwise to become directly or
indirectly liable.

“Indemnified Person” shall have the meaning given such term in Section 12.4.

“Initial Appraisal” shall mean the appraisal of the Diabetes Customer List performed
by Healthcare Appraisers, Inc. in connection with the extension of the Term Loan under this
Agreement, which appraisal shall be satisfactory to and approved by Lender in its Permitted
Discretion.

“Initial Principal Repayment Date” shall have the meaning given such term in
Section 2.4.

“Insured Event” shall have the meaning given such term in Section 12.4.

“Insurer” shall mean a Person that insures another Person against any costs incurred
in the receipt by such other Person of Services, or that has an agreement with any Borrower to
compensate it for providing Services to such Person.

“Inventory” shall mean all “inventory” (as defined in the UCC) of Borrower (or, if
referring to another Person, of such other Person), now owned or hereafter acquired, and all
documents of title or other documents representing any of the foregoing, and all collateral
security and guaranties of any kind, now or hereafter in existence, given by any Person with
respect to any of the foregoing.

“Joint Venture” means NationsHealth Specialty Rx, LLC, a Delaware limited liability
company of which NationsHealth Holdings, Inc. owns 51% of the membership interests.

“Joint Venture Dissolution Consent” means that certain consent letter issued by Lender
to Borrower dated September 27, 2006 in connection with the dissolution of the Joint Venture.

“Landlord Waiver and Consent” shall mean a waiver/consent in form and substance
satisfactory to Lender from the owner/lessor of any premises not owned by Borrower at which any of
the Collateral is now or hereafter located for the purpose of providing Lender access to such
Collateral, in each case as such may be modified, amended or supplemented from time to time.

“Liability Event” shall mean any event, fact, condition or circumstance or series
thereof (i) in or for which any Borrower becomes liable or otherwise responsible for any amount
owed or owing to any Medicaid or Medicare program by a provider under common ownership with such
Borrower or any provider owned by such Borrower pursuant to any applicable law, ordinance, rule,
decree, order or regulation of any Governmental Authority after the failure of any such provider to
pay any such amount when owed or owing, (ii) in which Medicaid or Medicare payments to any Borrower
are lawfully set-off against payments to such Borrower or any other Borrower to satisfy any
liability of or for any amounts owed or owing to any Medicaid or Medicare program by a provider
under common ownership with such Borrower or any provider owned by such Borrower pursuant to any
applicable law, ordinance, rule, decree, order or regulation of any Governmental Authority, or
(iii) any of the foregoing under clauses (i) or (ii) in each case pursuant to statutory or
regulatory provisions that are similar to any applicable law, ordinance, rule, decree, order or
regulation of any Governmental Authority referenced in clauses (i) and (ii) above or successor
provisions thereto.

“Lien” shall mean any mortgage, pledge, security interest, encumbrance, restriction,
lien or charge of any kind (including any agreement to give any of the foregoing, any conditional
sale or other title retention agreement or any lease in the nature thereof), or any other
arrangement pursuant to which title to the property is retained by or vested in some other Person
for security purposes.

“Loan” or “Loans” shall mean, individually and collectively, all Advances
under the Revolving Facility and all Term Loan Draws.

“Loan Documents” shall mean, collectively and each individually, this Agreement, the
Original Credit Agreement, the First Restated Credit Agreement, the Second Restated Credit
Agreement, any Notes, the Security Documents, the Guaranties, the Equity Participation Fee
Agreement, the Lockbox Agreements, the Uniform Commercial Code Financing Statements, the
Subordination Agreements, the Landlord Waiver and Consents, the Warehouse Waiver and Consents, the
Escrow Agreement, the Collateral Patent, Trademark and Copyright Assignment, the Borrowing
Certificates and all other agreements, documents, instruments and certificates heretofore or
hereafter executed or delivered to Lender in connection with any of the foregoing or the Loans, as
the same may be amended, modified or supplemented from time to time.

“Lockbox Accounts” shall have the meaning given such term in Section 2.5.

“Lockbox Agreement” shall have the meaning given such term in Section 2.5.

“Lockbox Bank” shall have the meaning given such term in Section 2.5.

“Management or Service Fee” shall mean any management, service or related or similar
fee paid by Borrower to any Person with respect to any facility owned, operated or leased by
Borrower.

“Material Adverse Effect” or “Material Adverse Change” shall mean, in the case
of Borrower or any Guarantor, any event, condition or circumstance or set of events, conditions or
circumstances or any change(s) which (i) has, had or would reasonably be likely to have any
material adverse effect upon or change in the validity or enforceability of any Loan Document to
which such Borrower or any Guarantor, as applicable, is a party, (ii) has been or would reasonably
be likely to be material and adverse to the value of any of the Collateral, to the priority of the
Lender’s security interest in the Collateral, or to the business, operations, prospects,
properties, assets, liabilities or condition of Borrower or any Guarantor, as applicable, either
individually or taken as a whole, or (iii) has materially impaired or would reasonably be likely to
materially impair the ability of any Borrower or Guarantor to pay any portion of the Obligations or
to otherwise perform the Obligations or to consummate the transactions under the Loan Documents
executed by such Person.

“Medicaid/Medicare Account Debtor” shall mean any Account Debtor which is (i) the
United States of America acting under the Medicaid or Medicare program established pursuant to the
Social Security Act or any other federal healthcare program, including, without limitation, TRICARE
(f/k/a CHAMPUS), (ii) any state or the District of Columbia acting pursuant to a health plan
adopted pursuant to Title XIX of the Social Security Act or any other state health care program, or
(iii) any agent, carrier, administrator or intermediary for any of the foregoing.

“MHR Subordinated Debt” shall mean all Junior Obligations as defined in the MHR
Subordination Agreement.

“MHR Subordinated Note” shall mean, individually or collectively, the note or notes
dated as of February 28, 2005 issued by the Borrower to MHR Capital Partners LP, MHR Capital
Partners (100) LP and OTQ LLC in the aggregate principal amount of $15,000,000

“MHR Subordination Agreement” shall mean the Senior Subordination Agreement dated as
of February 28, 2005 by and among the Lender as the Senior Lender, MHR Capital Partners LP, MHR
Capital Partners (100) LP and OTQ LLC as the Junior Lender and MHR Capital Partners LP in its
capacity as the collateral agent for the Junior Lender and attached hereto as Exhibit C-2.

“Minimum Liquidity Account” shall have the meaning given such term in Section
6.19.

“Minimum Liquidity Amount” shall have the meaning given such term in Section
6.19.

“Minimum Termination Fee” shall mean the amount equal to 3% of the Facility Cap if the
date of such termination is on or after the date hereof but prior to the end of the Term.

“Note” shall mean any promissory note or notes issued pursuant to Section
2.10.

“Obligations” shall mean all present and future obligations, Indebtedness and
liabilities of Borrower and/or Guarantors to Lender at any time and from time to time of every
kind, nature and description, direct or indirect, secured or unsecured, joint and several, absolute
or contingent, due or to become due, matured or unmatured, now existing or hereafter arising,
contractual or tortious, liquidated or unliquidated, including but not limited to under any of the
Loan Documents (including the Equity Participation Fee Agreement) or otherwise and, including,
without limitation, all applicable fees, charges and expenses and/or all amounts paid or advanced
by Lender on behalf of or for the benefit of any Borrower and/or Guarantor for any reason at any
time, including in each case obligations of performance as well as obligations of payment and
interest that accrue after the commencement of any proceeding under any Debtor Relief Law by or
against any such Person.

“Offer” shall have the meaning given such term in Section 6.13.

“Option Period” shall have the meaning given such term in Section 6.13.

“Original Credit Agreement” shall have the meaning given such term in the Preamble
hereof.

“Payment Office” shall mean initially the address set forth beneath Lender’s name on
the signature page of the Agreement, and thereafter, such other office of Lender, if any, which it
may designate by notice to Borrower to be the Payment Office.

“Permit” shall mean collectively all licenses, leases, powers, permits, franchises,
certificates, authorizations, approvals, certificates of need, provider numbers and other rights.

“Permitted Discretion” shall mean a determination or judgment made by Lender in good
faith in the exercise of reasonable (from the perspective of a secured lender) business judgment.

“Permitted Indebtedness” shall have the meaning given such term in Section
7.2.

“Permitted Liens” shall have the meaning given such term in Section 7.3.

“Permitted Subordinated Debt” shall mean the MHR Subordinated Debt, Deferred Purchase
Price Obligations and other Indebtedness incurred by Borrower which is subordinated to Borrower’s
indebtedness owed to Lender pursuant to a written agreement or self-executing subordination
provisions contained in the note or other instrument evidencing such Indebtedness approved, in each
case, by Lender in writing; provided, that Deferred Purchase Price Obligations that are subject to
the subordination provisions set forth on Exhibit D-2 attached hereto shall be deemed to
constitute Permitted Subordinated Debt without the written approval of Lender.

“Person” shall mean an individual, a partnership, a corporation, a limited liability
company, a business trust, a joint stock company, a trust, an unincorporated association, a joint
venture, a Governmental Authority or any other entity of whatever nature.

“Prime Rate” shall mean a fluctuating interest rate per annum equal at all times to
the rate of interest announced publicly from time to time by Citibank, N.A. as its base rate;
provided, that such rate is not necessarily the best rate offered to its customers, and,
should Lender be unable to determine such rate, such other indication of the prevailing prime rate
of interest as may reasonably be chosen by Lender; provided, that each change in the
fluctuating interest rate shall take effect simultaneously with the corresponding change in the
Prime Rate.

“Receipt” shall have the meaning given such term in Section 12.5.

“Released Parties” shall have the meaning given such term in Section 12.11.

“Releasing Parties” shall have the meaning given such term in Section 12.11.

“Restatement Date” shall mean the date of this Agreement.

“Restatement Fee” shall have the meaning given such term in Section 3.1.

“Revolver Termination” shall have the meaning given such term in Section
11.1(b).

“Revolving Facility Maturity Date” shall have the meaning assigned to such term in
Section 2.2.

“Second Restated Credit Agreement” shall have the meaning given such term in the
Preamble hereof.

“Security Documents” shall mean this Agreement, the Original Credit Agreement, the
First Restated Credit Agreement, the Second Restated Credit Agreement, any guaranties, Collateral
Patent, Trademark and Copyright Assignment, the Lockbox Agreements, the Escrow Agreement, Uniform
Commercial Code Financing Statements and all other documents or instruments necessary to create or
perfect the Liens in the Collateral, as such may be modified, amended or supplemented from time to
time.

“Services” shall mean medical and health care services provided to a Person,
including, but not limited to, medical and health care services which are covered by a policy of
insurance issued by an Insurer, physician services, nurse and therapist services, dental services,
hospital services, skilled nursing facility services, comprehensive outpatient rehabilitation
services, home health care services, residential and out-patient behavioral healthcare services.

“Solvency Certificate” shall have the meaning given such term in Section
4.1(d).

“Subordination Agreement” shall mean, collectively and each individually, the Employee
Subordination Agreement, the MHR Subordination Agreement and each other subordination agreement to
which Lender and other service providers, employees or creditors of any Borrower are a party and
which shall include, in the case of Deferred Purchase Price Obligations, self-executing
subordination provisions contained in the note or other instrument evidencing such Indebtedness.

“Subsidiary” shall mean, (i) as to Borrower, any Person in which more than 50% of all
equity, membership, partnership or other ownership interests is owned directly or indirectly by
Borrower or one or more of its Subsidiaries, and (ii) as to any other Person, any Person in which
more than 50% of all equity, membership, partnership or other ownership interests is owned directly
or indirectly by such Person or by one or more of such Person’s Subsidiaries.

“Tax Distributions” means, as to Borrower, the aggregate distributions from Borrower
to its members to permit such members (and in the case of any member that is a partnership, S
corporation or other flow-through entity for federal tax purposes, the beneficial owners of such
entity) to pay taxes on their allocable share of the taxable income of Borrower, including any
income allocated to a member pursuant to Section 704(c) of the Internal Revenue Code of 1986, as
amended, and the rules and regulations promulgated thereunder, and determined (i) taking into
account the principles of Section 754 of the Internal Revenue Code of 1986, as amended, and the
rules and regulations promulgated thereunder and (ii)  in an amount equal to the estimated tax
liability of each member on the income of Borrower allocable to such member computed at the highest
marginal federal and state rate applicable to such member or, in the case of a member that itself
is a pass-through entity, at the highest marginal rates applicable to its owners; provided,
however, that the amount of such distributions in any fiscal year shall not exceed the lesser of
(x) the actual tax liability incurred by the members from the Borrower’s operations, or (y)
twenty-five percent (25%) of Borrower’s net income from the preceding fiscal year.

“Term” shall mean the period commencing on the date set forth on the first page hereof
and ending on April 30, 2010.

“Term Loan” shall have the meaning given such term in the third recital hereof.

“Term Loan Amount” shall have the meaning given such term in the third recital hereof.

“Term Loan Borrowing Date” shall have the meaning given such term in Section
2.5.

“Term Loan Draw(s)” shall mean a borrowing or borrowings under the Term Loan.

“Term Loan Draw Termination Date” shall mean earlier of (i) the occurrence and
continuance of an Event of Default if required pursuant hereto or Lender’s demand upon the
occurrence and continuance of an Event of Default, and (ii) December 31, 2007.

“Term Loan Maturity Date” shall have the meaning assigned to such term in Section
2.6(b).

“Term Loan Obligations” shall mean all of the Obligations related to the Term Loan.

“Termination Date” shall have the meaning given such term in Section 11.1.

“Transferee” shall have the meaning given such term in Section 12.2.

“Transaction” shall have the meaning given such term in Section 6.13.

“UCC” shall mean the Uniform Commercial Code as in effect in the State of Maryland
from time to time.

“Unused Line Fee” shall have the meaning given such term in Section 3.2.

“US Bio Note” shall mean the promissory note in the principal amount of $1,500,000
issued by Borrower to US Bioservices Corporation in connection with the dissolution of the Joint
Venture.

“US Bio Reserve” shall mean a reserve against the Borrowing Base established by
Borrower in the amount of $250,000 on August 1, 2007 and increasing on a cumulative basis by the
amount of $250,000 as of the first day of each subsequent calendar month through and including
January 1, 2008 as follows:

	 	 	 	 	 
	Date	 	Cumulative Amount of Reserve
	August 1, 2007

	 	$	250,000	 
	 

	 	 	 	 
	 
	 	 	 	 
	September 1, 2007

	 	$	500,000	 
	 

	 	 	 	 
	 
	 	 	 	 
	October 1, 2007

	 	$	750,000	 
	 

	 	 	 	 
	 
	 	 	 	 
	November 1, 2007

	 	$	1,000,000	 
	 

	 	 	 	 
	 
	 	 	 	 
	December 1, 2007

	 	$	1,250,000	 
	 

	 	 	 	 
	 
	 	 	 	 
	January 1, 2008

	 	$	1,500,000	 
	 

	 	 	 	 

“Warehouse Waiver and Consent” shall mean a waiver/consent in form and substance
satisfactory to Lender from any warehouseman, fulfillment house or other person owning a facility
not owned by Borrower at which any Inventory is now or hereafter located for the purpose of
providing Lender access to such Inventory, in each case as such may be modified, amended or
supplemented from time to time.

“Yield Maintenance” shall mean an amount equal to the product of: (A) the all-in
effective yield (measured as a percentage per annum) on the Revolving Facility for the six months
prior to the Termination Date; (B) the greater of (i) the average outstanding principal amount of
the Revolving Facility for the sixth months prior to the Termination Date and (ii) the Minimum
Balance); and (C) the quotient of (i) the number of months remaining in the Term, and (ii) twelve.

4Exhibit 10.ac

    
      
        	
                Exhibit
                  (10.ac)

              

      

    

     

     

    THIRD
      AMENDMENT TO THE

    MET-PRO
      CORPORATION SALARIED PENSION PLAN

    Amended
      and Restated Effective September 1, 2000

    
 

    
      	
              This
                Third Amendment to the Met-Pro Corporation Salaried Pension Plan
                (the
                “Plan”) is made by Met-Pro Corporation (the “Company”) and is effective as
                of March 28, 2005.

              
 

              WITNESSETH

              

              WHEREAS,
                the Company maintains the Plan for the benefit of its eligible
                employees;

              

              WHEREAS,
                Section
                16.1 of the Plan permits the Company to amend the Plan; and 

              

              WHEREAS,
                the
                Company desires to amend the Plan, effective March 28, 2005, to eliminate
                the mandatory distribution of benefits with an Actuarial Equivalent
                present value not exceeding $5,000.

              

              NOW
                THEREFORE, the
                Plan is hereby amended, effective March 28, 2005, as follows:

              

              1.    Section
                8.1 is amended by deleting the following parenthetical
                phrase:

              

              “(if
                the Actuarial Equivalent present value of such benefit as of the
                Participant’s Annuity Starting Date or at the time of any prior
                distribution is in excess of $5,000)”

              

              2.    Section
                8.2 is deleted in its entirety and it is retitled “Reserved.”

              

              3.    The
                second sentence of Section 8.3 is amended to read as follows:

              

              A
                Participant’s Annuity Starting Date shall be the earliest of (a) the first
                day of the month coincident with or next following the day of the
                Participant’s Retirement, (b) the first day of the month coincident with
                or next following the Participant’s Normal Retirement Date if the
                Participant has a Separation from Service prior to that time, unless
                the
                Participant elects under Section 8.4 to commence to receive distribution
                prior to his Normal Retirement Date, and (c) effective for all
                Participants (except Participants that attained age 701⁄2 after January 1,
                1988 and before January 1, 2003, or Participants who are Five Percent
                Owners during the Plan Year ending with or within the calendar year
                in
                which they attain age 701⁄2 or subsequent Plan Year), the first day of April
                immediately following the calendar year in which the Participant
                retires
                or attains age 701⁄2, whichever occurs later.

              

              4.    The
                first sentence of Section 8.4 is amended to read as follows:

              

              A
                Participant who has a Separation from Service before his Normal Retirement
                Date with a Vested Interest may elect to have distribution of his
                Retirement Benefit commence before his Normal Retirement
                Date.

              

              

              IN
                WITNESS WHEREOF,
                the Company has caused this Third Amendment to be executed by its
                duly
                authorized officer this 31st
                day of August, 2005.

            

    

     

    
      	 	 	 	 	 	 	 
	
              ATTEST:

            	 	
              Met-Pro
                Corporation

            
	 	 	 	 	 	 	 
	
              By

            	/s/
              Gary J. Morgan	 	
              By

            	/s/
              Raymond J. De Hont
	 	 	 	 	 	 	 
	
              Title:

            	 	
              Vice
                President-Finance

            	 	Title:	 	
              President

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00121-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00121-of-00352.parquet"}]]